ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-71387,Metabolism of carbohydrates,5/30,295/10899,0.0011476344497933161,0.2036801760992852,0.16762196310563185,HK2/CD44/PFKFB3/PYGL/GYS1,5
R-HSA-8982491,Glycogen metabolism,2/30,27/10899,0.0024632642668274943,0.2036801760992852,0.16762196310563185,PYGL/GYS1,2
R-HSA-76002,"Platelet activation, signaling and aggregation",4/30,263/10899,0.005541969265686342,0.2036801760992852,0.16762196310563185,GNAI2/EGF/TGFB2/RHOB,4
R-HSA-194068,Bile acid and bile salt metabolism,2/30,45/10899,0.006737565152338411,0.2036801760992852,0.16762196310563185,ABCC3/ACOX2,2
R-HSA-418597,G alpha (z) signalling events,2/30,48/10899,0.00763761452988947,0.2036801760992852,0.16762196310563185,GNAI2/RGS19,2
R-HSA-8957322,Metabolism of steroids,3/30,154/10899,0.00849290313057599,0.2036801760992852,0.16762196310563185,ABCC3/SREBF1/ACOX2,3
R-HSA-9033241,Peroxisomal protein import,2/30,63/10899,0.012890520864076261,0.2036801760992852,0.16762196310563185,ACOX2/DDO,2
R-HSA-9614085,FOXO-mediated transcription,2/30,65/10899,0.013682205537174008,0.2036801760992852,0.16762196310563185,SREBF1/CDKN1A,2
R-HSA-70171,Glycolysis,2/30,71/10899,0.01618063584395105,0.2036801760992852,0.16762196310563185,HK2/PFKFB3,2
R-HSA-9009391,Extra-nuclear estrogen signaling,2/30,77/10899,0.018859235454500307,0.2036801760992852,0.16762196310563185,GNAI2/EGF,2
R-HSA-70326,Glucose metabolism,2/30,91/10899,0.0257755500011314,0.2036801760992852,0.16762196310563185,HK2/PFKFB3,2
R-HSA-877300,Interferon gamma signaling,2/30,92/10899,0.026303814142897543,0.2036801760992852,0.16762196310563185,CD44/GBP1,2
R-HSA-549127,Organic cation transport,1/30,10/10899,0.02719810134564271,0.2036801760992852,0.16762196310563185,SLC22A4,1
R-HSA-9702518,STAT5 activation downstream of FLT3 ITD mutants,1/30,10/10899,0.02719810134564271,0.2036801760992852,0.16762196310563185,CDKN1A,1
R-HSA-1296071,Potassium Channels,2/30,103/10899,0.0324007327430971,0.2036801760992852,0.16762196310563185,KCNMB1/KCNJ8,2
R-HSA-1475029,Reversible hydration of carbon dioxide,1/30,12/10899,0.032551245131799744,0.2036801760992852,0.16762196310563185,CA3,1
R-HSA-2160916,Hyaluronan uptake and degradation,1/30,12/10899,0.032551245131799744,0.2036801760992852,0.16762196310563185,CD44,1
R-HSA-9634600,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",1/30,12/10899,0.032551245131799744,0.2036801760992852,0.16762196310563185,PFKFB3,1
R-HSA-2219528,PI3K/AKT Signaling in Cancer,2/30,104/10899,0.03298032145064811,0.2036801760992852,0.16762196310563185,EGF/CDKN1A,2
R-HSA-179812,GRB2 events in EGFR signaling,1/30,13/10899,0.035217127619725286,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-8847993,ERBB2 Activates PTK6 Signaling,1/30,13/10899,0.035217127619725286,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-170670,Adenylate cyclase inhibitory pathway,1/30,14/10899,0.037875908271149505,0.2036801760992852,0.16762196310563185,GNAI2,1
R-HSA-180336,SHC1 events in EGFR signaling,1/30,14/10899,0.037875908271149505,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-198323,AKT phosphorylates targets in the cytosol,1/30,14/10899,0.037875908271149505,0.2036801760992852,0.16762196310563185,CDKN1A,1
R-HSA-3296469,Defects in cobalamin (B12) metabolism,1/30,14/10899,0.037875908271149505,0.2036801760992852,0.16762196310563185,TCN2,1
R-HSA-3322077,Glycogen synthesis,1/30,14/10899,0.037875908271149505,0.2036801760992852,0.16762196310563185,GYS1,1
R-HSA-6804116,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,1/30,14/10899,0.037875908271149505,0.2036801760992852,0.16762196310563185,CDKN1A,1
R-HSA-549132,Organic cation/anion/zwitterion transport,1/30,15/10899,0.04052760535446309,0.2036801760992852,0.16762196310563185,SLC22A4,1
R-HSA-5576893,Phase 2 - plateau phase,1/30,15/10899,0.04052760535446309,0.2036801760992852,0.16762196310563185,KCNE4,1
R-HSA-5637810,Constitutive Signaling by EGFRvIII,1/30,15/10899,0.04052760535446309,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-5637812,Signaling by EGFRvIII in Cancer,1/30,15/10899,0.04052760535446309,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-6785631,ERBB2 Regulates Cell Motility,1/30,15/10899,0.04052760535446309,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-1963640,GRB2 events in ERBB2 signaling,1/30,16/10899,0.0431722370927361,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-1963642,PI3K events in ERBB2 signaling,1/30,16/10899,0.0431722370927361,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-3229121,Glycogen storage diseases,1/30,16/10899,0.0431722370927361,0.2036801760992852,0.16762196310563185,GYS1,1
R-HSA-418457,cGMP effects,1/30,16/10899,0.0431722370927361,0.2036801760992852,0.16762196310563185,KCNMB1,1
R-HSA-70221,Glycogen breakdown (glycogenolysis),1/30,16/10899,0.0431722370927361,0.2036801760992852,0.16762196310563185,PYGL,1
R-HSA-9665348,Signaling by ERBB2 ECD mutants,1/30,16/10899,0.0431722370927361,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-9703648,Signaling by FLT3 ITD and TKD mutants,1/30,16/10899,0.0431722370927361,0.2036801760992852,0.16762196310563185,CDKN1A,1
R-HSA-180292,GAB1 signalosome,1/30,17/10899,0.04580982166383063,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-2142845,Hyaluronan metabolism,1/30,17/10899,0.04580982166383063,0.2036801760992852,0.16762196310563185,CD44,1
R-HSA-9617828,FOXO-mediated transcription of cell cycle genes,1/30,17/10899,0.04580982166383063,0.2036801760992852,0.16762196310563185,CDKN1A,1
R-HSA-9659787,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,1/30,17/10899,0.04580982166383063,0.2036801760992852,0.16762196310563185,CDKN1A,1
R-HSA-9661069,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",1/30,17/10899,0.04580982166383063,0.2036801760992852,0.16762196310563185,CDKN1A,1
R-HSA-9006931,Signaling by Nuclear Receptors,3/30,299/10899,0.04809467282293982,0.2036801760992852,0.16762196310563185,GNAI2/EGF/SREBF1,3
R-HSA-1368082,RORA activates gene expression,1/30,18/10899,0.048440377200504314,0.2036801760992852,0.16762196310563185,SREBF1,1
R-HSA-159418,Recycling of bile acids and salts,1/30,18/10899,0.048440377200504314,0.2036801760992852,0.16762196310563185,ABCC3,1
R-HSA-114608,Platelet degranulation ,2/30,129/10899,0.048741058655338725,0.2036801760992852,0.16762196310563185,EGF/TGFB2,2
R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,1/30,19/10899,0.05106392179052199,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-5637815,Signaling by Ligand-Responsive EGFR Variants in Cancer,1/30,19/10899,0.05106392179052199,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-9703465,Signaling by FLT3 fusion proteins,1/30,19/10899,0.05106392179052199,0.2036801760992852,0.16762196310563185,CDKN1A,1
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,2/30,134/10899,0.05216785116692019,0.2036801760992852,0.16762196310563185,EGF/TGFB2,2
R-HSA-5625900,RHO GTPases activate CIT,1/30,20/10899,0.05368047347676119,0.2036801760992852,0.16762196310563185,RHOB,1
R-HSA-5627117,RHO GTPases Activate ROCKs,1/30,20/10899,0.05368047347676119,0.2036801760992852,0.16762196310563185,RHOB,1
R-HSA-418594,G alpha (i) signalling events,3/30,318/10899,0.055921511607070554,0.2036801760992852,0.16762196310563185,GNAI2/CCR10/RGS19,3
R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,1/30,21/10899,0.056290050257320035,0.2036801760992852,0.16762196310563185,RHOB,1
R-HSA-901032,ER Quality Control Compartment (ERQC),1/30,21/10899,0.056290050257320035,0.2036801760992852,0.16762196310563185,AMFR,1
R-HSA-1250196,SHC1 events in ERBB2 signaling,1/30,22/10899,0.05889267008562349,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-196741,"Cobalamin (Cbl, vitamin B12) transport and metabolism",1/30,22/10899,0.05889267008562349,0.2036801760992852,0.16762196310563185,TCN2,1
R-HSA-3296482,Defects in vitamin and cofactor metabolism,1/30,22/10899,0.05889267008562349,0.2036801760992852,0.16762196310563185,TCN2,1
R-HSA-392154,Nitric oxide stimulates guanylate cyclase,1/30,22/10899,0.05889267008562349,0.2036801760992852,0.16762196310563185,KCNMB1,1
R-HSA-392170,ADP signalling through P2Y purinoceptor 12,1/30,22/10899,0.05889267008562349,0.2036801760992852,0.16762196310563185,GNAI2,1
R-HSA-9665686,Signaling by ERBB2 TMD/JMD mutants,1/30,22/10899,0.05889267008562349,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-8856828,Clathrin-mediated endocytosis,2/30,146/10899,0.06073272348281481,0.2036801760992852,0.16762196310563185,ACTR3/EGF,2
R-HSA-193368,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,1/30,24/10899,0.0640771104764406,0.2036801760992852,0.16762196310563185,ACOX2,1
R-HSA-3371571,HSF1-dependent transactivation,1/30,24/10899,0.0640771104764406,0.2036801760992852,0.16762196310563185,HSPB8,1
R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,1/30,24/10899,0.0640771104764406,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-1643713,Signaling by EGFR in Cancer,1/30,25/10899,0.06665896672340244,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-400685,Sema4D in semaphorin signaling,1/30,25/10899,0.06665896672340244,0.2036801760992852,0.16762196310563185,RHOB,1
R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,1/30,25/10899,0.06665896672340244,0.2036801760992852,0.16762196310563185,CDKN1A,1
R-HSA-9013507,NOTCH3 Activation and Transmission of Signal to the Nucleus,1/30,25/10899,0.06665896672340244,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-9664565,Signaling by ERBB2 KD Mutants,1/30,25/10899,0.06665896672340244,0.2036801760992852,0.16762196310563185,EGF,1
R-HSA-1227990,Signaling by ERBB2 in Cancer,1/30,26/10899,0.06923393738721484,0.20387827535880454,0.16778499216131285,EGF,1
R-HSA-901042,Calnexin/calreticulin cycle,1/30,26/10899,0.06923393738721484,0.20387827535880454,0.16778499216131285,AMFR,1
R-HSA-191273,Cholesterol biosynthesis,1/30,27/10899,0.07180204019953718,0.20387827535880454,0.16778499216131285,SREBF1,1
R-HSA-9609507,Protein localization,2/30,163/10899,0.07362861836985513,0.20387827535880454,0.16778499216131285,ACOX2/DDO,2
R-HSA-400042,"Adrenaline,noradrenaline inhibits insulin secretion",1/30,28/10899,0.07436329284799326,0.20387827535880454,0.16778499216131285,GNAI2,1
R-HSA-9682385,FLT3 signaling in disease,1/30,28/10899,0.07436329284799326,0.20387827535880454,0.16778499216131285,CDKN1A,1
R-HSA-9658195,Leishmania infection,2/30,164/10899,0.07441314630429499,0.20387827535880454,0.16778499216131285,ACTR3/GNAI2,2
R-HSA-390918,Peroxisomal lipid metabolism,1/30,29/10899,0.07691771297627625,0.20387827535880454,0.16778499216131285,ACOX2,1
R-HSA-8863795,Downregulation of ERBB2 signaling,1/30,29/10899,0.07691771297627625,0.20387827535880454,0.16778499216131285,EGF,1
R-HSA-9615017,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",1/30,29/10899,0.07691771297627625,0.20387827535880454,0.16778499216131285,SREBF1,1
R-HSA-9753281,Paracetamol ADME,1/30,29/10899,0.07691771297627625,0.20387827535880454,0.16778499216131285,ABCC3,1
R-HSA-182971,EGFR downregulation,1/30,31/10899,0.08200612602807256,0.21225114971971723,0.1746755873291453,EGF,1
R-HSA-389661,Glyoxylate metabolism and glycine degradation,1/30,31/10899,0.08200612602807256,0.21225114971971723,0.1746755873291453,DDO,1
R-HSA-392518,Signal amplification,1/30,33/10899,0.08706741962985398,0.22266353120087698,0.18324462854809015,GNAI2,1
R-HSA-192105,Synthesis of bile acids and bile salts,1/30,34/10899,0.08958794028244954,0.22266353120087698,0.18324462854809015,ACOX2,1
R-HSA-5663084,Diseases of carbohydrate metabolism,1/30,34/10899,0.08958794028244954,0.22266353120087698,0.18324462854809015,GYS1,1
R-HSA-114604,GPVI-mediated activation cascade,1/30,35/10899,0.09210173336036276,0.22266353120087698,0.18324462854809015,RHOB,1
R-HSA-1296065,Inwardly rectifying K+ channels,1/30,35/10899,0.09210173336036276,0.22266353120087698,0.18324462854809015,KCNJ8,1
R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,1/30,35/10899,0.09210173336036276,0.22266353120087698,0.18324462854809015,AMFR,1
R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,1/30,36/10899,0.09460881620270367,0.22380580176983667,0.184184678968478,ACTR3,1
R-HSA-9687139,Aberrant regulation of mitotic cell cycle due to RB1 defects,1/30,36/10899,0.09460881620270367,0.22380580176983667,0.184184678968478,CDKN1A,1
R-HSA-196854,Metabolism of vitamins and cofactors,2/30,190/10899,0.09572082304535329,0.2240274581912524,0.18436709477940388,TCN2/RETSAT,2
R-HSA-2129379,Molecules associated with elastic fibres,1/30,37/10899,0.09710920610548524,0.2248844772969132,0.18507239279937354,TGFB2,1
R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,1/30,38/10899,0.09960292032172868,0.22590353062660112,0.18591103955873395,CDKN1A,1
R-HSA-9675126,Diseases of mitotic cell cycle,1/30,38/10899,0.09960292032172868,0.22590353062660112,0.18591103955873395,CDKN1A,1
R-HSA-112316,Neuronal System,3/30,410/10899,0.10163655272872694,0.22816368979918292,0.18777107485865774,GNAI2/KCNMB1/KCNJ8,3
R-HSA-913531,Interferon Signaling,2/30,200/10899,0.10434116194598013,0.23186924876884474,0.19082062578105882,CD44/GBP1,2
R-HSA-2426168,Activation of gene expression by SREBF (SREBP),1/30,42/10899,0.10951136388271954,0.23308995310692776,0.1918252245664669,SREBF1,1
R-HSA-3928662,EPHB-mediated forward signaling,1/30,42/10899,0.10951136388271954,0.23308995310692776,0.1918252245664669,ACTR3,1
R-HSA-9660821,ADORA2B mediated anti-inflammatory cytokines production,1/30,43/10899,0.11197195696400519,0.23308995310692776,0.1918252245664669,GNAI2,1
R-HSA-977444,GABA B receptor activation,1/30,43/10899,0.11197195696400519,0.23308995310692776,0.1918252245664669,GNAI2,1
R-HSA-991365,Activation of GABAB receptors,1/30,43/10899,0.11197195696400519,0.23308995310692776,0.1918252245664669,GNAI2,1
R-HSA-1566948,Elastic fibre formation,1/30,44/10899,0.11442597697976453,0.23308995310692776,0.1918252245664669,TGFB2,1
R-HSA-6811438,Intra-Golgi traffic,1/30,44/10899,0.11442597697976453,0.23308995310692776,0.1918252245664669,RAB36,1
R-HSA-9749641,Aspirin ADME,1/30,44/10899,0.11442597697976453,0.23308995310692776,0.1918252245664669,ABCC3,1
R-HSA-975634,Retinoid metabolism and transport,1/30,44/10899,0.11442597697976453,0.23308995310692776,0.1918252245664669,RETSAT,1
R-HSA-9634597,GPER1 signaling,1/30,45/10899,0.11687344088493323,0.23589134857509458,0.19413067921012572,GNAI2,1
R-HSA-2173789,TGF-beta receptor signaling activates SMADs,1/30,46/10899,0.11931436559227138,0.2369417395368192,0.19499511579106654,TGFB2,1
R-HSA-69231,Cyclin D associated events in G1,1/30,47/10899,0.12174876797246437,0.2369417395368192,0.19499511579106654,CDKN1A,1
R-HSA-69236,G1 Phase,1/30,47/10899,0.12174876797246437,0.2369417395368192,0.19499511579106654,CDKN1A,1
R-HSA-9024446,NR1H2 and NR1H3-mediated signaling,1/30,47/10899,0.12174876797246437,0.2369417395368192,0.19499511579106654,SREBF1,1
R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,1/30,48/10899,0.12417666485422119,0.2369417395368192,0.19499511579106654,CDKN1A,1
R-HSA-6806667,Metabolism of fat-soluble vitamins,1/30,48/10899,0.12417666485422119,0.2369417395368192,0.19499511579106654,RETSAT,1
R-HSA-8939211,ESR-mediated signaling,2/30,223/10899,0.12493291721032286,0.2369417395368192,0.19499511579106654,GNAI2/EGF,2
R-HSA-9012852,Signaling by NOTCH3,1/30,49/10899,0.12659807302437842,0.2380476586783184,0.19590525020416635,EGF,1
R-HSA-1227986,Signaling by ERBB2,1/30,50/10899,0.12901300922799763,0.23851144563159227,0.19628693133317643,EGF,1
R-HSA-177929,Signaling by EGFR,1/30,50/10899,0.12901300922799763,0.23851144563159227,0.19628693133317643,EGF,1
R-HSA-1660499,Synthesis of PIPs at the plasma membrane,1/30,53/10899,0.13621915286574582,0.24791740586024003,0.2040277215691928,PLEKHA4,1
R-HSA-8848021,Signaling by PTK6,1/30,54/10899,0.13860836782186148,0.24791740586024003,0.2040277215691928,EGF,1
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,1/30,54/10899,0.13860836782186148,0.24791740586024003,0.2040277215691928,EGF,1
R-HSA-9662361,Sensory processing of sound by outer hair cells of the cochlea,1/30,54/10899,0.13860836782186148,0.24791740586024003,0.2040277215691928,KCNMB1,1
R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),1/30,55/10899,0.14099119391364046,0.250145666620975,0.20586150554453445,SREBF1,1
R-HSA-112040,G-protein mediated events,1/30,56/10899,0.14336764763759757,0.2507648982535088,0.20637111243829434,GNAI2,1
R-HSA-6798695,Neutrophil degranulation,3/30,482/10899,0.14520467898003483,0.2507648982535088,0.20637111243829434,RNASE3/CD44/PYGL,3
R-HSA-1236394,Signaling by ERBB4,1/30,58/10899,0.14810150376281295,0.2507648982535088,0.20637111243829434,EGF,1
R-HSA-5668914,Diseases of metabolism,2/30,249/10899,0.1492933719685593,0.2507648982535088,0.20637111243829434,TCN2/GYS1,2
R-HSA-380108,Chemokine receptors bind chemokines,1/30,59/10899,0.15045893895210527,0.2507648982535088,0.20637111243829434,CCR10,1
R-HSA-9664407,Parasite infection,1/30,59/10899,0.15045893895210527,0.2507648982535088,0.20637111243829434,ACTR3,1
R-HSA-9664417,Leishmania phagocytosis,1/30,59/10899,0.15045893895210527,0.2507648982535088,0.20637111243829434,ACTR3,1
R-HSA-9664422,FCGR3A-mediated phagocytosis,1/30,59/10899,0.15045893895210527,0.2507648982535088,0.20637111243829434,ACTR3,1
R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,1/30,60/10899,0.15281006734983915,0.2508822001266016,0.2064676479510788,CDKN1A,1
R-HSA-977443,GABA receptor activation,1/30,60/10899,0.15281006734983915,0.2508822001266016,0.2064676479510788,GNAI2,1
R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,1/30,61/10899,0.15515490524812336,0.25284503077471954,0.2080829918337405,ACTR3,1
R-HSA-373755,Semaphorin interactions,1/30,65/10899,0.1644716762704167,0.26209119299930633,0.21569227366450092,RHOB,1
R-HSA-8873719,RAB geranylgeranylation,1/30,65/10899,0.1644716762704167,0.26209119299930633,0.21569227366450092,RAB36,1
R-HSA-1257604,PIP3 activates AKT signaling,2/30,267/10899,0.16670076138413234,0.26209119299930633,0.21569227366450092,EGF/CDKN1A,2
R-HSA-69563,p53-Dependent G1 DNA Damage Response,1/30,66/10899,0.16678530463592223,0.26209119299930633,0.21569227366450092,CDKN1A,1
R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,1/30,66/10899,0.16678530463592223,0.26209119299930633,0.21569227366450092,CDKN1A,1
R-HSA-69615,G1/S DNA Damage Checkpoints,1/30,68/10899,0.17139399658976096,0.26742325709040715,0.22008038382559825,CDKN1A,1
R-HSA-9662360,Sensory processing of sound by inner hair cells of the cochlea,1/30,69/10899,0.17368909215825,0.2688553420077989,0.22125894174804506,KCNMB1,1
R-HSA-400253,Circadian Clock,1/30,70/10899,0.17597804204146839,0.2688553420077989,0.22125894174804506,SREBF1,1
R-HSA-9013026,RHOB GTPase cycle,1/30,70/10899,0.17597804204146839,0.2688553420077989,0.22125894174804506,RHOB,1
R-HSA-3000178,ECM proteoglycans,1/30,76/10899,0.18958356905472462,0.28497321557636923,0.2345234118618924,TGFB2,1
R-HSA-9659379,Sensory processing of sound,1/30,76/10899,0.18958356905472462,0.28497321557636923,0.2345234118618924,KCNMB1,1
R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,1/30,77/10899,0.19182994186525393,0.28497321557636923,0.2345234118618924,CDKN1A,1
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,1/30,78/10899,0.19407029501107176,0.28497321557636923,0.2345234118618924,EGF,1
R-HSA-422356,Regulation of insulin secretion,1/30,78/10899,0.19407029501107176,0.28497321557636923,0.2345234118618924,GNAI2,1
R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,1/30,79/10899,0.19630464406842962,0.28497321557636923,0.2345234118618924,GNAI2,1
R-HSA-9664433,Leishmania parasite growth and survival,1/30,79/10899,0.19630464406842962,0.28497321557636923,0.2345234118618924,GNAI2,1
R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,1/30,80/10899,0.19853300457470935,0.28497321557636923,0.2345234118618924,CDKN1A,1
R-HSA-416482,G alpha (12/13) signalling events,1/30,80/10899,0.19853300457470935,0.28497321557636923,0.2345234118618924,RHOB,1
R-HSA-1474244,Extracellular matrix organization,2/30,300/10899,0.19948125090345847,0.28497321557636923,0.2345234118618924,CD44/TGFB2,2
R-HSA-69202,Cyclin E associated events during G1/S transition ,1/30,83/10899,0.20518230957983485,0.28639015146980523,0.2356895026450072,CDKN1A,1
R-HSA-1483255,PI Metabolism,1/30,84/10899,0.20738687048151794,0.28639015146980523,0.2356895026450072,PLEKHA4,1
R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,1/30,84/10899,0.20738687048151794,0.28639015146980523,0.2356895026450072,SREBF1,1
R-HSA-9006925,Intracellular signaling by second messengers,2/30,309/10899,0.20857073731209405,0.28639015146980523,0.2356895026450072,EGF/CDKN1A,2
R-HSA-216083,Integrin cell surface interactions,1/30,85/10899,0.20958551993926655,0.28639015146980523,0.2356895026450072,CD44,1
R-HSA-425366,"Transport of bile salts and organic acids, metal ions and amine compounds",1/30,85/10899,0.20958551993926655,0.28639015146980523,0.2356895026450072,SLC22A4,1
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,1/30,85/10899,0.20958551993926655,0.28639015146980523,0.2356895026450072,CDKN1A,1
R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,1/30,86/10899,0.21177827325920606,0.28760012417916875,0.2366852696594116,ACTR3,1
R-HSA-418346,Platelet homeostasis,1/30,88/10899,0.21614615251914815,0.29173100340007724,0.24008484490341292,KCNMB1,1
R-HSA-3371556,Cellular response to heat stress,1/30,89/10899,0.21832130888067114,0.2928700484984613,0.2410222408695471,HSPB8,1
R-HSA-9616222,Transcriptional regulation of granulopoiesis,1/30,90/10899,0.22049062994760726,0.29398750659680967,0.2419418714576616,CDKN1A,1
R-HSA-111885,Opioid Signalling,1/30,92/10899,0.2248118266237369,0.29545574625655285,0.2431501835221392,GNAI2,1
R-HSA-2682334,EPH-Ephrin signaling,1/30,92/10899,0.2248118266237369,0.29545574625655285,0.2431501835221392,ACTR3,1
R-HSA-195258,RHO GTPase Effectors,2/30,327/10899,0.22688845477758843,0.29545574625655285,0.2431501835221392,ACTR3/RHOB,2
R-HSA-170834,Signaling by TGF-beta Receptor Complex,1/30,93/10899,0.2269637323516247,0.29545574625655285,0.2431501835221392,TGFB2,1
R-HSA-5625740,RHO GTPases activate PKNs,1/30,95/10899,0.23125023360179653,0.2975149204233639,0.24484481489386895,RHOB,1
R-HSA-6803157,Antimicrobial peptides,1/30,95/10899,0.23125023360179653,0.2975149204233639,0.24484481489386895,RNASE3,1
R-HSA-8878159,Transcriptional regulation by RUNX3,1/30,96/10899,0.233384859017564,0.298515517348047,0.2456682726500674,CDKN1A,1
R-HSA-382556,ABC-family proteins mediated transport,1/30,103/10899,0.24816761849209246,0.3155888790072852,0.25971907746054096,ABCC3,1
R-HSA-2187338,Visual phototransduction,1/30,105/10899,0.25234040013004133,0.3177803204908179,0.2615225604039267,RETSAT,1
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1/30,106/10899,0.2544183867889349,0.3177803204908179,0.2615225604039267,EGF,1
R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,1/30,106/10899,0.2544183867889349,0.3177803204908179,0.2615225604039267,EGF,1
R-HSA-163685,Integration of energy metabolism,1/30,108/10899,0.25855762439934726,0.3177803204908179,0.2615225604039267,GNAI2,1
R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,1/30,108/10899,0.25855762439934726,0.3177803204908179,0.2615225604039267,CDKN1A,1
R-HSA-9748784,Drug ADME,1/30,108/10899,0.25855762439934726,0.3177803204908179,0.2615225604039267,ABCC3,1
R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),1/30,112/10899,0.2667695611376859,0.3260516858349495,0.2683296170507718,CDKN1A,1
R-HSA-199418,Negative regulation of the PI3K/AKT network,1/30,113/10899,0.2688087669563448,0.3267288880132368,0.2688869317620896,EGF,1
R-HSA-1989781,PPARA activates gene expression,1/30,117/10899,0.2769109048707503,0.3347274674261817,0.27546949472393906,SREBF1,1
R-HSA-400206,Regulation of lipid metabolism by PPARalpha,1/30,119/10899,0.28092936102068233,0.3377292864729514,0.2779398912600366,SREBF1,1
R-HSA-8878166,Transcriptional regulation by RUNX2,1/30,121/10899,0.2849262256173716,0.3406726610642486,0.2803621899667501,CDKN1A,1
R-HSA-9006936,Signaling by TGFB family members,1/30,122/10899,0.28691659611574605,0.3411981142998061,0.2807946203807017,TGFB2,1
R-HSA-1630316,Glycosaminoglycan metabolism,1/30,124/10899,0.29088128327063745,0.34221327443604405,0.2816300631722468,CD44,1
R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,1/30,124/10899,0.29088128327063745,0.34221327443604405,0.2816300631722468,TCN2,1
R-HSA-69206,G1/S Transition,1/30,131/10899,0.3045905769187577,0.3564357815006739,0.2933347101345259,CDKN1A,1
R-HSA-5576891,Cardiac conduction,1/30,132/10899,0.30652801030401333,0.35680509135916894,0.29363863977883764,KCNE4,1
R-HSA-202733,Cell surface interactions at the vascular wall,1/30,137/10899,0.31613717346986636,0.3660535692808979,0.3012498273507868,CD44,1
R-HSA-1474228,Degradation of the extracellular matrix,1/30,140/10899,0.321840753887241,0.36877586382913025,0.3034901845866527,CD44,1
R-HSA-5663220,RHO GTPases Activate Formins,1/30,140/10899,0.321840753887241,0.36877586382913025,0.3034901845866527,RHOB,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,2/30,433/10899,0.3358825655886518,0.3828713182875824,0.315090271509398,EGF/CDKN1A,2
R-HSA-453279,Mitotic G1 phase and G1/S transition,1/30,149/10899,0.33867694711026053,0.38406664105287275,0.3160739821104982,CDKN1A,1
R-HSA-418555,G alpha (s) signalling events,1/30,157/10899,0.35330267629962697,0.3985978912098356,0.3280327142970896,GNAI2,1
R-HSA-69242,S Phase,1/30,163/10899,0.36406627023697113,0.4086458135312941,0.33630181783436647,CDKN1A,1
R-HSA-8978868,Fatty acid metabolism,1/30,177/10899,0.3885121337979561,0.4338714184545703,0.35706164580950284,ACOX2,1
R-HSA-69275,G2/M Transition,1/30,196/10899,0.42024008611324437,0.4658343377137948,0.38336605783144834,CDKN1A,1
R-HSA-2559583,Cellular Senescence,1/30,197/10899,0.42186512558036593,0.4658343377137948,0.38336605783144834,CDKN1A,1
R-HSA-453274,Mitotic G2-G2/M phases,1/30,198/10899,0.4234857615579952,0.4658343377137948,0.38336605783144834,CDKN1A,1
R-HSA-375276,Peptide ligand-binding receptors,1/30,201/10899,0.4283213636293609,0.46823460459138494,0.38534139707999143,CCR10,1
R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,1/30,202/10899,0.4299245005793625,0.46823460459138494,0.38534139707999143,RAB36,1
R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,1/30,205/10899,0.43470787989528414,0.4688026155733456,0.3858088510938539,GNAI2,1
R-HSA-397014,Muscle contraction,1/30,205/10899,0.43470787989528414,0.4688026155733456,0.3858088510938539,KCNE4,1
R-HSA-1483257,Phospholipid metabolism,1/30,212/10899,0.44571869860104274,0.4783322619133142,0.39365143085689014,PLEKHA4,1
R-HSA-416476,G alpha (q) signalling events,1/30,216/10899,0.4519172078392759,0.48263002778951797,0.39718834822869425,RGS19,1
R-HSA-157118,Signaling by NOTCH,1/30,236/10899,0.4819181698336412,0.5121835621420342,0.421509917169521,EGF,1
R-HSA-425407,SLC-mediated transmembrane transport,1/30,250/10899,0.5019676418205046,0.5309273134639952,0.4369353967263502,SLC22A4,1
R-HSA-112315,Transmission across Chemical Synapses,1/30,270/10899,0.5293137429148536,0.5571723609630037,0.45853419179730454,GNAI2,1
R-HSA-5673001,RAF/MAP kinase cascade,1/30,280/10899,0.5424367229233826,0.5682670430625913,0.4676647435730417,EGF,1
R-HSA-5684996,MAPK1/MAPK3 signaling,1/30,286/10899,0.5501399904370448,0.5736056772329378,0.47205826068930756,EGF,1
R-HSA-69620,Cell Cycle Checkpoints,1/30,293/10899,0.5589687386147577,0.5800618985624844,0.4773715146064466,CDKN1A,1
R-HSA-446203,Asparagine N-linked glycosylation,1/30,304/10899,0.5725050441616,0.5913197639227793,0.4866363607402777,AMFR,1
R-HSA-5683057,MAPK family signaling cascades,1/30,325/10899,0.5972404311652142,0.6139854899829305,0.5052894941486318,EGF,1
R-HSA-373076,Class A/1 (Rhodopsin-like receptors),1/30,335/10899,0.6085272674847652,0.6226790644030156,0.5124440147240129,CCR10,1
R-HSA-3700989,Transcriptional Regulation by TP53,1/30,362/10899,0.6374956409350458,0.6493011157671764,0.5343530713490638,CDKN1A,1
R-HSA-71291,Metabolism of amino acids and derivatives,1/30,374/10899,0.6496948782764631,0.6586768351189949,0.542068974356302,DDO,1
R-HSA-9012999,RHO GTPase cycle,1/30,449/10899,0.7174189729407687,0.7240007983805923,0.5958284082366597,RHOB,1
R-HSA-500792,GPCR ligand binding,1/30,467/10899,0.7316816434313662,0.735022655501829,0.6048990274943283,CCR10,1
R-HSA-449147,Signaling by Interleukins,1/30,473/10899,0.7362793060162635,0.7362793060162635,0.6059332087789345,CDKN1A,1
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,5/26,161/4383,0.002209121255870161,0.048013479812712936,0.04013510696418728,CD44/TGFB2/RETSAT/CDKN1A/RHOB,5
HALLMARK_ESTROGEN_RESPONSE_EARLY,HALLMARK_ESTROGEN_RESPONSE_EARLY,5/26,200/4383,0.005648644683848581,0.048013479812712936,0.04013510696418728,RETREG1/CD44/AMFR/TIPARP/HSPB8,5
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,5/26,200/4383,0.005648644683848581,0.048013479812712936,0.04013510696418728,HK2/PFKFB3/TIPARP/CDKN1A/GYS1,5
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,5/26,200/4383,0.005648644683848581,0.048013479812712936,0.04013510696418728,CD44/PFKFB3/TIPARP/CDKN1A/RHOB,5
HALLMARK_ESTROGEN_RESPONSE_LATE,HALLMARK_ESTROGEN_RESPONSE_LATE,4/26,200/4383,0.0285874936239555,0.13885354045921242,0.11606952298448099,CD44/AMFR/HSPB8/ACOX2,4
HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,4/26,200/4383,0.0285874936239555,0.13885354045921242,0.11606952298448099,HK2/CD44/PYGL/GYS1,4
HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,4/26,200/4383,0.0285874936239555,0.13885354045921242,0.11606952298448099,TGFB2/ABCC3/RETSAT/ACOX2,4
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,3/26,199/4383,0.1115862331368119,0.29514660717714886,0.24671697813569718,HK2/CD44/RHOB,3
HALLMARK_ADIPOGENESIS,HALLMARK_ADIPOGENESIS,3/26,200/4383,0.11285017333243927,0.29514660717714886,0.24671697813569718,PFKFB3/HSPB8/RETSAT,3
HALLMARK_KRAS_SIGNALING_DN,HALLMARK_KRAS_SIGNALING_DN,3/26,200/4383,0.11285017333243927,0.29514660717714886,0.24671697813569718,EGF/KCNMB1/TGFB2,3
HALLMARK_MTORC1_SIGNALING,HALLMARK_MTORC1_SIGNALING,3/26,200/4383,0.11285017333243927,0.29514660717714886,0.24671697813569718,ACTR3/HK2/CDKN1A,3
HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,3/26,200/4383,0.11285017333243927,0.29514660717714886,0.24671697813569718,AEBP1/HSPB8/CDKN1A,3
HALLMARK_P53_PATHWAY,HALLMARK_P53_PATHWAY,3/26,200/4383,0.11285017333243927,0.29514660717714886,0.24671697813569718,TCN2/RETSAT/CDKN1A,3
HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,2/26,105/4383,0.12752057236796746,0.30969281860792097,0.2588763499199339,ACTR3/CDKN1A,2
HALLMARK_ANGIOGENESIS,HALLMARK_ANGIOGENESIS,1/26,36/4383,0.19349944000450103,0.438598730676869,0.3666305179032651,KCNJ8,1
HALLMARK_MYC_TARGETS_V2,HALLMARK_MYC_TARGETS_V2,1/26,58/4383,0.29344313401945044,0.5680483697272656,0.47483919450885975,HK2,1
HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,2/26,200/4383,0.334146099839568,0.5680483697272656,0.47483919450885975,GNAI2/LAP3,2
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,2/26,200/4383,0.334146099839568,0.5680483697272656,0.47483919450885975,CD44/RHOB,2
HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,2/26,200/4383,0.334146099839568,0.5680483697272656,0.47483919450885975,SLC22A4/ERMAP,2
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,2/26,200/4383,0.334146099839568,0.5680483697272656,0.47483919450885975,LAP3/CDKN1A,2
HALLMARK_IL6_JAK_STAT3_SIGNALING,HALLMARK_IL6_JAK_STAT3_SIGNALING,1/26,87/4383,0.4071318346999746,0.6591658276094827,0.5510054905713943,CD44,1
HALLMARK_INTERFERON_ALPHA_RESPONSE,HALLMARK_INTERFERON_ALPHA_RESPONSE,1/26,97/4383,0.4420870868454755,0.6832254978520984,0.5711172892262124,LAP3,1
HALLMARK_PEROXISOME,HALLMARK_PEROXISOME,1/26,104/4383,0.4653673964145112,0.6879344120910165,0.5750535333268559,RETSAT,1
HALLMARK_BILE_ACID_METABOLISM,HALLMARK_BILE_ACID_METABOLISM,1/26,112/4383,0.49082998963133595,0.6953424853110592,0.581246040352898,RETSAT,1
HALLMARK_SPERMATOGENESIS,HALLMARK_SPERMATOGENESIS,1/26,135/4383,0.5577055168087406,0.7041439926408339,0.5886033375016259,PACRG,1
HALLMARK_COAGULATION,HALLMARK_COAGULATION,1/26,138/4383,0.565779027601834,0.7041439926408339,0.5886033375016259,ACOX2,1
HALLMARK_FATTY_ACID_METABOLISM,HALLMARK_FATTY_ACID_METABOLISM,1/26,158/4383,0.6160919211359842,0.7041439926408339,0.5886033375016259,RETSAT,1
HALLMARK_UV_RESPONSE_UP,HALLMARK_UV_RESPONSE_UP,1/26,158/4383,0.6160919211359842,0.7041439926408339,0.5886033375016259,RHOB,1
HALLMARK_ALLOGRAFT_REJECTION,HALLMARK_ALLOGRAFT_REJECTION,1/26,200/4383,0.7041439926408339,0.7041439926408339,0.5886033375016259,TGFB2,1
HALLMARK_APICAL_JUNCTION,HALLMARK_APICAL_JUNCTION,1/26,200/4383,0.7041439926408339,0.7041439926408339,0.5886033375016259,GNAI2,1
HALLMARK_E2F_TARGETS,HALLMARK_E2F_TARGETS,1/26,200/4383,0.7041439926408339,0.7041439926408339,0.5886033375016259,CDKN1A,1
HALLMARK_G2M_CHECKPOINT,HALLMARK_G2M_CHECKPOINT,1/26,200/4383,0.7041439926408339,0.7041439926408339,0.5886033375016259,EGF,1
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,1/26,200/4383,0.7041439926408339,0.7041439926408339,0.5886033375016259,CDKN1A,1
HALLMARK_OXIDATIVE_PHOSPHORYLATION,HALLMARK_OXIDATIVE_PHOSPHORYLATION,1/26,200/4383,0.7041439926408339,0.7041439926408339,0.5886033375016259,RETSAT,1
WP_AMPACTIVATED_PROTEIN_KINASE_AMPK_SIGNALING,WP_AMPACTIVATED_PROTEIN_KINASE_AMPK_SIGNALING,4/46,68/21728,1.2965093703431767e-5,0.013155836485327213,0.009655572186327269,PFKFB3/SREBF1/CDKN1A/GYS1,4
BOQUEST_STEM_CELL_UP,BOQUEST_STEM_CELL_UP,6/46,262/21728,1.814598135907202e-5,0.013155836485327213,0.009655572186327269,CD44/AEBP1/HSPB8/TGFB2/SCARA3/ACOX2,6
DELASERNA_MYOD_TARGETS_UP,DELASERNA_MYOD_TARGETS_UP,4/46,86/21728,3.2880105716550074e-5,0.015892051096332536,0.011663784869976185,HSPB8/CDKN1A/RHOB/GYS1,4
HUANG_FOXA2_TARGETS_DN,HUANG_FOXA2_TARGETS_DN,3/46,38/21728,7.112190048735166e-5,0.024084313465425947,0.01767639993723821,CD44/CDKN1A/ACOX2,3
WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,3/46,40/21728,8.304935677733085e-5,0.024084313465425947,0.01767639993723821,HK2/PYGL/GYS1,3
HALMOS_CEBPA_TARGETS_DN,HALMOS_CEBPA_TARGETS_DN,3/46,45/21728,1.1839784957322218e-4,0.027621219578780717,0.020272270776150493,SH3BP2/RHOB/MTMR11,3
KEGG_STARCH_AND_SUCROSE_METABOLISM,KEGG_STARCH_AND_SUCROSE_METABOLISM,3/46,52/21728,1.824947451239945e-4,0.027621219578780717,0.020272270776150493,HK2/PYGL/GYS1,3
KEGG_INSULIN_SIGNALING_PATHWAY,KEGG_INSULIN_SIGNALING_PATHWAY,4/46,137/21728,2.009902801661242e-4,0.027621219578780717,0.020272270776150493,HK2/PYGL/SREBF1/GYS1,4
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,5/46,266/21728,2.4087844703247195e-4,0.027621219578780717,0.020272270776150493,AMFR/SREBF1/RHOB/ACOX2/KCNJ8,5
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,5/46,274/21728,2.7616450293383387e-4,0.027621219578780717,0.020272270776150493,HK2/AEBP1/KCNE4/PACRG/MTMR11,5
WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,3/46,60/21728,2.792504860210199e-4,0.027621219578780717,0.020272270776150493,TGFB2/SREBF1/CDKN1A,3
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,3/46,63/21728,3.226237900496737e-4,0.027621219578780717,0.020272270776150493,PFKFB3/CDKN1A/RHOB,3
BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,5/46,286/21728,3.3630492943845843e-4,0.027621219578780717,0.020272270776150493,HK2/GBP1/LAP3/PLEKHA4/HSPB8,5
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,5/46,293/21728,3.7569390760237544e-4,0.027621219578780717,0.020272270776150493,HK2/CD44/PFKFB3/PYGL/GYS1,5
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,4/46,162/21728,3.8071384360452095e-4,0.027621219578780717,0.020272270776150493,CD44/TCN2/CDKN1A/RHOB,4
ENK_UV_RESPONSE_EPIDERMIS_UP,ENK_UV_RESPONSE_EPIDERMIS_UP,5/46,296/21728,3.936050579759646e-4,0.027621219578780717,0.020272270776150493,HK2/PYGL/SH3BP2/MTMR11/GYS1,5
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,4/46,164/21728,3.988179255906527e-4,0.027621219578780717,0.020272270776150493,CD44/TIPARP/TGFB2/CDKN1A,4
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,4/46,169/21728,4.467631878811169e-4,0.027621219578780717,0.020272270776150493,AEBP1/TGFB2/ABCC3/SCARA3,4
SMID_BREAST_CANCER_LUMINAL_B_UP,SMID_BREAST_CANCER_LUMINAL_B_UP,4/46,169/21728,4.467631878811169e-4,0.027621219578780717,0.020272270776150493,RETREG1/SREBF1/KCNE4/ACOX2,4
SA_MMP_CYTOKINE_CONNECTION,SA_MMP_CYTOKINE_CONNECTION,2/46,15/21728,4.523956708208773e-4,0.027621219578780717,0.020272270776150493,CD44/TGFB2,2
VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP,VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP,2/46,15/21728,4.523956708208773e-4,0.027621219578780717,0.020272270776150493,HK2/PFKFB3,2
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,4/46,172/21728,4.7743030010827237e-4,0.027621219578780717,0.020272270776150493,HK2/PFKFB3/TIPARP/GYS1,4
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,5/46,309/21728,4.787999427885334e-4,0.027621219578780717,0.020272270776150493,EGF/PFKFB3/SREBF1/CDKN1A/GYS1,5
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,5/46,316/21728,5.300772776502961e-4,0.027621219578780717,0.020272270776150493,AMFR/CA3/TGFB2/CDKN1A/RHOB,5
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,3/46,75/21728,5.389400825515497e-4,0.027621219578780717,0.020272270776150493,HK2/CD44/HSPB8,3
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,6/46,491/21728,5.621049699376225e-4,0.027621219578780717,0.020272270776150493,AEBP1/HSPB8/TGFB2/ABCC3/ACOX2/KCNJ8,6
FRIDMAN_SENESCENCE_UP,FRIDMAN_SENESCENCE_UP,3/46,77/21728,5.821110849156938e-4,0.027621219578780717,0.020272270776150493,CD44/CDKN1A/RHOB,3
HE_PTEN_TARGETS_UP,HE_PTEN_TARGETS_UP,2/46,17/21728,5.843817869819651e-4,0.027621219578780717,0.020272270776150493,TGFB2/CDKN1A,2
LE_SKI_TARGETS_UP,LE_SKI_TARGETS_UP,2/46,17/21728,5.843817869819651e-4,0.027621219578780717,0.020272270776150493,CD44/HSPB8,2
MATTHEWS_AP1_TARGETS,MATTHEWS_AP1_TARGETS,2/46,17/21728,5.843817869819651e-4,0.027621219578780717,0.020272270776150493,CD44/CA3,2
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,4/46,182/21728,5.905226254773808e-4,0.027621219578780717,0.020272270776150493,SLC22A4/GBP1/TCN2/CDKN1A,4
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,5/46,329/21728,6.361649328214024e-4,0.028826223518469796,0.021156669311922296,EGF/SREBF1/RETSAT/RHOB/ACOX2,5
VERRECCHIA_RESPONSE_TO_TGFB1_C1,VERRECCHIA_RESPONSE_TO_TGFB1_C1,2/46,19/21728,7.32795535681591e-4,0.03219859171934263,0.023631779476047485,CD44/RHOB,2
WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,3/46,89/21728,8.878297312939762e-4,0.03543996552619758,0.026010747838102186,EGF/TGFB2/CDKN1A,3
MOOTHA_GLYCOGEN_METABOLISM,MOOTHA_GLYCOGEN_METABOLISM,2/46,21/21728,8.975016558209415e-4,0.03543996552619758,0.026010747838102186,PYGL/GYS1,2
WP_FOXA2_PATHWAY,WP_FOXA2_PATHWAY,2/46,21/21728,8.975016558209415e-4,0.03543996552619758,0.026010747838102186,ABCC3/SREBF1,2
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,4/46,204/21728,9.043301548064212e-4,0.03543996552619758,0.026010747838102186,HK2/GBP1/LAP3/PLEKHA4,4
ELVIDGE_HIF1A_TARGETS_DN,ELVIDGE_HIF1A_TARGETS_DN,3/46,92/21728,9.77428079627324e-4,0.037296597775253154,0.02737340134357963,HK2/PFKFB3/GYS1,3
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,2/46,23/21728,0.0010783656936940184,0.04009308348349556,0.02942584929351289,MTMR11/RGS19,2
RIGGINS_TAMOXIFEN_RESISTANCE_DN,RIGGINS_TAMOXIFEN_RESISTANCE_DN,4/46,221/21728,0.0012162173740167773,0.04398736396192866,0.03228401086425399,RETREG1/LAP3/PYGL/ACOX2,4
MENSE_HYPOXIA_UP,MENSE_HYPOXIA_UP,3/46,100/21728,0.0012437806361648793,0.04398736396192866,0.03228401086425399,HK2/PFKFB3/TIPARP,3
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,2/46,25/21728,0.0012752539988143449,0.044026626149542863,0.03231282688725069,CD44/PFKFB3,2
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,2/46,26/21728,0.0013796657044229713,0.04511774219607594,0.0331136387370111,CD44/TGFB2,2
HOEGERKORP_CD44_TARGETS_DIRECT_UP,HOEGERKORP_CD44_TARGETS_DIRECT_UP,2/46,26/21728,0.0013796657044229713,0.04511774219607594,0.0331136387370111,PYGL/SH3BP2,2
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,3/46,105/21728,0.001431321476565168,0.04511774219607594,0.0331136387370111,HK2/PFKFB3/GYS1,3
LE_EGR2_TARGETS_DN,LE_EGR2_TARGETS_DN,3/46,105/21728,0.001431321476565168,0.04511774219607594,0.0331136387370111,TIPARP/CA3/CDKN1A,3
REACTOME_GLYCOGEN_METABOLISM,REACTOME_GLYCOGEN_METABOLISM,2/46,27/21728,0.001488033719761394,0.04541779671912082,0.0333338602417649,PYGL/GYS1,2
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,5/46,399/21728,0.0015034856844950342,0.04541779671912082,0.0333338602417649,HK2/CD44/RASSF8/HSPB8/CDKN1A,5
SENESE_HDAC1_AND_HDAC2_TARGETS_DN,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,4/46,238/21728,0.001596796349338424,0.0464099053147585,0.03406200673192076,EGF/TGFB2/ABCC3/SCARA3,4
BIOCARTA_G1_PATHWAY,BIOCARTA_G1_PATHWAY,2/46,28/21728,0.0016003415625778792,0.0464099053147585,0.03406200673192076,TGFB2/CDKN1A,2
DOANE_BREAST_CANCER_ESR1_UP,DOANE_BREAST_CANCER_ESR1_UP,3/46,111/21728,0.0016787061599485209,0.04772792023383049,0.03502934835310535,RHOB/KCNE4/ACOX2,3
WINTER_HYPOXIA_METAGENE,WINTER_HYPOXIA_METAGENE,4/46,243/21728,0.0017228875073308308,0.04804205549287893,0.03525990424922004,HK2/EGF/PFKFB3/CDKN1A,4
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,3/46,114/21728,0.0018118073894277673,0.04956831537113703,0.036380084820486054,CD44/CDKN1A/RHOB,3
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,3/46,118/21728,0.0019992852496975968,0.0536845113344725,0.039401118663631,TGFB2/CDKN1A/RHOB,3
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,5/46,428/21728,0.002043867713386351,0.053883785171094704,0.0395473733633225,CD44/PFKFB3/AEBP1/TGFB2/RHOB,5
KASLER_HDAC7_TARGETS_2_DN,KASLER_HDAC7_TARGETS_2_DN,2/46,33/21728,0.00222040476267078,0.05567511879630563,0.040862101708214145,CDKN1A/ACOX2,2
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,4/46,261/21728,0.0022342438195621234,0.05567511879630563,0.040862101708214145,GNAI2/EGF/TGFB2/RHOB,4
MARKEY_RB1_CHRONIC_LOF_DN,MARKEY_RB1_CHRONIC_LOF_DN,3/46,123/21728,0.0022500799276936505,0.05567511879630563,0.040862101708214145,CA3/TGFB2/RHOB,3
RICKMAN_METASTASIS_DN,RICKMAN_METASTASIS_DN,4/46,262/21728,0.0022654013855048496,0.05567511879630563,0.040862101708214145,ACTR3/CD44/GBP1/CDKN1A,4
KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM,KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM,2/46,34/21728,0.0023560082019710364,0.05693686488096671,0.041788145477065226,HK2/PFKFB3,2
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,5/46,445/21728,0.002420217455403128,0.05752975918581206,0.04222329331169219,CD44/TIPARP/CHI3L2/ABCC3/CDKN1A,5
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,3/46,130/21728,0.002632756749585214,0.05886278291777222,0.04320165047540306,TGFB2/CDKN1A/RHOB,3
HEIDENBLAD_AMPLICON_12P11_12_UP,HEIDENBLAD_AMPLICON_12P11_12_UP,2/46,36/21728,0.002638676475624272,0.05886278291777222,0.04320165047540306,ACTR3/RASSF8,2
SEMENZA_HIF1_TARGETS,SEMENZA_HIF1_TARGETS,2/46,36/21728,0.002638676475624272,0.05886278291777222,0.04320165047540306,HK2/CDKN1A,2
WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,2/46,36/21728,0.002638676475624272,0.05886278291777222,0.04320165047540306,TGFB2/CDKN1A,2
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,3/46,133/21728,0.00280831139882697,0.06169775042877434,0.045282341694004254,HK2/PFKFB3/GYS1,3
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,3/46,134/21728,0.0028683958454999115,0.06207722352201301,0.04556085152867888,EGF/TGFB2/RHOB,3
GEISS_RESPONSE_TO_DSRNA_UP,GEISS_RESPONSE_TO_DSRNA_UP,2/46,39/21728,0.003091091742906391,0.06455932181516841,0.04738255851552468,CD44/GBP1,2
NEWMAN_ERCC6_TARGETS_DN,NEWMAN_ERCC6_TARGETS_DN,2/46,39/21728,0.003091091742906391,0.06455932181516841,0.04738255851552468,AEBP1/CDKN1A,2
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,3/46,138/21728,0.0031166569152150264,0.06455932181516841,0.04738255851552468,SH3BP2/ABCC3/RHOB,3
PIONTEK_PKD1_TARGETS_UP,PIONTEK_PKD1_TARGETS_UP,2/46,41/21728,0.003411457793185839,0.0683433247450453,0.05015978317041074,EGF/ACOX2,2
WP_BLADDER_CANCER,WP_BLADDER_CANCER,2/46,41/21728,0.003411457793185839,0.0683433247450453,0.05015978317041074,EGF/CDKN1A,2
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,3/46,143/21728,0.003445062316366697,0.0683433247450453,0.05015978317041074,HK2/CD44/PFKFB3,3
KEGG_BLADDER_CANCER,KEGG_BLADDER_CANCER,2/46,42/21728,0.0035772200309395824,0.0683433247450453,0.05015978317041074,EGF/CDKN1A,2
BROWNE_HCMV_INFECTION_24HR_DN,BROWNE_HCMV_INFECTION_24HR_DN,3/46,145/21728,0.0035821328831885818,0.0683433247450453,0.05015978317041074,CD44/CDKN1A/MTMR11,3
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,3/46,145/21728,0.0035821328831885818,0.0683433247450453,0.05015978317041074,GNAI2/CA3/RHOB,3
KATSANOU_ELAVL1_TARGETS_DN,KATSANOU_ELAVL1_TARGETS_DN,3/46,147/21728,0.003722503418534421,0.07009909034902481,0.051448406782478466,CD44/FHL3/AEBP1,3
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,2/46,45/21728,0.004096634686759603,0.07519139614938511,0.055185845014176664,ABCC3/ACOX2,2
SAGIV_CD24_TARGETS_DN,SAGIV_CD24_TARGETS_DN,2/46,45/21728,0.004096634686759603,0.07519139614938511,0.055185845014176664,HSPB8/CDKN1A,2
REACTOME_METABOLISM_OF_STEROIDS,REACTOME_METABOLISM_OF_STEROIDS,3/46,153/21728,0.004163659530507128,0.0754663289904417,0.05538762875450929,ABCC3/SREBF1/ACOX2,3
BURTON_ADIPOGENESIS_PEAK_AT_2HR,BURTON_ADIPOGENESIS_PEAK_AT_2HR,2/46,46/21728,0.0042770966886628075,0.07563158778733013,0.055508918513967886,HK2/RHOB,2
KHETCHOUMIAN_TRIM24_TARGETS_UP,KHETCHOUMIAN_TRIM24_TARGETS_UP,2/46,46/21728,0.0042770966886628075,0.07563158778733013,0.055508918513967886,CD44/CDKN1A,2
AMIT_EGF_RESPONSE_60_HELA,AMIT_EGF_RESPONSE_60_HELA,2/46,47/21728,0.0044611946015965746,0.07724191412715155,0.0566907986806172,TIPARP/RHOB,2
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,3/46,157/21728,0.004474703990814296,0.07724191412715155,0.0566907986806172,EGF/TIPARP/ABCC3,3
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,3/46,159/21728,0.004635376940524443,0.07838283391106012,0.05752816340042234,SLC22A4/PFKFB3/CDKN1A,3
REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS,REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS,2/46,48/21728,0.004648912907828393,0.07838283391106012,0.05752816340042234,GNAI2/RGS19,2
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,4/46,324/21728,0.004838734966976489,0.08023039398261163,0.05888415848741949,CD44/GBP1/CHI3L2/FNDC4,4
NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,2/46,50/21728,0.005035148863736316,0.08023039398261163,0.05888415848741949,RAB36/CA3,2
ROY_WOUND_BLOOD_VESSEL_UP,ROY_WOUND_BLOOD_VESSEL_UP,2/46,50/21728,0.005035148863736316,0.08023039398261163,0.05888415848741949,GBP1/KCNJ8,2
WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,2/46,50/21728,0.005035148863736316,0.08023039398261163,0.05888415848741949,CD44/CDKN1A,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,2/46,50/21728,0.005035148863736316,0.08023039398261163,0.05888415848741949,HK2/RHOB,2
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,4/46,329/21728,0.0051065944476917004,0.08048436901253223,0.05907056048760078,CD44/SREBF1/RETSAT/RHOB,4
TAVOR_CEBPA_TARGETS_UP,TAVOR_CEBPA_TARGETS_UP,2/46,51/21728,0.005233635712061353,0.08159969658590281,0.059889142104063695,GBP1/KCNMB1,2
GENTILE_RESPONSE_CLUSTER_D3,GENTILE_RESPONSE_CLUSTER_D3,2/46,53/21728,0.005641270495419804,0.0861036022985128,0.06319473097916256,TIPARP/RHOB,2
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,2/46,53/21728,0.005641270495419804,0.0861036022985128,0.06319473097916256,TCN2/CDKN1A,2
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,2/46,54/21728,0.005850387908067717,0.0875715428060256,0.06427210873095598,CD44/RHOB,2
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,3/46,173/21728,0.00585823424288585,0.0875715428060256,0.06427210873095598,PFKFB3/TIPARP/TGFB2,3
LAU_APOPTOSIS_CDKN2A_UP,LAU_APOPTOSIS_CDKN2A_UP,2/46,55/21728,0.006063018396837867,0.08880178460015058,0.06517503029455697,CDKN1A/RHOB,2
WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,WP_NRP1TRIGGERED_SIGNALING_PATHWAYS_IN_PANCREATIC_CANCER,2/46,55/21728,0.006063018396837867,0.08880178460015058,0.06517503029455697,EGF/TGFB2,2
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,2/46,56/21728,0.0062791468159568275,0.09014616715977623,0.06616172413686663,HK2/LAP3,2
PID_TXA2PATHWAY,PID_TXA2PATHWAY,2/46,56/21728,0.0062791468159568275,0.09014616715977623,0.06616172413686663,GNAI2/EGF,2
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,3/46,182/21728,0.0067371970393305045,0.09577387948067874,0.07029211771685386,GBP1/HSPB8/RHOB,3
BARIS_THYROID_CANCER_DN,BARIS_THYROID_CANCER_DN,2/46,59/21728,0.006948368886220887,0.09781684354388628,0.07179152727612997,CD44/ABCC3,2
CHANG_IMMORTALIZED_BY_HPV31_DN,CHANG_IMMORTALIZED_BY_HPV31_DN,2/46,60/21728,0.007178338486227781,0.10008260389452195,0.07345445556251302,GBP1/CDKN1A,2
MASSARWEH_RESPONSE_TO_ESTRADIOL,MASSARWEH_RESPONSE_TO_ESTRADIOL,2/46,62/21728,0.007648531479450629,0.10562257757336582,0.07752045439322892,AMFR/TIPARP,2
REACTOME_PEROXISOMAL_PROTEIN_IMPORT,REACTOME_PEROXISOMAL_PROTEIN_IMPORT,2/46,63/21728,0.007888725174185079,0.10690328507073238,0.07846041466897309,ACOX2/DDO,2
WP_ENDOMETRIAL_CANCER,WP_ENDOMETRIAL_CANCER,2/46,63/21728,0.007888725174185079,0.10690328507073238,0.07846041466897309,EGF/CDKN1A,2
RIGGI_EWING_SARCOMA_PROGENITOR_DN,RIGGI_EWING_SARCOMA_PROGENITOR_DN,3/46,194/21728,0.008025469466082008,0.10694701556268713,0.07849251015163461,CD44/CHI3L2/SCARA3,3
KIM_GERMINAL_CENTER_T_HELPER_UP,KIM_GERMINAL_CENTER_T_HELPER_UP,2/46,64/21728,0.008132297277289372,0.10694701556268713,0.07849251015163461,ACTR3/CHI3L2,2
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,4/46,378/21728,0.008275154600934129,0.10694701556268713,0.07849251015163461,RASSF8/GBP1/LAP3/PLEKHA4,4
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,2/46,65/21728,0.008379233052259015,0.10694701556268713,0.07849251015163461,KCNMB1/SH3BP2,2
KEGG_GLIOMA,KEGG_GLIOMA,2/46,65/21728,0.008379233052259015,0.10694701556268713,0.07849251015163461,EGF/CDKN1A,2
PID_RB_1PATHWAY,PID_RB_1PATHWAY,2/46,65/21728,0.008379233052259015,0.10694701556268713,0.07849251015163461,TGFB2/CDKN1A,2
GAJATE_RESPONSE_TO_TRABECTEDIN_UP,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,2/46,66/21728,0.008629517807471995,0.10694701556268713,0.07849251015163461,CD44/CDKN1A,2
KYNG_RESPONSE_TO_H2O2,KYNG_RESPONSE_TO_H2O2,2/46,66/21728,0.008629517807471995,0.10694701556268713,0.07849251015163461,AEBP1/RAB36,2
PID_HIF1_TFPATHWAY,PID_HIF1_TFPATHWAY,2/46,66/21728,0.008629517807471995,0.10694701556268713,0.07849251015163461,HK2/PFKFB3,2
REACTOME_FOXO_MEDIATED_TRANSCRIPTION,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,2/46,66/21728,0.008629517807471995,0.10694701556268713,0.07849251015163461,SREBF1/CDKN1A,2
SHEPARD_BMYB_MORPHOLINO_DN,SHEPARD_BMYB_MORPHOLINO_DN,3/46,202/21728,0.008959702018137347,0.1093098123715883,0.08022665721065392,AEBP1/PYGL/TCN2,3
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,4/46,387/21728,0.008970943222220005,0.1093098123715883,0.08022665721065392,RASSF8/TCN2/RHOB/GYS1,4
WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,2/46,68/21728,0.009140075715849008,0.11038139997957469,0.081013136391542645,ACTR3/CDKN1A,2
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,4/46,390/21728,0.009211137515536922,0.11038139997957469,0.081013136391542645,CD44/GBP1/SREBF1/TCN2,4
ENGELMANN_CANCER_PROGENITORS_DN,ENGELMANN_CANCER_PROGENITORS_DN,2/46,69/21728,0.009400319709127131,0.11172511129700279,0.08199933758349896,CD44/ABCC3,2
KEGG_PANCREATIC_CANCER,KEGG_PANCREATIC_CANCER,2/46,70/21728,0.00966385436264349,0.11336346777929353,0.0832017901450931,EGF/TGFB2,2
MIKKELSEN_MEF_ICP_WITH_H3K27ME3,MIKKELSEN_MEF_ICP_WITH_H3K27ME3,3/46,208/21728,0.009700597201097602,0.11336346777929353,0.0832017901450931,EGF/CA3/ABCC3,3
BAE_BRCA1_TARGETS_UP,BAE_BRCA1_TARGETS_UP,2/46,71/21728,0.009930665207434377,0.11336346777929353,0.0832017901450931,TGFB2/MTMR11,2
KEGG_MELANOMA,KEGG_MELANOMA,2/46,71/21728,0.009930665207434377,0.11336346777929353,0.0832017901450931,EGF/CDKN1A,2
REACTOME_GLYCOLYSIS,REACTOME_GLYCOLYSIS,2/46,72/21728,0.01020073781871878,0.11336346777929353,0.0832017901450931,HK2/PFKFB3,2
WP_NONSMALL_CELL_LUNG_CANCER,WP_NONSMALL_CELL_LUNG_CANCER,2/46,72/21728,0.01020073781871878,0.11336346777929353,0.0832017901450931,EGF/CDKN1A,2
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,2/46,72/21728,0.01020073781871878,0.11336346777929353,0.0832017901450931,RASSF8/HSPB8,2
FURUKAWA_DUSP6_TARGETS_PCI35_UP,FURUKAWA_DUSP6_TARGETS_PCI35_UP,2/46,73/21728,0.010474057815782775,0.11336346777929353,0.0832017901450931,KCNMB1/TGFB2,2
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,2/46,73/21728,0.010474057815782775,0.11336346777929353,0.0832017901450931,EGF/AEBP1,2
KEGG_CHRONIC_MYELOID_LEUKEMIA,KEGG_CHRONIC_MYELOID_LEUKEMIA,2/46,73/21728,0.010474057815782775,0.11336346777929353,0.0832017901450931,TGFB2/CDKN1A,2
WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,2/46,73/21728,0.010474057815782775,0.11336346777929353,0.0832017901450931,AMFR/SREBF1,2
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,3/46,214/21728,0.010476348056845056,0.11336346777929353,0.0832017901450931,PACRG/MTMR11/HSPB6,3
WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,2/46,74/21728,0.010750610861864083,0.11546952407187348,0.08474750550756013,TGFB2/CDKN1A,2
REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,2/46,75/21728,0.011030382664037022,0.11760334457980648,0.08631359809087794,GNAI2/EGF,2
FOSTER_TOLERANT_MACROPHAGE_DN,FOSTER_TOLERANT_MACROPHAGE_DN,4/46,414/21728,0.011285537713864844,0.1180170540359108,0.08661723530330731,PFKFB3/TIPARP/PLEKHA4/CDKN1A,4
BRUECKNER_TARGETS_OF_MIRLET7A3_DN,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,2/46,76/21728,0.011313358973097655,0.1180170540359108,0.08661723530330731,ACTR3/TGFB2,2
SANA_RESPONSE_TO_IFNG_UP,SANA_RESPONSE_TO_IFNG_UP,2/46,76/21728,0.011313358973097655,0.1180170540359108,0.08661723530330731,GBP1/LAP3,2
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,3/46,222/21728,0.011565437148995364,0.11928590139008013,0.0875484909657866,CD44/TIPARP/CDKN1A,3
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,2/46,77/21728,0.011599525583449172,0.11928590139008013,0.0875484909657866,GBP1/RHOB,2
RODWELL_AGING_KIDNEY_NO_BLOOD_UP,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,3/46,223/21728,0.01170600290291423,0.11953312823398332,0.0877299402138346,AEBP1/MICALL2/ABCC3,3
KEGG_PEROXISOME,KEGG_PEROXISOME,2/46,78/21728,0.01188886833298768,0.12055146211770724,0.0884773344471884,ACOX2/DDO,2
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,2/46,79/21728,0.012181373102988141,0.12181373102988141,0.08940376193917249,CD44/RHOB,2
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,2/46,79/21728,0.012181373102988141,0.12181373102988141,0.08940376193917249,GNAI2/CD44,2
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,3/46,228/21728,0.012423682124232808,0.12338588411053132,0.09055762528910864,CD44/TIPARP/HSPB8,3
FALVELLA_SMOKERS_WITH_LUNG_CANCER,FALVELLA_SMOKERS_WITH_LUNG_CANCER,2/46,81/21728,0.01277581244568687,0.12516843274490513,0.0918659059928124,MICALL2/RHOB,2
HARRIS_HYPOXIA,HARRIS_HYPOXIA,2/46,81/21728,0.01277581244568687,0.12516843274490513,0.0918659059928124,HK2/CDKN1A,2
WARTERS_RESPONSE_TO_IR_SKIN,WARTERS_RESPONSE_TO_IR_SKIN,2/46,82/21728,0.013077718996807054,0.12689128472320382,0.09313037303459823,MICALL2/CDKN1A,2
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,4/46,433/21728,0.013126684626538326,0.12689128472320382,0.09313037303459823,PYGL/ABCC3/RETSAT/RHOB,4
SANA_TNF_SIGNALING_UP,SANA_TNF_SIGNALING_UP,2/46,83/21728,0.013382731525006861,0.12765890971319935,0.09369376241019567,GBP1/RHOB,2
STEIN_ESR1_TARGETS,STEIN_ESR1_TARGETS,2/46,83/21728,0.013382731525006861,0.12765890971319935,0.09369376241019567,TIPARP/HSPB8,2
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,3/46,235/21728,0.013470215990427241,0.12765890971319935,0.09369376241019567,GNAI2/FHL3/AEBP1,3
HINATA_NFKB_TARGETS_KERATINOCYTE_UP,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,2/46,84/21728,0.013690836126754825,0.1280755637664161,0.0939995607752063,GBP1/CDKN1A,2
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,2/46,84/21728,0.013690836126754825,0.1280755637664161,0.0939995607752063,CD44/CDKN1A,2
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,3/46,238/21728,0.013933730131842757,0.1295122351998205,0.0950539889560933,CD44/RAB36/CDKN1A,3
HUMMERICH_SKIN_CANCER_PROGRESSION_UP,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,2/46,87/21728,0.014633563977807502,0.1334507406781187,0.09794460894778806,CD44/CDKN1A,2
KEGG_ERBB_SIGNALING_PATHWAY,KEGG_ERBB_SIGNALING_PATHWAY,2/46,87/21728,0.014633563977807502,0.1334507406781187,0.09794460894778806,EGF/CDKN1A,2
WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,2/46,87/21728,0.014633563977807502,0.1334507406781187,0.09794460894778806,HK2/TGFB2,2
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,3/46,244/21728,0.014887891127129446,0.13425467919346168,0.0985346502102285,HSPB8/CDKN1A/RHOB,3
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,4/46,452/21728,0.01515047572865485,0.13425467919346168,0.0985346502102285,CD44/CA3/TCN2/HSPB6,4
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,4/46,453/21728,0.015262160881038449,0.13425467919346168,0.0985346502102285,PFKFB3/TIPARP/GBP1/CHI3L2,4
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,2/46,89/21728,0.015277256597876675,0.13425467919346168,0.0985346502102285,AEBP1/CHI3L2,2
KEGG_PROSTATE_CANCER,KEGG_PROSTATE_CANCER,2/46,89/21728,0.015277256597876675,0.13425467919346168,0.0985346502102285,EGF/CDKN1A,2
WALLACE_PROSTATE_CANCER_RACE_DN,WALLACE_PROSTATE_CANCER_RACE_DN,2/46,89/21728,0.015277256597876675,0.13425467919346168,0.0985346502102285,RETREG1/PYGL,2
BILD_E2F3_ONCOGENIC_SIGNATURE,BILD_E2F3_ONCOGENIC_SIGNATURE,3/46,248/21728,0.015544168799757948,0.13548056810006082,0.09943437702298474,RETREG1/PFKFB3/SREBF1,3
KEGG_GAP_JUNCTION,KEGG_GAP_JUNCTION,2/46,90/21728,0.015603624050144937,0.13548056810006082,0.09943437702298474,GNAI2/EGF,2
WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,WP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,2/46,91/21728,0.015932987440593734,0.1367031466796504,0.10033167425998298,CDKN1A/RHOB,2
WP_ERBB_SIGNALING_PATHWAY,WP_ERBB_SIGNALING_PATHWAY,2/46,91/21728,0.015932987440593734,0.1367031466796504,0.10033167425998298,EGF/CDKN1A,2
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,4/46,461/21728,0.01617452115017348,0.13792241605875805,0.10122654274802496,PFKFB3/MICALL2/CDKN1A/RHOB,4
REACTOME_GLUCOSE_METABOLISM,REACTOME_GLUCOSE_METABOLISM,2/46,92/21728,0.016265333204170777,0.13792241605875805,0.10122654274802496,HK2/PFKFB3,2
DE_YY1_TARGETS_DN,DE_YY1_TARGETS_DN,2/46,93/21728,0.01660064781763464,0.13913837766225565,0.10211898353287874,EGF/TGFB2,2
REACTOME_INTERFERON_GAMMA_SIGNALING,REACTOME_INTERFERON_GAMMA_SIGNALING,2/46,93/21728,0.01660064781763464,0.13913837766225565,0.10211898353287874,CD44/GBP1,2
MASSARWEH_TAMOXIFEN_RESISTANCE_DN,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,3/46,257/21728,0.017080062113260148,0.14233385094383458,0.10446426374171813,CD44/AMFR/TIPARP,3
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,2/46,95/21728,0.017280129709652235,0.14236470499429396,0.10448690871087564,KCNMB1/TGFB2,2
HECKER_IFNB1_TARGETS,HECKER_IFNB1_TARGETS,2/46,95/21728,0.017280129709652235,0.14236470499429396,0.10448690871087564,GBP1/LAP3,2
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,4/46,474/21728,0.017729440525033374,0.1452411794423638,0.10659806346005794,GNAI2/AMFR/CHI3L2/CDKN1A,4
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,3/46,262/21728,0.017968926527133212,0.14637608687833234,0.10743101548747296,HSPB6/GYS1/KCNJ8,3
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,4/46,480/21728,0.018477669474157698,0.14832044870877273,0.10885805709224626,KCNMB1/AEBP1/PLEKHA4/CDKN1A,4
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,3/46,265/21728,0.018514483597439905,0.14832044870877273,0.10885805709224626,CCR10/EGF/TGFB2,3
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,3/46,265/21728,0.018514483597439905,0.14832044870877273,0.10885805709224626,SLC22A4/CA3/DDO,3
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,3/46,266/21728,0.018698378406594912,0.14841826457946158,0.10892984790550683,PYGL/TGFB2/ABCC3,3
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,4/46,482/21728,0.01873140856416653,0.14841826457946158,0.10892984790550683,HK2/CD44/LAP3/CDKN1A,4
PID_CXCR4_PATHWAY,PID_CXCR4_PATHWAY,2/46,100/21728,0.019029850686033616,0.14982884597024018,0.10996512760501838,GNAI2/RHOB,2
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,4/46,485/21728,0.019116094141030646,0.14982884597024018,0.10996512760501838,SH3BP2/PRUNE2/MTMR11/HSPB6,4
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,2/46,102/21728,0.01974986680418025,0.15282989027690908,0.11216770894370603,TIPARP/CDKN1A,2
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,2/46,102/21728,0.01974986680418025,0.15282989027690908,0.11216770894370603,GBP1/TGFB2,2
REACTOME_POTASSIUM_CHANNELS,REACTOME_POTASSIUM_CHANNELS,2/46,103/21728,0.0201141352583292,0.15282989027690908,0.11216770894370603,KCNMB1/KCNJ8,2
WIELAND_UP_BY_HBV_INFECTION,WIELAND_UP_BY_HBV_INFECTION,2/46,103/21728,0.0201141352583292,0.15282989027690908,0.11216770894370603,GBP1/LAP3,2
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,4/46,497/21728,0.020704081894430484,0.15282989027690908,0.11216770894370603,AEBP1/RAB36/ABCC3/ACOX2,4
PID_ERBB1_DOWNSTREAM_PATHWAY,PID_ERBB1_DOWNSTREAM_PATHWAY,2/46,105/21728,0.020851127604053842,0.15282989027690908,0.11216770894370603,ACTR3/EGF,2
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,2/46,105/21728,0.020851127604053842,0.15282989027690908,0.11216770894370603,EGF/CDKN1A,2
WOO_LIVER_CANCER_RECURRENCE_UP,WOO_LIVER_CANCER_RECURRENCE_UP,2/46,105/21728,0.020851127604053842,0.15282989027690908,0.11216770894370603,HK2/TGFB2,2
CHEN_HOXA5_TARGETS_6HR_UP,CHEN_HOXA5_TARGETS_6HR_UP,1/46,10/21728,0.020974584941451657,0.15282989027690908,0.11216770894370603,TIPARP,1
MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,1/46,10/21728,0.020974584941451657,0.15282989027690908,0.11216770894370603,CDKN1A,1
REACTOME_ORGANIC_CATION_TRANSPORT,REACTOME_ORGANIC_CATION_TRANSPORT,1/46,10/21728,0.020974584941451657,0.15282989027690908,0.11216770894370603,SLC22A4,1
REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,1/46,10/21728,0.020974584941451657,0.15282989027690908,0.11216770894370603,CDKN1A,1
TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,1/46,10/21728,0.020974584941451657,0.15282989027690908,0.11216770894370603,HSPB8,1
WP_LIVER_X_RECEPTOR_PATHWAY,WP_LIVER_X_RECEPTOR_PATHWAY,1/46,10/21728,0.020974584941451657,0.15282989027690908,0.11216770894370603,SREBF1,1
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,4/46,500/21728,0.02111347239117811,0.15307267483604128,0.11234589782884773,AEBP1/MICALL2/CHI3L2/RGS19,4
MACAEVA_PBMC_RESPONSE_TO_IR,MACAEVA_PBMC_RESPONSE_TO_IR,2/46,106/21728,0.02122382547600028,0.1531071987074647,0.11237123622014288,RETSAT/CDKN1A,2
BHAT_ESR1_TARGETS_VIA_AKT1_UP,BHAT_ESR1_TARGETS_VIA_AKT1_UP,3/46,281/21728,0.021579616097462378,0.15490318485802201,0.11368937923155009,HK2/TIPARP/HSPB8,3
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,2/46,108/21728,0.021977559871358437,0.15621304810524378,0.11465073802860362,RETREG1/ACOX2,2
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,2/46,108/21728,0.021977559871358437,0.15621304810524378,0.11465073802860362,RETREG1/ABCC3,2
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,3/46,286/21728,0.02259129164800845,0.15690101653723412,0.11515566440591193,AEBP1/CDKN1A/RHOB,3
GROSS_HYPOXIA_VIA_HIF1A_DN,GROSS_HYPOXIA_VIA_HIF1A_DN,2/46,110/21728,0.02274232660810227,0.15690101653723412,0.11515566440591193,PFKFB3/GYS1,2
WP_BURN_WOUND_HEALING,WP_BURN_WOUND_HEALING,2/46,110/21728,0.02274232660810227,0.15690101653723412,0.11515566440591193,EGF/TGFB2,2
AGARWAL_AKT_PATHWAY_TARGETS,AGARWAL_AKT_PATHWAY_TARGETS,1/46,11/21728,0.023048218291331635,0.15690101653723412,0.11515566440591193,EGF,1
BIOCARTA_EGFR_SMRTE_PATHWAY,BIOCARTA_EGFR_SMRTE_PATHWAY,1/46,11/21728,0.023048218291331635,0.15690101653723412,0.11515566440591193,EGF,1
BIOCARTA_EPONFKB_PATHWAY,BIOCARTA_EPONFKB_PATHWAY,1/46,11/21728,0.023048218291331635,0.15690101653723412,0.11515566440591193,CDKN1A,1
BIOCARTA_MONOCYTE_PATHWAY,BIOCARTA_MONOCYTE_PATHWAY,1/46,11/21728,0.023048218291331635,0.15690101653723412,0.11515566440591193,CD44,1
KORKOLA_CHORIOCARCINOMA_DN,KORKOLA_CHORIOCARCINOMA_DN,1/46,11/21728,0.023048218291331635,0.15690101653723412,0.11515566440591193,RASSF8,1
WHITESIDE_CISPLATIN_RESISTANCE_UP,WHITESIDE_CISPLATIN_RESISTANCE_UP,1/46,11/21728,0.023048218291331635,0.15690101653723412,0.11515566440591193,CDKN1A,1
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,3/46,289/21728,0.02321061507761977,0.1572681862735919,0.11542514433582678,RETREG1/AEBP1/RHOB,3
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,2/46,113/21728,0.02390993836702156,0.15804102978015144,0.1159923637805685,GNAI2/CD44,2
CERVERA_SDHB_TARGETS_2,CERVERA_SDHB_TARGETS_2,2/46,114/21728,0.02430454784876435,0.15804102978015144,0.1159923637805685,PFKFB3/TGFB2,2
REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,3/46,295/21728,0.02447698433399209,0.15804102978015144,0.1159923637805685,GNAI2/EGF/SREBF1,3
MARZEC_IL2_SIGNALING_UP,MARZEC_IL2_SIGNALING_UP,2/46,115/21728,0.0247018390273825,0.15804102978015144,0.1159923637805685,HK2/RHOB,2
BIOCARTA_CBL_PATHWAY,BIOCARTA_CBL_PATHWAY,1/46,12/21728,0.025117554846039725,0.15804102978015144,0.1159923637805685,EGF,1
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,1/46,12/21728,0.025117554846039725,0.15804102978015144,0.1159923637805685,KCNJ8,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,1/46,12/21728,0.025117554846039725,0.15804102978015144,0.1159923637805685,RHOB,1
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,1/46,12/21728,0.025117554846039725,0.15804102978015144,0.1159923637805685,CDKN1A,1
REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION,REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION,1/46,12/21728,0.025117554846039725,0.15804102978015144,0.1159923637805685,CD44,1
REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM,REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM,1/46,12/21728,0.025117554846039725,0.15804102978015144,0.1159923637805685,PFKFB3,1
REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE,REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE,1/46,12/21728,0.025117554846039725,0.15804102978015144,0.1159923637805685,CA3,1
WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,1/46,12/21728,0.025117554846039725,0.15804102978015144,0.1159923637805685,CDKN1A,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,3/46,300/21728,0.025560525706654593,0.15804102978015144,0.1159923637805685,TIPARP/GBP1/SREBF1,3
BURTON_ADIPOGENESIS_5,BURTON_ADIPOGENESIS_5,2/46,118/21728,0.025909677026365062,0.15804102978015144,0.1159923637805685,HK2/GYS1,2
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,3/46,303/21728,0.026222966349651815,0.15804102978015144,0.1159923637805685,MICALL2/PLEKHA4/GYS1,3
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,3/46,303/21728,0.026222966349651815,0.15804102978015144,0.1159923637805685,AMFR/GBP1/HSPB8,3
RODRIGUES_DCC_TARGETS_DN,RODRIGUES_DCC_TARGETS_DN,2/46,119/21728,0.02631756947015741,0.15804102978015144,0.1159923637805685,CD44/TGFB2,2
CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,CDKN1A,1
COLLIS_PRKDC_REGULATORS,COLLIS_PRKDC_REGULATORS,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,TIPARP,1
GRANDVAUX_IRF3_TARGETS_UP,GRANDVAUX_IRF3_TARGETS_UP,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,GBP1,1
KORKOLA_EMBRYONAL_CARCINOMA_DN,KORKOLA_EMBRYONAL_CARCINOMA_DN,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,RASSF8,1
KORKOLA_SEMINOMA_DN,KORKOLA_SEMINOMA_DN,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,RASSF8,1
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,CDKN1A,1
RAY_ALZHEIMERS_DISEASE,RAY_ALZHEIMERS_DISEASE,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,EGF,1
REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,EGF,1
TSAI_DNAJB4_TARGETS_UP,TSAI_DNAJB4_TARGETS_UP,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,CDKN1A,1
WACKER_HYPOXIA_TARGETS_OF_VHL,WACKER_HYPOXIA_TARGETS_OF_VHL,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,HK2,1
WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,WP_MAMMARY_GLAND_DEVELOPMENT_PATHWAY_PUBERTY_STAGE_2_OF_4,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,EGF,1
WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,SREBF1,1
WP_VITAMIN_B12_DISORDERS,WP_VITAMIN_B12_DISORDERS,1/46,13/21728,0.027182603311552755,0.15804102978015144,0.1159923637805685,TCN2,1
WP_CELL_CYCLE,WP_CELL_CYCLE,2/46,122/21728,0.027556912042147424,0.15804102978015144,0.1159923637805685,TGFB2/CDKN1A,2
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,3/46,309/21728,0.027575539723852106,0.15804102978015144,0.1159923637805685,AMFR/TIPARP/HSPB8,3
KARLSSON_TGFB1_TARGETS_UP,KARLSSON_TGFB1_TARGETS_UP,2/46,123/21728,0.027975206787840875,0.15804102978015144,0.1159923637805685,ACTR3/CD44,2
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,3/46,314/21728,0.028730861990688486,0.15804102978015144,0.1159923637805685,GNAI2/CCR10/RGS19,3
KEGG_CELL_CYCLE,KEGG_CELL_CYCLE,2/46,125/21728,0.028819493371572365,0.15804102978015144,0.1159923637805685,TGFB2/CDKN1A,2
RASHI_RESPONSE_TO_IONIZING_RADIATION_2,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,2/46,125/21728,0.028819493371572365,0.15804102978015144,0.1159923637805685,TGFB2/CDKN1A,2
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,3/46,315/21728,0.02896499725185886,0.15804102978015144,0.1159923637805685,HK2/SH3BP2/CDKN1A,3
ELLWOOD_MYC_TARGETS_UP,ELLWOOD_MYC_TARGETS_UP,1/46,14/21728,0.0292433723766079,0.15804102978015144,0.1159923637805685,RGS19,1
FARMER_BREAST_CANCER_CLUSTER_6,FARMER_BREAST_CANCER_CLUSTER_6,1/46,14/21728,0.0292433723766079,0.15804102978015144,0.1159923637805685,RHOB,1
LIM_MAMMARY_LUMINAL_PROGENITOR_DN,LIM_MAMMARY_LUMINAL_PROGENITOR_DN,1/46,14/21728,0.0292433723766079,0.15804102978015144,0.1159923637805685,HSPB8,1
OZANNE_AP1_TARGETS_UP,OZANNE_AP1_TARGETS_UP,1/46,14/21728,0.0292433723766079,0.15804102978015144,0.1159923637805685,CD44,1
PID_S1P_S1P4_PATHWAY,PID_S1P_S1P4_PATHWAY,1/46,14/21728,0.0292433723766079,0.15804102978015144,0.1159923637805685,GNAI2,1
REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY,REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY,1/46,14/21728,0.0292433723766079,0.15804102978015144,0.1159923637805685,GNAI2,1
REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,1/46,14/21728,0.0292433723766079,0.15804102978015144,0.1159923637805685,CDKN1A,1
REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM,REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM,1/46,14/21728,0.0292433723766079,0.15804102978015144,0.1159923637805685,TCN2,1
REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,1/46,14/21728,0.0292433723766079,0.15804102978015144,0.1159923637805685,EGF,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST,1/46,14/21728,0.0292433723766079,0.15804102978015144,0.1159923637805685,CDKN1A,1
STEINER_ERYTHROCYTE_MEMBRANE_GENES,STEINER_ERYTHROCYTE_MEMBRANE_GENES,1/46,14/21728,0.0292433723766079,0.15804102978015144,0.1159923637805685,ERMAP,1
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,2/46,126/21728,0.02924546076400902,0.15804102978015144,0.1159923637805685,CD44/ABCC3,2
MATTIOLI_MGUS_VS_PCL,MATTIOLI_MGUS_VS_PCL,2/46,127/21728,0.029673961323518277,0.15804102978015144,0.1159923637805685,ACTR3/RNASE3,2
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,2/46,128/21728,0.03010498292278659,0.15804102978015144,0.1159923637805685,CD44/LAP3,2
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,3/46,321/21728,0.030391277642265846,0.15804102978015144,0.1159923637805685,TGFB2/ABCC3/SREBF1,3
BIOCARTA_ERYTH_PATHWAY,BIOCARTA_ERYTH_PATHWAY,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,TGFB2,1
HUMMEL_BURKITTS_LYMPHOMA_DN,HUMMEL_BURKITTS_LYMPHOMA_DN,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,CD44,1
IBRAHIM_NRF3_DOWN,IBRAHIM_NRF3_DOWN,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,CDKN1A,1
PID_ERBB_NETWORK_PATHWAY,PID_ERBB_NETWORK_PATHWAY,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,EGF,1
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,RGS19,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII,REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,EGF,1
REACTOME_ERBB2_REGULATES_CELL_MOTILITY,REACTOME_ERBB2_REGULATES_CELL_MOTILITY,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,EGF,1
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,PYGL,1
REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT,REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,SLC22A4,1
REACTOME_PHASE_2_PLATEAU_PHASE,REACTOME_PHASE_2_PLATEAU_PHASE,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,KCNE4,1
SA_G1_AND_S_PHASES,SA_G1_AND_S_PHASES,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,CDKN1A,1
SANCHEZ_MDM2_TARGETS,SANCHEZ_MDM2_TARGETS,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,CDKN1A,1
SCHAVOLT_TARGETS_OF_TP53_AND_TP63,SCHAVOLT_TARGETS_OF_TP53_AND_TP63,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,CDKN1A,1
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,GBP1,1
WP_CODEINE_AND_MORPHINE_METABOLISM,WP_CODEINE_AND_MORPHINE_METABOLISM,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,ABCC3,1
WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,1/46,15/21728,0.03129987071273532,0.15804102978015144,0.1159923637805685,EGF,1
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,3/46,325/21728,0.03136255059774839,0.15804102978015144,0.1159923637805685,EGF/TGFB2/CDKN1A,3
WP_ADIPOGENESIS,WP_ADIPOGENESIS,2/46,131/21728,0.0314130532555958,0.15804102978015144,0.1159923637805685,SREBF1/CDKN1A,2
XU_GH1_AUTOCRINE_TARGETS_DN,XU_GH1_AUTOCRINE_TARGETS_DN,2/46,131/21728,0.0314130532555958,0.15804102978015144,0.1159923637805685,RETREG1/CD44,2
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,2/46,132/21728,0.03185403849950641,0.15804102978015144,0.1159923637805685,EGF/TGFB2,2
WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,2/46,132/21728,0.03185403849950641,0.15804102978015144,0.1159923637805685,SREBF1/GYS1,2
QI_HYPOXIA,QI_HYPOXIA,2/46,133/21728,0.032297484714783976,0.15804102978015144,0.1159923637805685,HK2/CDKN1A,2
SENESE_HDAC2_TARGETS_DN,SENESE_HDAC2_TARGETS_DN,2/46,133/21728,0.032297484714783976,0.15804102978015144,0.1159923637805685,EGF/SCARA3,2
AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,CDKN1A,1
BIOCARTA_P53_PATHWAY,BIOCARTA_P53_PATHWAY,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,CDKN1A,1
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,CD44,1
INGA_TP53_TARGETS,INGA_TP53_TARGETS,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,CDKN1A,1
KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,ACOX2,1
KOINUMA_COLON_CANCER_MSI_UP,KOINUMA_COLON_CANCER_MSI_UP,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,LAP3,1
LEE_LIVER_CANCER_HEPATOBLAST,LEE_LIVER_CANCER_HEPATOBLAST,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,CD44,1
REACTOME_CGMP_EFFECTS,REACTOME_CGMP_EFFECTS,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,KCNMB1,1
REACTOME_GLYCOGEN_STORAGE_DISEASES,REACTOME_GLYCOGEN_STORAGE_DISEASES,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,GYS1,1
REACTOME_GLYCOGEN_SYNTHESIS,REACTOME_GLYCOGEN_SYNTHESIS,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,GYS1,1
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,EGF,1
REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,EGF,1
REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS,REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,EGF,1
REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,CDKN1A,1
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,TGFB2,1
WP_ID_SIGNALING_PATHWAY,WP_ID_SIGNALING_PATHWAY,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,SREBF1,1
WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,1/46,16/21728,0.03335210697429403,0.15804102978015144,0.1159923637805685,ACOX2,1
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,2/46,137/21728,0.03409564183520619,0.15824862973829687,0.11614472933968649,CD44/ABCC3,2
ZHANG_BREAST_CANCER_PROGENITORS_DN,ZHANG_BREAST_CANCER_PROGENITORS_DN,2/46,137/21728,0.03409564183520619,0.15824862973829687,0.11614472933968649,AEBP1/MTMR11,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,3/46,339/21728,0.03489019780607868,0.15824862973829687,0.11614472933968649,TIPARP/GBP1/DDO,3
BIOCARTA_SPRY_PATHWAY,BIOCARTA_SPRY_PATHWAY,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,EGF,1
KANG_AR_TARGETS_UP,KANG_AR_TARGETS_UP,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,TGFB2,1
KASLER_HDAC7_TARGETS_1_DN,KASLER_HDAC7_TARGETS_1_DN,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,HK2,1
KIM_HYPOXIA,KIM_HYPOXIA,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,GYS1,1
REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,CDKN1A,1
REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF,REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,CDKN1A,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,CDKN1A,1
REACTOME_GAB1_SIGNALOSOME,REACTOME_GAB1_SIGNALOSOME,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,EGF,1
REACTOME_HYALURONAN_METABOLISM,REACTOME_HYALURONAN_METABOLISM,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,CD44,1
RUAN_RESPONSE_TO_TROGLITAZONE_DN,RUAN_RESPONSE_TO_TROGLITAZONE_DN,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,HK2,1
SA_TRKA_RECEPTOR,SA_TRKA_RECEPTOR,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,CDKN1A,1
WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,ABCC3,1
WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,TGFB2,1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP,1/46,17/21728,0.035400089798500844,0.15824862973829687,0.11614472933968649,AEBP1,1
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,3/46,341/21728,0.03541036987638538,0.15824862973829687,0.11614472933968649,SLC22A4/GBP1/HSPB8,3
HOELZEL_NF1_TARGETS_UP,HOELZEL_NF1_TARGETS_UP,2/46,140/21728,0.03546952045858378,0.15824862973829687,0.11614472933968649,RETREG1/HSPB8,2
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,2/46,141/21728,0.03593222914795036,0.15982126461511664,0.11729894629828161,RASSF8/RHOB,2
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,3/46,345/21728,0.036462833465181956,0.16063180567434762,0.1178938334205194,EGF/CDKN1A/GYS1,3
DARWICHE_SKIN_TUMOR_PROMOTER_UP,DARWICHE_SKIN_TUMOR_PROMOTER_UP,2/46,143/21728,0.03686470056843903,0.16063180567434762,0.1178938334205194,PLEKHA4/CA3,2
BIOCARTA_CALCINEURIN_PATHWAY,BIOCARTA_CALCINEURIN_PATHWAY,1/46,18/21728,0.03744382780546862,0.16063180567434762,0.1178938334205194,CDKN1A,1
BIOCARTA_CARDIACEGF_PATHWAY,BIOCARTA_CARDIACEGF_PATHWAY,1/46,18/21728,0.03744382780546862,0.16063180567434762,0.1178938334205194,EGF,1
CHEN_PDGF_TARGETS,CHEN_PDGF_TARGETS,1/46,18/21728,0.03744382780546862,0.16063180567434762,0.1178938334205194,TIPARP,1
KIM_PTEN_TARGETS_UP,KIM_PTEN_TARGETS_UP,1/46,18/21728,0.03744382780546862,0.16063180567434762,0.1178938334205194,CDKN1A,1
PODAR_RESPONSE_TO_ADAPHOSTIN_DN,PODAR_RESPONSE_TO_ADAPHOSTIN_DN,1/46,18/21728,0.03744382780546862,0.16063180567434762,0.1178938334205194,HK2,1
REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS,REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS,1/46,18/21728,0.03744382780546862,0.16063180567434762,0.1178938334205194,ABCC3,1
REACTOME_RORA_ACTIVATES_GENE_EXPRESSION,REACTOME_RORA_ACTIVATES_GENE_EXPRESSION,1/46,18/21728,0.03744382780546862,0.16063180567434762,0.1178938334205194,SREBF1,1
STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA,STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA,1/46,18/21728,0.03744382780546862,0.16063180567434762,0.1178938334205194,TIPARP,1
WEBER_METHYLATED_IN_COLON_CANCER,WEBER_METHYLATED_IN_COLON_CANCER,1/46,18/21728,0.03744382780546862,0.16063180567434762,0.1178938334205194,TGFB2,1
WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,1/46,18/21728,0.03744382780546862,0.16063180567434762,0.1178938334205194,SLC22A4,1
REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,2/46,145/21728,0.037806500443075514,0.1612336048307632,0.11833551686671623,ACTR3/EGF,2
WP_NRF2_PATHWAY,WP_NRF2_PATHWAY,2/46,145/21728,0.037806500443075514,0.1612336048307632,0.11833551686671623,TGFB2/ABCC3,2
BIOCARTA_MCALPAIN_PATHWAY,BIOCARTA_MCALPAIN_PATHWAY,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,EGF,1
BIOCARTA_TGFB_PATHWAY,BIOCARTA_TGFB_PATHWAY,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,TGFB2,1
BIOCARTA_TOB1_PATHWAY,BIOCARTA_TOB1_PATHWAY,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,TGFB2,1
FARMER_BREAST_CANCER_CLUSTER_4,FARMER_BREAST_CANCER_CLUSTER_4,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,AEBP1,1
GENTLES_LEUKEMIC_STEM_CELL_DN,GENTLES_LEUKEMIC_STEM_CELL_DN,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,RNASE3,1
MANN_RESPONSE_TO_AMIFOSTINE_UP,MANN_RESPONSE_TO_AMIFOSTINE_UP,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,CDKN1A,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS,REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,EGF,1
REACTOME_RHO_GTPASES_ACTIVATE_CIT,REACTOME_RHO_GTPASES_ACTIVATE_CIT,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,RHOB,1
REACTOME_RHO_GTPASES_ACTIVATE_ROCKS,REACTOME_RHO_GTPASES_ACTIVATE_ROCKS,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,RHOB,1
REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,CDKN1A,1
SA_CASPASE_CASCADE,SA_CASPASE_CASCADE,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,SREBF1,1
WAGSCHAL_EHMT2_TARGETS_UP,WAGSCHAL_EHMT2_TARGETS_UP,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,CDKN1A,1
WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,1/46,19/21728,0.039483329598234085,0.1621836484913298,0.11903279029018835,SREBF1,1
VANTVEER_BREAST_CANCER_ESR1_UP,VANTVEER_BREAST_CANCER_ESR1_UP,2/46,149/21728,0.03971771888604294,0.16228138315225776,0.11910452150049554,RETREG1/SREBF1,2
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,2/46,150/21728,0.04020121102545094,0.16228138315225776,0.11910452150049554,GNAI2/MICALL2,2
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,3/46,361/21728,0.04083346954604056,0.16228138315225776,0.11910452150049554,RETREG1/RASSF8/HSPB8,3
HUANG_GATA2_TARGETS_UP,HUANG_GATA2_TARGETS_UP,2/46,152/21728,0.0411749412660688,0.16228138315225776,0.11910452150049554,CD44/CDKN1A,2
WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,2/46,152/21728,0.0411749412660688,0.16228138315225776,0.11910452150049554,GNAI2/RGS19,2
BIOCARTA_ATM_PATHWAY,BIOCARTA_ATM_PATHWAY,1/46,20/21728,0.04151860376279637,0.16228138315225776,0.11910452150049554,CDKN1A,1
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,1/46,20/21728,0.04151860376279637,0.16228138315225776,0.11910452150049554,TGFB2,1
FARMER_BREAST_CANCER_CLUSTER_7,FARMER_BREAST_CANCER_CLUSTER_7,1/46,20/21728,0.04151860376279637,0.16228138315225776,0.11910452150049554,SREBF1,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,1/46,20/21728,0.04151860376279637,0.16228138315225776,0.11910452150049554,MTMR11,1
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,1/46,20/21728,0.04151860376279637,0.16228138315225776,0.11910452150049554,CD44,1
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,1/46,20/21728,0.04151860376279637,0.16228138315225776,0.11910452150049554,CA3,1
IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,1/46,20/21728,0.04151860376279637,0.16228138315225776,0.11910452150049554,AMFR,1
LAMB_CCND1_TARGETS,LAMB_CCND1_TARGETS,1/46,20/21728,0.04151860376279637,0.16228138315225776,0.11910452150049554,GNAI2,1
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,1/46,20/21728,0.04151860376279637,0.16228138315225776,0.11910452150049554,RHOB,1
WP_TP53_NETWORK,WP_TP53_NETWORK,1/46,20/21728,0.04151860376279637,0.16228138315225776,0.11910452150049554,CDKN1A,1
ZHU_SKIL_TARGETS_UP,ZHU_SKIL_TARGETS_UP,1/46,20/21728,0.04151860376279637,0.16228138315225776,0.11910452150049554,CDKN1A,1
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,2/46,154/21728,0.04215759135147852,0.16228138315225776,0.11910452150049554,TGFB2/CDKN1A,2
WP_MALE_INFERTILITY,WP_MALE_INFERTILITY,2/46,155/21728,0.04265223343023412,0.16228138315225776,0.11910452150049554,TCN2/PACRG,2
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,2/46,156/21728,0.04314907205415041,0.16228138315225776,0.11910452150049554,EGF/CDKN1A,2
BIOCARTA_P53HYPOXIA_PATHWAY,BIOCARTA_P53HYPOXIA_PATHWAY,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,CDKN1A,1
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,GBP1,1
CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,CA3,1
CHIBA_RESPONSE_TO_TSA_DN,CHIBA_RESPONSE_TO_TSA_DN,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,TGFB2,1
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,CDKN1A,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,CDKN1A,1
KANG_CISPLATIN_RESISTANCE_UP,KANG_CISPLATIN_RESISTANCE_UP,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,CDKN1A,1
MACLACHLAN_BRCA1_TARGETS_UP,MACLACHLAN_BRCA1_TARGETS_UP,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,CDKN1A,1
MALTA_CURATED_STEMNESS_MARKERS,MALTA_CURATED_STEMNESS_MARKERS,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,CD44,1
MURAKAMI_UV_RESPONSE_6HR_DN,MURAKAMI_UV_RESPONSE_6HR_DN,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,TGFB2,1
OUYANG_PROSTATE_CANCER_MARKERS,OUYANG_PROSTATE_CANCER_MARKERS,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,CDKN1A,1
OUYANG_PROSTATE_CANCER_PROGRESSION_DN,OUYANG_PROSTATE_CANCER_PROGRESSION_DN,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,EGF,1
PID_S1P_META_PATHWAY,PID_S1P_META_PATHWAY,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,GNAI2,1
PID_S1P_S1P1_PATHWAY,PID_S1P_S1P1_PATHWAY,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,GNAI2,1
REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM,REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,TCN2,1
REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC,REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,AMFR,1
WP_GALANIN_RECEPTOR_PATHWAY,WP_GALANIN_RECEPTOR_PATHWAY,1/46,21/21728,0.0435496588681451,0.16228138315225776,0.11910452150049554,CDKN1A,1
GROSS_HYPOXIA_VIA_ELK3_DN,GROSS_HYPOXIA_VIA_ELK3_DN,2/46,157/21728,0.04364809615819347,0.16228138315225776,0.11910452150049554,CD44/PFKFB3,2
HASLINGER_B_CLL_WITH_17P13_DELETION,HASLINGER_B_CLL_WITH_17P13_DELETION,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,GNAI2,1
KANG_FLUOROURACIL_RESISTANCE_UP,KANG_FLUOROURACIL_RESISTANCE_UP,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,CDKN1A,1
KIM_LIVER_CANCER_POOR_SURVIVAL_UP,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,PFKFB3,1
MURATA_VIRULENCE_OF_H_PILORI,MURATA_VIRULENCE_OF_H_PILORI,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,CDKN1A,1
PID_HEDGEHOG_2PATHWAY,PID_HEDGEHOG_2PATHWAY,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,TGFB2,1
REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,GNAI2,1
REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM,REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,TCN2,1
REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE,REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,KCNMB1,1
REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,EGF,1
TIAN_TNF_SIGNALING_NOT_VIA_NFKB,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,TIPARP,1
WENG_POR_DOSAGE,WENG_POR_DOSAGE,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,RETSAT,1
WENG_POR_TARGETS_LIVER_DN,WENG_POR_TARGETS_LIVER_DN,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,RETSAT,1
WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,CDKN1A,1
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,1/46,22/21728,0.04557650346629616,0.16349493726266623,0.11999519533397862,SCARA3,1
MULLIGHAN_NPM1_SIGNATURE_3_DN,MULLIGHAN_NPM1_SIGNATURE_3_DN,2/46,161/21728,0.04566582730439988,0.16349493726266623,0.11999519533397862,RETREG1/DDO,2
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,2/46,162/21728,0.046175614061699725,0.1635711407928984,0.12005112402295483,ERMAP/SCARA3,2
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,2/46,164/21728,0.0472015362320543,0.1635711407928984,0.12005112402295483,SLC22A4/RGS19,2
DARWICHE_PAPILLOMA_RISK_LOW_UP,DARWICHE_PAPILLOMA_RISK_LOW_UP,2/46,164/21728,0.0472015362320543,0.1635711407928984,0.12005112402295483,PLEKHA4/CA3,2
LIU_CMYB_TARGETS_UP,LIU_CMYB_TARGETS_UP,2/46,164/21728,0.0472015362320543,0.1635711407928984,0.12005112402295483,TIPARP/ABCC3,2
REACTOME_PROTEIN_LOCALIZATION,REACTOME_PROTEIN_LOCALIZATION,2/46,164/21728,0.0472015362320543,0.1635711407928984,0.12005112402295483,ACOX2/DDO,2
BIOCARTA_CELLCYCLE_PATHWAY,BIOCARTA_CELLCYCLE_PATHWAY,1/46,23/21728,0.04759914609232341,0.1635711407928984,0.12005112402295483,CDKN1A,1
BRACHAT_RESPONSE_TO_CISPLATIN,BRACHAT_RESPONSE_TO_CISPLATIN,1/46,23/21728,0.04759914609232341,0.1635711407928984,0.12005112402295483,CDKN1A,1
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,1/46,23/21728,0.04759914609232341,0.1635711407928984,0.12005112402295483,CDKN1A,1
KEGG_NITROGEN_METABOLISM,KEGG_NITROGEN_METABOLISM,1/46,23/21728,0.04759914609232341,0.1635711407928984,0.12005112402295483,CA3,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,1/46,23/21728,0.04759914609232341,0.1635711407928984,0.12005112402295483,RHOB,1
PID_PRL_SIGNALING_EVENTS_PATHWAY,PID_PRL_SIGNALING_EVENTS_PATHWAY,1/46,23/21728,0.04759914609232341,0.1635711407928984,0.12005112402295483,CDKN1A,1
WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,1/46,23/21728,0.04759914609232341,0.1635711407928984,0.12005112402295483,CDKN1A,1
WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,1/46,23/21728,0.04759914609232341,0.1635711407928984,0.12005112402295483,ABCC3,1
WU_HBX_TARGETS_1_DN,WU_HBX_TARGETS_1_DN,1/46,23/21728,0.04759914609232341,0.1635711407928984,0.12005112402295483,TGFB2,1
WU_HBX_TARGETS_2_UP,WU_HBX_TARGETS_2_UP,1/46,23/21728,0.04759914609232341,0.1635711407928984,0.12005112402295483,TGFB2,1
YAN_ESCAPE_FROM_ANOIKIS,YAN_ESCAPE_FROM_ANOIKIS,1/46,23/21728,0.04759914609232341,0.1635711407928984,0.12005112402295483,CD44,1
BROWN_MYELOID_CELL_DEVELOPMENT_UP,BROWN_MYELOID_CELL_DEVELOPMENT_UP,2/46,165/21728,0.047717650038204155,0.1635711407928984,0.12005112402295483,CD44/PYGL,2
WP_CHEMOKINE_SIGNALING_PATHWAY,WP_CHEMOKINE_SIGNALING_PATHWAY,2/46,165/21728,0.047717650038204155,0.1635711407928984,0.12005112402295483,GNAI2/CCR10,2
CAIRO_LIVER_DEVELOPMENT_UP,CAIRO_LIVER_DEVELOPMENT_UP,2/46,166/21728,0.04823585131118951,0.1638849957479937,0.12028147419326433,TGFB2/RHOB,2
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,2/46,168/21728,0.04927847342229841,0.1638849957479937,0.12028147419326433,PFKFB3/KCNJ8,2
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SMIRNOV_RESPONSE_TO_IR_6HR_UP,2/46,168/21728,0.04927847342229841,0.1638849957479937,0.12028147419326433,RETSAT/CDKN1A,2
BIOCARTA_CTCF_PATHWAY,BIOCARTA_CTCF_PATHWAY,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,TGFB2,1
BIOCARTA_G2_PATHWAY,BIOCARTA_G2_PATHWAY,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,CDKN1A,1
BRACHAT_RESPONSE_TO_METHOTREXATE_UP,BRACHAT_RESPONSE_TO_METHOTREXATE_UP,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,CDKN1A,1
JEON_SMAD6_TARGETS_UP,JEON_SMAD6_TARGETS_UP,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,TGFB2,1
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,RASSF8,1
OSADA_ASCL1_TARGETS_DN,OSADA_ASCL1_TARGETS_DN,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,CD44,1
PID_S1P_S1P2_PATHWAY,PID_S1P_S1P2_PATHWAY,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,GNAI2,1
REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING,REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,EGF,1
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,RHOB,1
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,ACOX2,1
VIETOR_IFRD1_TARGETS,VIETOR_IFRD1_TARGETS,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,RETREG1,1
WANG_LSD1_TARGETS_UP,WANG_LSD1_TARGETS_UP,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,TGFB2,1
WENG_POR_TARGETS_GLOBAL_DN,WENG_POR_TARGETS_GLOBAL_DN,1/46,24/21728,0.04961759526439258,0.1638849957479937,0.12028147419326433,RETSAT,1
BASAKI_YBX1_TARGETS_DN,BASAKI_YBX1_TARGETS_DN,3/46,395/21728,0.05096248963556488,0.16409456432637437,0.12043528459815933,HK2/PFKFB3/PRUNE2,3
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,3/46,395/21728,0.05096248963556488,0.16409456432637437,0.12043528459815933,HK2/GBP1/HSPB8,3
GENTILE_UV_LOW_DOSE_UP,GENTILE_UV_LOW_DOSE_UP,1/46,25/21728,0.0516318594837919,0.16409456432637437,0.12043528459815933,CDKN1A,1
LU_TUMOR_ANGIOGENESIS_UP,LU_TUMOR_ANGIOGENESIS_UP,1/46,25/21728,0.0516318594837919,0.16409456432637437,0.12043528459815933,CD44,1
REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,1/46,25/21728,0.0516318594837919,0.16409456432637437,0.12043528459815933,EGF,1
REACTOME_SIGNALING_BY_EGFR_IN_CANCER,REACTOME_SIGNALING_BY_EGFR_IN_CANCER,1/46,25/21728,0.0516318594837919,0.16409456432637437,0.12043528459815933,EGF,1
STEGER_ADIPOGENESIS_DN,STEGER_ADIPOGENESIS_DN,1/46,25/21728,0.0516318594837919,0.16409456432637437,0.12043528459815933,CD44,1
VALK_AML_WITH_EVI1,VALK_AML_WITH_EVI1,1/46,25/21728,0.0516318594837919,0.16409456432637437,0.12043528459815933,RNASE3,1
WANG_BARRETTS_ESOPHAGUS_DN,WANG_BARRETTS_ESOPHAGUS_DN,1/46,25/21728,0.0516318594837919,0.16409456432637437,0.12043528459815933,ACTR3,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,3/46,398/21728,0.051910219124641825,0.16409456432637437,0.12043528459815933,RNASE3/AEBP1/TCN2,3
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,2/46,173/21728,0.051920813335755725,0.16409456432637437,0.12043528459815933,ACTR3/LAP3,2
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,2/46,173/21728,0.051920813335755725,0.16409456432637437,0.12043528459815933,RNASE3/CHI3L2,2
LU_EZH2_TARGETS_DN,LU_EZH2_TARGETS_DN,3/46,400/21728,0.05254683238083117,0.16409456432637437,0.12043528459815933,RETREG1/HK2/SLC22A4,3
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,2/46,175/21728,0.05299184166493507,0.16409456432637437,0.12043528459815933,HK2/MTMR11,2
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,2/46,175/21728,0.05299184166493507,0.16409456432637437,0.12043528459815933,SLC22A4/KCNJ8,2
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,CD44,1
BIOCARTA_NKT_PATHWAY,BIOCARTA_NKT_PATHWAY,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,TGFB2,1
BIOCARTA_RACCYCD_PATHWAY,BIOCARTA_RACCYCD_PATHWAY,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,CDKN1A,1
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,CDKN1A,1
DALESSIO_TSA_RESPONSE,DALESSIO_TSA_RESPONSE,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,HSPB8,1
KEGG_GALACTOSE_METABOLISM,KEGG_GALACTOSE_METABOLISM,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,HK2,1
NOJIMA_SFRP2_TARGETS_DN,NOJIMA_SFRP2_TARGETS_DN,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,CD44,1
PID_HDAC_CLASSIII_PATHWAY,PID_HDAC_CLASSIII_PATHWAY,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,CDKN1A,1
PID_INSULIN_GLUCOSE_PATHWAY,PID_INSULIN_GLUCOSE_PATHWAY,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,GYS1,1
PID_RXR_VDR_PATHWAY,PID_RXR_VDR_PATHWAY,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,SREBF1,1
REACTOME_CALNEXIN_CALRETICULIN_CYCLE,REACTOME_CALNEXIN_CALRETICULIN_CYCLE,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,AMFR,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,CDKN1A,1
REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,EGF,1
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,GBP1,1
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,AEBP1,1
TOMIDA_METASTASIS_UP,TOMIDA_METASTASIS_UP,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,GNAI2,1
WILLIAMS_ESR1_TARGETS_UP,WILLIAMS_ESR1_TARGETS_UP,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,HSPB8,1
WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,GNAI2,1
YANG_BREAST_CANCER_ESR1_BULK_UP,YANG_BREAST_CANCER_ESR1_BULK_UP,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,RETREG1,1
ZHENG_FOXP3_TARGETS_UP,ZHENG_FOXP3_TARGETS_UP,1/46,26/21728,0.053641947234966514,0.16409456432637437,0.12043528459815933,CD44,1
BAKKER_FOXO3_TARGETS_DN,BAKKER_FOXO3_TARGETS_DN,2/46,177/21728,0.05407079732032476,0.1650582233988861,0.1211425508938467,PFKFB3/HSPB8,2
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,2/46,178/21728,0.05461322196870303,0.16636380641726764,0.12210076826704723,HK2/CDKN1A,2
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,2/46,179/21728,0.055157597403277296,0.16705881393177907,0.12261086089657254,RHOB/KCNJ8,2
BIOCARTA_EGF_PATHWAY,BIOCARTA_EGF_PATHWAY,1/46,27/21728,0.05564786698555124,0.16705881393177907,0.12261086089657254,EGF,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,1/46,27/21728,0.05564786698555124,0.16705881393177907,0.12261086089657254,TCN2,1
NAKAMURA_CANCER_MICROENVIRONMENT_UP,NAKAMURA_CANCER_MICROENVIRONMENT_UP,1/46,27/21728,0.05564786698555124,0.16705881393177907,0.12261086089657254,RHOB,1
PID_GLYPICAN_1PATHWAY,PID_GLYPICAN_1PATHWAY,1/46,27/21728,0.05564786698555124,0.16705881393177907,0.12261086089657254,TGFB2,1
WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,1/46,27/21728,0.05564786698555124,0.16705881393177907,0.12261086089657254,CDKN1A,1
WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,1/46,27/21728,0.05564786698555124,0.16705881393177907,0.12261086089657254,HSPB8,1
REACTOME_NEURONAL_SYSTEM,REACTOME_NEURONAL_SYSTEM,3/46,411/21728,0.056116301503306355,0.16811701896651698,0.1233875180944818,GNAI2/KCNMB1/KCNJ8,3
FERNANDEZ_BOUND_BY_MYC,FERNANDEZ_BOUND_BY_MYC,2/46,181/21728,0.05625215954722906,0.1681765594710972,0.12343121715083794,AEBP1/TGFB2,2
BROWNE_HCMV_INFECTION_18HR_DN,BROWNE_HCMV_INFECTION_18HR_DN,2/46,182/21728,0.05680232579731684,0.16921449275360873,0.1241929961335016,CD44/ACOX2,2
ABBUD_LIF_SIGNALING_1_DN,ABBUD_LIF_SIGNALING_1_DN,1/46,28/21728,0.057649627186401875,0.16921449275360873,0.1241929961335016,HK2,1
CHIN_BREAST_CANCER_COPY_NUMBER_UP,CHIN_BREAST_CANCER_COPY_NUMBER_UP,1/46,28/21728,0.057649627186401875,0.16921449275360873,0.1241929961335016,TGFB2,1
PID_IL8_CXCR1_PATHWAY,PID_IL8_CXCR1_PATHWAY,1/46,28/21728,0.057649627186401875,0.16921449275360873,0.1241929961335016,GNAI2,1
REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION,REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION,1/46,28/21728,0.057649627186401875,0.16921449275360873,0.1241929961335016,GNAI2,1
REACTOME_FLT3_SIGNALING_IN_DISEASE,REACTOME_FLT3_SIGNALING_IN_DISEASE,1/46,28/21728,0.057649627186401875,0.16921449275360873,0.1241929961335016,CDKN1A,1
WP_7OXOC_AND_7BETAHC_PATHWAYS,WP_7OXOC_AND_7BETAHC_PATHWAYS,1/46,28/21728,0.057649627186401875,0.16921449275360873,0.1241929961335016,ACOX2,1
WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,1/46,28/21728,0.057649627186401875,0.16921449275360873,0.1241929961335016,EGF,1
WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,1/46,28/21728,0.057649627186401875,0.16921449275360873,0.1241929961335016,CDKN1A,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,2/46,184/21728,0.05790837775236625,0.16963060149683043,0.12449839427462472,ERMAP/GBP1,2
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,2/46,186/21728,0.05902198816115655,0.1699184530331276,0.12470965954010309,TGFB2/CDKN1A,2
MOOTHA_PGC,MOOTHA_PGC,3/46,421/21728,0.059460281628192474,0.1699184530331276,0.12470965954010309,HSPB8/TCN2/GYS1,3
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,3/46,421/21728,0.059460281628192474,0.1699184530331276,0.12470965954010309,ABCC3/CDKN1A/SCARA3,3
LEE_LIVER_CANCER_SURVIVAL_UP,LEE_LIVER_CANCER_SURVIVAL_UP,2/46,187/21728,0.05958160260079768,0.1699184530331276,0.12470965954010309,AMFR/ACOX2,2
BIOCARTA_INFLAM_PATHWAY,BIOCARTA_INFLAM_PATHWAY,1/46,29/21728,0.059647236271628934,0.1699184530331276,0.12470965954010309,TGFB2,1
GILDEA_METASTASIS,GILDEA_METASTASIS,1/46,29/21728,0.059647236271628934,0.1699184530331276,0.12470965954010309,GBP1,1
KRIGE_AMINO_ACID_DEPRIVATION,KRIGE_AMINO_ACID_DEPRIVATION,1/46,29/21728,0.059647236271628934,0.1699184530331276,0.12470965954010309,CDKN1A,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,1/46,29/21728,0.059647236271628934,0.1699184530331276,0.12470965954010309,RHOB,1
PID_S1P_S1P3_PATHWAY,PID_S1P_S1P3_PATHWAY,1/46,29/21728,0.059647236271628934,0.1699184530331276,0.12470965954010309,GNAI2,1
REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,1/46,29/21728,0.059647236271628934,0.1699184530331276,0.12470965954010309,EGF,1
REACTOME_PEROXISOMAL_LIPID_METABOLISM,REACTOME_PEROXISOMAL_LIPID_METABOLISM,1/46,29/21728,0.059647236271628934,0.1699184530331276,0.12470965954010309,ACOX2,1
WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,1/46,29/21728,0.059647236271628934,0.1699184530331276,0.12470965954010309,ACOX2,1
WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,1/46,29/21728,0.059647236271628934,0.1699184530331276,0.12470965954010309,TGFB2,1
YANAGIHARA_ESX1_TARGETS,YANAGIHARA_ESX1_TARGETS,1/46,29/21728,0.059647236271628934,0.1699184530331276,0.12470965954010309,TGFB2,1
XIE_ST_HSC_S1PR3_OE_UP,XIE_ST_HSC_S1PR3_OE_UP,2/46,188/21728,0.06014307649700773,0.1709950214130612,0.12549979430025762,GBP1/ABCC3,2
KEGG_CHEMOKINE_SIGNALING_PATHWAY,KEGG_CHEMOKINE_SIGNALING_PATHWAY,2/46,189/21728,0.060706399865075894,0.17155281929944632,0.125909183529394,GNAI2/CCR10,2
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,2/46,189/21728,0.060706399865075894,0.17155281929944632,0.125909183529394,TCN2/RETSAT,2
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,3/46,425/21728,0.06082397682183564,0.17155281929944632,0.125909183529394,RETREG1/TGFB2/RHOB,3
DIRMEIER_LMP1_RESPONSE_LATE_DN,DIRMEIER_LMP1_RESPONSE_LATE_DN,1/46,30/21728,0.06164070265862864,0.17155281929944632,0.125909183529394,CHI3L2,1
DORSEY_GAB2_TARGETS,DORSEY_GAB2_TARGETS,1/46,30/21728,0.06164070265862864,0.17155281929944632,0.125909183529394,CD44,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,1/46,30/21728,0.06164070265862864,0.17155281929944632,0.125909183529394,MTMR11,1
KEGG_ASTHMA,KEGG_ASTHMA,1/46,30/21728,0.06164070265862864,0.17155281929944632,0.125909183529394,RNASE3,1
REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,1/46,30/21728,0.06164070265862864,0.17155281929944632,0.125909183529394,SREBF1,1
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,1/46,30/21728,0.06164070265862864,0.17155281929944632,0.125909183529394,HSPB8,1
WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,1/46,30/21728,0.06164070265862864,0.17155281929944632,0.125909183529394,ACOX2,1
WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,1/46,30/21728,0.06164070265862864,0.17155281929944632,0.125909183529394,TGFB2,1
BURTON_ADIPOGENESIS_6,BURTON_ADIPOGENESIS_6,2/46,193/21728,0.06297798948981258,0.17213348952382132,0.1263353596432547,CA3/RETSAT,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,2/46,194/21728,0.06355041157339311,0.17213348952382132,0.1263353596432547,RETREG1/GBP1,2
BIOCARTA_IL1R_PATHWAY,BIOCARTA_IL1R_PATHWAY,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,TGFB2,1
BURTON_ADIPOGENESIS_1,BURTON_ADIPOGENESIS_1,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,RHOB,1
DASU_IL6_SIGNALING_SCAR_UP,DASU_IL6_SIGNALING_SCAR_UP,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,SREBF1,1
MOSERLE_IFNA_RESPONSE,MOSERLE_IFNA_RESPONSE,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,GBP1,1
PID_AR_NONGENOMIC_PATHWAY,PID_AR_NONGENOMIC_PATHWAY,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,GNAI2,1
PID_AVB3_OPN_PATHWAY,PID_AVB3_OPN_PATHWAY,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,CD44,1
REACTOME_EGFR_DOWNREGULATION,REACTOME_EGFR_DOWNREGULATION,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,EGF,1
REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION,REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,DDO,1
SIMBULAN_PARP1_TARGETS_UP,SIMBULAN_PARP1_TARGETS_UP,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,CDKN1A,1
WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,SREBF1,1
WP_ONECARBON_METABOLISM,WP_ONECARBON_METABOLISM,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,TCN2,1
WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,CDKN1A,1
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,1/46,31/21728,0.06363003474811602,0.17213348952382132,0.1263353596432547,GNAI2,1
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,3/46,434/21728,0.06394622747994193,0.17266672224565327,0.12672671955742681,CD44/ABCC3/CDKN1A,3
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,2/46,195/21728,0.06412462389548365,0.1728265885658946,0.12684405157177453,ABCC3/GYS1,2
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,2/46,197/21728,0.06527838024468977,0.17406371135347054,0.12775202335997002,TIPARP/HSPB8,2
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,1/46,32/21728,0.06561524092415816,0.17406371135347054,0.12775202335997002,DDO,1
LI_PROSTATE_CANCER_EPIGENETIC,LI_PROSTATE_CANCER_EPIGENETIC,1/46,32/21728,0.06561524092415816,0.17406371135347054,0.12775202335997002,CD44,1
LIU_BREAST_CANCER,LIU_BREAST_CANCER,1/46,32/21728,0.06561524092415816,0.17406371135347054,0.12775202335997002,RASSF8,1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,1/46,32/21728,0.06561524092415816,0.17406371135347054,0.12775202335997002,CDKN1A,1
TSAI_RESPONSE_TO_RADIATION_THERAPY,TSAI_RESPONSE_TO_RADIATION_THERAPY,1/46,32/21728,0.06561524092415816,0.17406371135347054,0.12775202335997002,TGFB2,1
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,1/46,32/21728,0.06561524092415816,0.17406371135347054,0.12775202335997002,CD44,1
WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,1/46,32/21728,0.06561524092415816,0.17406371135347054,0.12775202335997002,ABCC3,1
AFFAR_YY1_TARGETS_UP,AFFAR_YY1_TARGETS_UP,2/46,199/21728,0.06643918083269544,0.17406371135347054,0.12775202335997002,TGFB2/CDKN1A,2
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,2/46,199/21728,0.06643918083269544,0.17406371135347054,0.12775202335997002,PFKFB3/GYS1,2
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,2/46,200/21728,0.0670221985714401,0.17406371135347054,0.12775202335997002,GNAI2/AEBP1,2
MEBARKI_HCC_PROGENITOR_WNT_UP,MEBARKI_HCC_PROGENITOR_WNT_UP,2/46,200/21728,0.0670221985714401,0.17406371135347054,0.12775202335997002,GBP1/TGFB2,2
CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,1/46,33/21728,0.06759632955420491,0.17406371135347054,0.12775202335997002,TCN2,1
CUI_TCF21_TARGETS_DN,CUI_TCF21_TARGETS_DN,1/46,33/21728,0.06759632955420491,0.17406371135347054,0.12775202335997002,EGF,1
DOANE_BREAST_CANCER_CLASSES_DN,DOANE_BREAST_CANCER_CLASSES_DN,1/46,33/21728,0.06759632955420491,0.17406371135347054,0.12775202335997002,PYGL,1
FRIDMAN_IMMORTALIZATION_DN,FRIDMAN_IMMORTALIZATION_DN,1/46,33/21728,0.06759632955420491,0.17406371135347054,0.12775202335997002,CDKN1A,1
GROSS_ELK3_TARGETS_DN,GROSS_ELK3_TARGETS_DN,1/46,33/21728,0.06759632955420491,0.17406371135347054,0.12775202335997002,ACOX2,1
LIEN_BREAST_CARCINOMA_METAPLASTIC,LIEN_BREAST_CARCINOMA_METAPLASTIC,1/46,33/21728,0.06759632955420491,0.17406371135347054,0.12775202335997002,KCNE4,1
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,1/46,33/21728,0.06759632955420491,0.17406371135347054,0.12775202335997002,SH3BP2,1
REACTOME_SIGNAL_AMPLIFICATION,REACTOME_SIGNAL_AMPLIFICATION,1/46,33/21728,0.06759632955420491,0.17406371135347054,0.12775202335997002,GNAI2,1
TANG_SENESCENCE_TP53_TARGETS_UP,TANG_SENESCENCE_TP53_TARGETS_UP,1/46,33/21728,0.06759632955420491,0.17406371135347054,0.12775202335997002,CDKN1A,1
WP_PREGNANE_X_RECEPTOR_PATHWAY,WP_PREGNANE_X_RECEPTOR_PATHWAY,1/46,33/21728,0.06759632955420491,0.17406371135347054,0.12775202335997002,ABCC3,1
WP_WHITE_FAT_CELL_DIFFERENTIATION,WP_WHITE_FAT_CELL_DIFFERENTIATION,1/46,33/21728,0.06759632955420491,0.17406371135347054,0.12775202335997002,SREBF1,1
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,1/46,33/21728,0.06759632955420491,0.17406371135347054,0.12775202335997002,TCN2,1
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,3/46,445/21728,0.06786250530853451,0.17406371135347054,0.12775202335997002,PFKFB3/RHOB/KCNE4,3
KIM_MYC_AMPLIFICATION_TARGETS_UP,KIM_MYC_AMPLIFICATION_TARGETS_UP,2/46,202/21728,0.06819342092330014,0.17406371135347054,0.12775202335997002,ABCC3/RHOB,2
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,3/46,446/21728,0.06822393562330747,0.17406371135347054,0.12775202335997002,CD44/EGF/CDKN1A,3
REACTOME_INTERFERON_SIGNALING,REACTOME_INTERFERON_SIGNALING,2/46,203/21728,0.06878160642407864,0.17406371135347054,0.12775202335997002,CD44/GBP1,2
BIOCARTA_NUCLEARRS_PATHWAY,BIOCARTA_NUCLEARRS_PATHWAY,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,ABCC3,1
MURAKAMI_UV_RESPONSE_6HR_UP,MURAKAMI_UV_RESPONSE_6HR_UP,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,CDKN1A,1
PETRETTO_CARDIAC_HYPERTROPHY,PETRETTO_CARDIAC_HYPERTROPHY,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,CD44,1
PID_IL8_CXCR2_PATHWAY,PID_IL8_CXCR2_PATHWAY,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,GNAI2,1
REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,GYS1,1
REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,ACOX2,1
SCHRAETS_MLL_TARGETS_DN,SCHRAETS_MLL_TARGETS_DN,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,HSPB8,1
WANG_RESPONSE_TO_BEXAROTENE_UP,WANG_RESPONSE_TO_BEXAROTENE_UP,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,EGF,1
WP_FLUOROPYRIMIDINE_ACTIVITY,WP_FLUOROPYRIMIDINE_ACTIVITY,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,ABCC3,1
WP_P38_MAPK_SIGNALING_PATHWAY,WP_P38_MAPK_SIGNALING_PATHWAY,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,TGFB2,1
WP_PURINERGIC_SIGNALING,WP_PURINERGIC_SIGNALING,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,GNAI2,1
WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,GNAI2,1
ZWANG_EGF_PERSISTENTLY_UP,ZWANG_EGF_PERSISTENTLY_UP,1/46,34/21728,0.06957330898912073,0.17406371135347054,0.12775202335997002,PRUNE2,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,2/46,207/21728,0.0711512890653997,0.17406371135347054,0.12775202335997002,MICALL2/RHOB,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,2/46,207/21728,0.0711512890653997,0.17406371135347054,0.12775202335997002,AMFR/PYGL,2
ABE_VEGFA_TARGETS_2HR,ABE_VEGFA_TARGETS_2HR,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,CDKN1A,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,CDKN1A,1
GYORFFY_MITOXANTRONE_RESISTANCE,GYORFFY_MITOXANTRONE_RESISTANCE,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,RASSF8,1
JAZAG_TGFB1_SIGNALING_DN,JAZAG_TGFB1_SIGNALING_DN,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,KCNMB1,1
PID_ARF6_PATHWAY,PID_ARF6_PATHWAY,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,EGF,1
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,EGF,1
PID_PI3KCI_AKT_PATHWAY,PID_PI3KCI_AKT_PATHWAY,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,CDKN1A,1
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,RHOB,1
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,KCNJ8,1
REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,AMFR,1
SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,ACTR3,1
VALK_AML_CLUSTER_9,VALK_AML_CLUSTER_9,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,MTMR11,1
WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,ABCC3,1
WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,TGFB2,1
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,1/46,35/21728,0.07154618756321962,0.17406371135347054,0.12775202335997002,CD44,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,3/46,456/21728,0.07188719068565737,0.174600379387275,0.12814590458115066,CD44/GBP1/RETSAT,3
BILD_MYC_ONCOGENIC_SIGNATURE,BILD_MYC_ONCOGENIC_SIGNATURE,2/46,209/21728,0.07234616282584955,0.17482632193183936,0.12831173246685268,ABCC3/MTMR11,2
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,2/46,210/21728,0.07294607504536466,0.17482632193183936,0.12831173246685268,HSPB8/ABCC3,2
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,3/46,459/21728,0.07300338570112955,0.17482632193183936,0.12831173246685268,ACTR3/HK2/PYGL,3
BIOCARTA_P38MAPK_PATHWAY,BIOCARTA_P38MAPK_PATHWAY,1/46,36/21728,0.07351497359429415,0.17482632193183936,0.12831173246685268,TGFB2,1
GUTIERREZ_MULTIPLE_MYELOMA_UP,GUTIERREZ_MULTIPLE_MYELOMA_UP,1/46,36/21728,0.07351497359429415,0.17482632193183936,0.12831173246685268,RHOB,1
KAAB_FAILED_HEART_ATRIUM_UP,KAAB_FAILED_HEART_ATRIUM_UP,1/46,36/21728,0.07351497359429415,0.17482632193183936,0.12831173246685268,PFKFB3,1
KYNG_DNA_DAMAGE_BY_4NQO,KYNG_DNA_DAMAGE_BY_4NQO,1/46,36/21728,0.07351497359429415,0.17482632193183936,0.12831173246685268,HSPB8,1
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,1/46,36/21728,0.07351497359429415,0.17482632193183936,0.12831173246685268,AEBP1,1
REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,1/46,36/21728,0.07351497359429415,0.17482632193183936,0.12831173246685268,ACTR3,1
SUBTIL_PROGESTIN_TARGETS,SUBTIL_PROGESTIN_TARGETS,1/46,36/21728,0.07351497359429415,0.17482632193183936,0.12831173246685268,EGF,1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,2/46,211/21728,0.0735476250885669,0.17482632193183936,0.12831173246685268,HK2/TIPARP,2
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,2/46,211/21728,0.0735476250885669,0.17482632193183936,0.12831173246685268,RNASE3/TGFB2,2
WANG_TUMOR_INVASIVENESS_DN,WANG_TUMOR_INVASIVENESS_DN,2/46,211/21728,0.0735476250885669,0.17482632193183936,0.12831173246685268,GNAI2/CD44,2
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,2/46,212/21728,0.07415080369161857,0.17597162905539593,0.12915231722323434,HSPB8/ABCC3,2
BIOCARTA_ALK_PATHWAY,BIOCARTA_ALK_PATHWAY,1/46,37/21728,0.07547967538364797,0.17709632573833262,0.1299777751879886,TGFB2,1
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,1/46,37/21728,0.07547967538364797,0.17709632573833262,0.1299777751879886,RAB36,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,1/46,37/21728,0.07547967538364797,0.17709632573833262,0.1299777751879886,RHOB,1
MATZUK_SPERMATID_DIFFERENTIATION,MATZUK_SPERMATID_DIFFERENTIATION,1/46,37/21728,0.07547967538364797,0.17709632573833262,0.1299777751879886,PACRG,1
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,1/46,37/21728,0.07547967538364797,0.17709632573833262,0.1299777751879886,CD44,1
WP_NEOVASCULARISATION_PROCESSES,WP_NEOVASCULARISATION_PROCESSES,1/46,37/21728,0.07547967538364797,0.17709632573833262,0.1299777751879886,TGFB2,1
WP_TYPE_II_INTERFERON_SIGNALING_IFNG,WP_TYPE_II_INTERFERON_SIGNALING_IFNG,1/46,37/21728,0.07547967538364797,0.17709632573833262,0.1299777751879886,GBP1,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,3/46,466/21728,0.07563838771364123,0.17718200676054893,0.13004065977126314,CD44/PYGL/TGFB2,3
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,3/46,467/21728,0.0760182847714411,0.17778469825578969,0.13048299813909497,RNASE3/CD44/RHOB,3
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,3/46,470/21728,0.07716314355162693,0.1779531485949084,0.13060663029361336,GBP1/RAB36/SCARA3,3
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,1/46,38/21728,0.0774403012161291,0.1779531485949084,0.13060663029361336,CHI3L2,1
BURTON_ADIPOGENESIS_PEAK_AT_8HR,BURTON_ADIPOGENESIS_PEAK_AT_8HR,1/46,38/21728,0.0774403012161291,0.1779531485949084,0.13060663029361336,CD44,1
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE,CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE,1/46,38/21728,0.0774403012161291,0.1779531485949084,0.13060663029361336,RGS19,1
LEE_AGING_MUSCLE_UP,LEE_AGING_MUSCLE_UP,1/46,38/21728,0.0774403012161291,0.1779531485949084,0.13060663029361336,RHOB,1
MA_MYELOID_DIFFERENTIATION_UP,MA_MYELOID_DIFFERENTIATION_UP,1/46,38/21728,0.0774403012161291,0.1779531485949084,0.13060663029361336,CDKN1A,1
NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,1/46,38/21728,0.0774403012161291,0.1779531485949084,0.13060663029361336,MICALL2,1
REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,1/46,38/21728,0.0774403012161291,0.1779531485949084,0.13060663029361336,CDKN1A,1
REACTOME_HSF1_DEPENDENT_TRANSACTIVATION,REACTOME_HSF1_DEPENDENT_TRANSACTIVATION,1/46,38/21728,0.0774403012161291,0.1779531485949084,0.13060663029361336,HSPB8,1
REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,1/46,38/21728,0.0774403012161291,0.1779531485949084,0.13060663029361336,TGFB2,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,1/46,38/21728,0.0774403012161291,0.1779531485949084,0.13060663029361336,CDKN1A,1
REACTOME_ESR_MEDIATED_SIGNALING,REACTOME_ESR_MEDIATED_SIGNALING,2/46,219/21728,0.07841788177591512,0.179630218917973,0.1318374964254597,GNAI2/EGF,2
WANG_CISPLATIN_RESPONSE_AND_XPC_DN,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,2/46,219/21728,0.07841788177591512,0.179630218917973,0.1318374964254597,KCNMB1/CDKN1A,2
ONGUSAHA_TP53_TARGETS,ONGUSAHA_TP53_TARGETS,1/46,39/21728,0.07939685936016172,0.1807306845717967,0.1326451703100446,CDKN1A,1
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,1/46,39/21728,0.07939685936016172,0.1807306845717967,0.1326451703100446,HK2,1
SESTO_RESPONSE_TO_UV_C6,SESTO_RESPONSE_TO_UV_C6,1/46,39/21728,0.07939685936016172,0.1807306845717967,0.1326451703100446,PYGL,1
WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_HUTCHINSONGILFORD_PROGERIA_SYNDROME,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_HUTCHINSONGILFORD_PROGERIA_SYNDROME,1/46,39/21728,0.07939685936016172,0.1807306845717967,0.1326451703100446,SREBF1,1
REACTOME_NEUTROPHIL_DEGRANULATION,REACTOME_NEUTROPHIL_DEGRANULATION,3/46,479/21728,0.08064385402287567,0.18127811870217383,0.13304695318177695,RNASE3/CD44/PYGL,3
AIYAR_COBRA1_TARGETS_UP,AIYAR_COBRA1_TARGETS_UP,1/46,40/21728,0.08134935806777477,0.18127811870217383,0.13304695318177695,ACOX2,1
BALDWIN_PRKCI_TARGETS_UP,BALDWIN_PRKCI_TARGETS_UP,1/46,40/21728,0.08134935806777477,0.18127811870217383,0.13304695318177695,RHOB,1
BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,1/46,40/21728,0.08134935806777477,0.18127811870217383,0.13304695318177695,LAP3,1
EHLERS_ANEUPLOIDY_UP,EHLERS_ANEUPLOIDY_UP,1/46,40/21728,0.08134935806777477,0.18127811870217383,0.13304695318177695,ERMAP,1
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,1/46,40/21728,0.08134935806777477,0.18127811870217383,0.13304695318177695,PLEKHA4,1
GU_PDEF_TARGETS_DN,GU_PDEF_TARGETS_DN,1/46,40/21728,0.08134935806777477,0.18127811870217383,0.13304695318177695,TGFB2,1
KAMMINGA_SENESCENCE,KAMMINGA_SENESCENCE,1/46,40/21728,0.08134935806777477,0.18127811870217383,0.13304695318177695,TGFB2,1
PID_ER_NONGENOMIC_PATHWAY,PID_ER_NONGENOMIC_PATHWAY,1/46,40/21728,0.08134935806777477,0.18127811870217383,0.13304695318177695,GNAI2,1
TRAYNOR_RETT_SYNDROM_UP,TRAYNOR_RETT_SYNDROM_UP,1/46,40/21728,0.08134935806777477,0.18127811870217383,0.13304695318177695,PRUNE2,1
WP_ATM_SIGNALING_PATHWAY,WP_ATM_SIGNALING_PATHWAY,1/46,40/21728,0.08134935806777477,0.18127811870217383,0.13304695318177695,CDKN1A,1
WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,1/46,40/21728,0.08134935806777477,0.18127811870217383,0.13304695318177695,SREBF1,1
WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,1/46,40/21728,0.08134935806777477,0.18127811870217383,0.13304695318177695,TGFB2,1
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,3/46,481/21728,0.08142665996830856,0.18127811870217383,0.13304695318177695,ACTR3/CD44/RGS19,3
VANTVEER_BREAST_CANCER_ESR1_DN,VANTVEER_BREAST_CANCER_ESR1_DN,2/46,224/21728,0.08151264371987403,0.18127811870217383,0.13304695318177695,GBP1/TCN2,2
LIN_MELANOMA_COPY_NUMBER_DN,LIN_MELANOMA_COPY_NUMBER_DN,1/46,41/21728,0.08329780557463962,0.18320025578141852,0.13445768319057289,PACRG,1
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,1/46,41/21728,0.08329780557463962,0.18320025578141852,0.13445768319057289,CDKN1A,1
PID_ECADHERIN_STABILIZATION_PATHWAY,PID_ECADHERIN_STABILIZATION_PATHWAY,1/46,41/21728,0.08329780557463962,0.18320025578141852,0.13445768319057289,EGF,1
PID_ERBB1_INTERNALIZATION_PATHWAY,PID_ERBB1_INTERNALIZATION_PATHWAY,1/46,41/21728,0.08329780557463962,0.18320025578141852,0.13445768319057289,EGF,1
THILLAINADESAN_ZNF217_TARGETS_UP,THILLAINADESAN_ZNF217_TARGETS_UP,1/46,41/21728,0.08329780557463962,0.18320025578141852,0.13445768319057289,PFKFB3,1
WP_OXIDATIVE_DAMAGE_RESPONSE,WP_OXIDATIVE_DAMAGE_RESPONSE,1/46,41/21728,0.08329780557463962,0.18320025578141852,0.13445768319057289,CDKN1A,1
ZHU_CMV_8_HR_UP,ZHU_CMV_8_HR_UP,1/46,41/21728,0.08329780557463962,0.18320025578141852,0.13445768319057289,GBP1,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,2/46,227/21728,0.08338770263154223,0.18320025578141852,0.13445768319057289,GNAI2/RGS19,2
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,2/46,228/21728,0.08401570281302286,0.18393036405526603,0.13499353761152372,RETREG1/TGFB2,2
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,1/46,42/21728,0.0852422101000957,0.18393036405526603,0.13499353761152372,KCNJ8,1
ELLWOOD_MYC_TARGETS_DN,ELLWOOD_MYC_TARGETS_DN,1/46,42/21728,0.0852422101000957,0.18393036405526603,0.13499353761152372,EGF,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1/46,42/21728,0.0852422101000957,0.18393036405526603,0.13499353761152372,AMFR,1
ONO_FOXP3_TARGETS_DN,ONO_FOXP3_TARGETS_DN,1/46,42/21728,0.0852422101000957,0.18393036405526603,0.13499353761152372,CDKN1A,1
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,1/46,42/21728,0.0852422101000957,0.18393036405526603,0.13499353761152372,KCNMB1,1
PID_TCPTP_PATHWAY,PID_TCPTP_PATHWAY,1/46,42/21728,0.0852422101000957,0.18393036405526603,0.13499353761152372,EGF,1
REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,1/46,42/21728,0.0852422101000957,0.18393036405526603,0.13499353761152372,SREBF1,1
REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,1/46,42/21728,0.0852422101000957,0.18393036405526603,0.13499353761152372,ACTR3,1
VARELA_ZMPSTE24_TARGETS_DN,VARELA_ZMPSTE24_TARGETS_DN,1/46,42/21728,0.0852422101000957,0.18393036405526603,0.13499353761152372,CA3,1
ZHAN_EARLY_DIFFERENTIATION_GENES_DN,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,1/46,42/21728,0.0852422101000957,0.18393036405526603,0.13499353761152372,GBP1,1
ZHAN_MULTIPLE_MYELOMA_DN,ZHAN_MULTIPLE_MYELOMA_DN,1/46,42/21728,0.0852422101000957,0.18393036405526603,0.13499353761152372,PYGL,1
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,2/46,232/21728,0.0865423728731491,0.18590403055649915,0.13644208703638522,PFKFB3/TIPARP,2
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,3/46,495/21728,0.08699960676845417,0.18590403055649915,0.13644208703638522,CD44/RHOB/ACOX2,3
FUJII_YBX1_TARGETS_UP,FUJII_YBX1_TARGETS_UP,1/46,43/21728,0.0871825798471858,0.18590403055649915,0.13644208703638522,CDKN1A,1
LASTOWSKA_COAMPLIFIED_WITH_MYCN,LASTOWSKA_COAMPLIFIED_WITH_MYCN,1/46,43/21728,0.0871825798471858,0.18590403055649915,0.13644208703638522,FNDC4,1
LUI_THYROID_CANCER_CLUSTER_2,LUI_THYROID_CANCER_CLUSTER_2,1/46,43/21728,0.0871825798471858,0.18590403055649915,0.13644208703638522,ABCC3,1
PID_CXCR3_PATHWAY,PID_CXCR3_PATHWAY,1/46,43/21728,0.0871825798471858,0.18590403055649915,0.13644208703638522,GNAI2,1
PID_THROMBIN_PAR1_PATHWAY,PID_THROMBIN_PAR1_PATHWAY,1/46,43/21728,0.0871825798471858,0.18590403055649915,0.13644208703638522,GNAI2,1
REACTOME_GABA_B_RECEPTOR_ACTIVATION,REACTOME_GABA_B_RECEPTOR_ACTIVATION,1/46,43/21728,0.0871825798471858,0.18590403055649915,0.13644208703638522,GNAI2,1
GAL_LEUKEMIC_STEM_CELL_DN,GAL_LEUKEMIC_STEM_CELL_DN,2/46,236/21728,0.08909209792597148,0.18673762767903992,0.1370538958863952,SLC22A4/ERMAP,2
GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,2/46,236/21728,0.08909209792597148,0.18673762767903992,0.1370538958863952,HSPB8/GYS1,2
IKEDA_MIR133_TARGETS_UP,IKEDA_MIR133_TARGETS_UP,1/46,44/21728,0.08911892300268665,0.18673762767903992,0.1370538958863952,ACTR3,1
KEGG_ABC_TRANSPORTERS,KEGG_ABC_TRANSPORTERS,1/46,44/21728,0.08911892300268665,0.18673762767903992,0.1370538958863952,ABCC3,1
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,1/46,44/21728,0.08911892300268665,0.18673762767903992,0.1370538958863952,HK2,1
NAKAMURA_METASTASIS_MODEL_DN,NAKAMURA_METASTASIS_MODEL_DN,1/46,44/21728,0.08911892300268665,0.18673762767903992,0.1370538958863952,CD44,1
PARENT_MTOR_SIGNALING_DN,PARENT_MTOR_SIGNALING_DN,1/46,44/21728,0.08911892300268665,0.18673762767903992,0.1370538958863952,FHL3,1
PID_CERAMIDE_PATHWAY,PID_CERAMIDE_PATHWAY,1/46,44/21728,0.08911892300268665,0.18673762767903992,0.1370538958863952,EGF,1
REACTOME_INTRA_GOLGI_TRAFFIC,REACTOME_INTRA_GOLGI_TRAFFIC,1/46,44/21728,0.08911892300268665,0.18673762767903992,0.1370538958863952,RAB36,1
VARELA_ZMPSTE24_TARGETS_UP,VARELA_ZMPSTE24_TARGETS_UP,1/46,44/21728,0.08911892300268665,0.18673762767903992,0.1370538958863952,CDKN1A,1
WHITFIELD_CELL_CYCLE_LITERATURE,WHITFIELD_CELL_CYCLE_LITERATURE,1/46,44/21728,0.08911892300268665,0.18673762767903992,0.1370538958863952,CDKN1A,1
WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,1/46,44/21728,0.08911892300268665,0.18673762767903992,0.1370538958863952,RETSAT,1
ZWANG_EGF_INTERVAL_DN,ZWANG_EGF_INTERVAL_DN,2/46,238/21728,0.09037543434025093,0.18700327084823284,0.1372488615808083,SREBF1/RHOB,2
ALFANO_MYC_TARGETS,ALFANO_MYC_TARGETS,2/46,239/21728,0.09101919123962465,0.18700327084823284,0.1372488615808083,GNAI2/TGFB2,2
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,2/46,239/21728,0.09101919123962465,0.18700327084823284,0.1372488615808083,HK2/CDKN1A,2
BURTON_ADIPOGENESIS_4,BURTON_ADIPOGENESIS_4,1/46,45/21728,0.09105124773713957,0.18700327084823284,0.1372488615808083,SREBF1,1
CHENG_RESPONSE_TO_NICKEL_ACETATE,CHENG_RESPONSE_TO_NICKEL_ACETATE,1/46,45/21728,0.09105124773713957,0.18700327084823284,0.1372488615808083,ABCC3,1
CHIBA_RESPONSE_TO_TSA,CHIBA_RESPONSE_TO_TSA,1/46,45/21728,0.09105124773713957,0.18700327084823284,0.1372488615808083,CDKN1A,1
KERLEY_RESPONSE_TO_CISPLATIN_UP,KERLEY_RESPONSE_TO_CISPLATIN_UP,1/46,45/21728,0.09105124773713957,0.18700327084823284,0.1372488615808083,CDKN1A,1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,1/46,45/21728,0.09105124773713957,0.18700327084823284,0.1372488615808083,GBP1,1
REACTOME_ELASTIC_FIBRE_FORMATION,REACTOME_ELASTIC_FIBRE_FORMATION,1/46,45/21728,0.09105124773713957,0.18700327084823284,0.1372488615808083,TGFB2,1
ROVERSI_GLIOMA_LOH_REGIONS,ROVERSI_GLIOMA_LOH_REGIONS,1/46,45/21728,0.09105124773713957,0.18700327084823284,0.1372488615808083,KCNJ8,1
SIG_CHEMOTAXIS,SIG_CHEMOTAXIS,1/46,45/21728,0.09105124773713957,0.18700327084823284,0.1372488615808083,ACTR3,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,1/46,45/21728,0.09105124773713957,0.18700327084823284,0.1372488615808083,RHOB,1
WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,1/46,45/21728,0.09105124773713957,0.18700327084823284,0.1372488615808083,HK2,1
WP_INTEGRATED_CANCER_PATHWAY,WP_INTEGRATED_CANCER_PATHWAY,1/46,45/21728,0.09105124773713957,0.18700327084823284,0.1372488615808083,CDKN1A,1
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,2/46,242/21728,0.09295871545158398,0.1882965994372635,0.138198084959037,PYGL/MTMR11,2
BIOCARTA_KERATINOCYTE_PATHWAY,BIOCARTA_KERATINOCYTE_PATHWAY,1/46,46/21728,0.09297956220488324,0.1882965994372635,0.138198084959037,EGF,1
FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,1/46,46/21728,0.09297956220488324,0.1882965994372635,0.138198084959037,MTMR11,1
HOLLERN_MICROACINAR_BREAST_TUMOR_UP,HOLLERN_MICROACINAR_BREAST_TUMOR_UP,1/46,46/21728,0.09297956220488324,0.1882965994372635,0.138198084959037,DDO,1
LANDIS_BREAST_CANCER_PROGRESSION_UP,LANDIS_BREAST_CANCER_PROGRESSION_UP,1/46,46/21728,0.09297956220488324,0.1882965994372635,0.138198084959037,RETREG1,1
PID_A6B1_A6B4_INTEGRIN_PATHWAY,PID_A6B1_A6B4_INTEGRIN_PATHWAY,1/46,46/21728,0.09297956220488324,0.1882965994372635,0.138198084959037,EGF,1
SESTO_RESPONSE_TO_UV_C5,SESTO_RESPONSE_TO_UV_C5,1/46,46/21728,0.09297956220488324,0.1882965994372635,0.138198084959037,SREBF1,1
STOSSI_RESPONSE_TO_ESTRADIOL,STOSSI_RESPONSE_TO_ESTRADIOL,1/46,46/21728,0.09297956220488324,0.1882965994372635,0.138198084959037,ACOX2,1
WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,1/46,46/21728,0.09297956220488324,0.1882965994372635,0.138198084959037,TGFB2,1
WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,1/46,46/21728,0.09297956220488324,0.1882965994372635,0.138198084959037,ACOX2,1
CHICAS_RB1_TARGETS_GROWING,CHICAS_RB1_TARGETS_GROWING,2/46,243/21728,0.09360794673077595,0.18930477372332655,0.13893802267461572,PYGL/SCARA3,2
KEGG_TYPE_II_DIABETES_MELLITUS,KEGG_TYPE_II_DIABETES_MELLITUS,1/46,47/21728,0.09490387454408533,0.18980774908817066,0.1393071755558189,HK2,1
MCDOWELL_ACUTE_LUNG_INJURY_UP,MCDOWELL_ACUTE_LUNG_INJURY_UP,1/46,47/21728,0.09490387454408533,0.18980774908817066,0.1393071755558189,CDKN1A,1
MELLMAN_TUT1_TARGETS_DN,MELLMAN_TUT1_TARGETS_DN,1/46,47/21728,0.09490387454408533,0.18980774908817066,0.1393071755558189,SCARA3,1
REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,1/46,47/21728,0.09490387454408533,0.18980774908817066,0.1393071755558189,CDKN1A,1
REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,1/46,47/21728,0.09490387454408533,0.18980774908817066,0.1393071755558189,SREBF1,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,1/46,47/21728,0.09490387454408533,0.18980774908817066,0.1393071755558189,CDKN1A,1
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,1/46,47/21728,0.09490387454408533,0.18980774908817066,0.1393071755558189,CD44,1
ZHAN_MULTIPLE_MYELOMA_CD2_DN,ZHAN_MULTIPLE_MYELOMA_CD2_DN,1/46,47/21728,0.09490387454408533,0.18980774908817066,0.1393071755558189,HK2,1
REACTOME_DISEASES_OF_METABOLISM,REACTOME_DISEASES_OF_METABOLISM,2/46,246/21728,0.09556369353180894,0.18982097513928733,0.139316882661212,TCN2/GYS1,2
DAUER_STAT3_TARGETS_DN,DAUER_STAT3_TARGETS_DN,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,LAP3,1
DAUER_STAT3_TARGETS_UP,DAUER_STAT3_TARGETS_UP,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,PFKFB3,1
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,AEBP1,1
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,CCR10,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,EGF,1
PARK_APL_PATHOGENESIS_DN,PARK_APL_PATHOGENESIS_DN,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,RNASE3,1
PID_AJDISS_2PATHWAY,PID_AJDISS_2PATHWAY,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,EGF,1
PID_HEDGEHOG_GLI_PATHWAY,PID_HEDGEHOG_GLI_PATHWAY,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,GNAI2,1
REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,RETSAT,1
SU_PANCREAS,SU_PANCREAS,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,RETREG1,1
WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,CDKN1A,1
WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,SREBF1,1
WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,1/46,48/21728,0.09682419287677169,0.18982097513928733,0.139316882661212,EGF,1
ZHENG_GLIOBLASTOMA_PLASTICITY_UP,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,2/46,248/21728,0.09687415282970527,0.18982097513928733,0.139316882661212,HSPB8/CA3,2
HSIAO_LIVER_SPECIFIC_GENES,HSIAO_LIVER_SPECIFIC_GENES,2/46,249/21728,0.09753134624101942,0.19059360114484927,0.13988394247364253,PYGL/ACOX2,2
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,2/46,249/21728,0.09753134624101942,0.19059360114484927,0.13988394247364253,EGF/TGFB2,2
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,2/46,250/21728,0.09818983792834424,0.19060099553187645,0.13988936949744255,HK2/TGFB2,2
JIANG_AGING_CEREBRAL_CORTEX_DN,JIANG_AGING_CEREBRAL_CORTEX_DN,1/46,49/21728,0.09874052530885946,0.19060099553187645,0.13988936949744255,ACTR3,1
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,1/46,49/21728,0.09874052530885946,0.19060099553187645,0.13988936949744255,AEBP1,1
NADLER_OBESITY_DN,NADLER_OBESITY_DN,1/46,49/21728,0.09874052530885946,0.19060099553187645,0.13988936949744255,SREBF1,1
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,1/46,49/21728,0.09874052530885946,0.19060099553187645,0.13988936949744255,CDKN1A,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_4,RASHI_RESPONSE_TO_IONIZING_RADIATION_4,1/46,49/21728,0.09874052530885946,0.19060099553187645,0.13988936949744255,RGS19,1
REACTOME_SIGNALING_BY_NOTCH3,REACTOME_SIGNALING_BY_NOTCH3,1/46,49/21728,0.09874052530885946,0.19060099553187645,0.13988936949744255,EGF,1
REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1/46,49/21728,0.09874052530885946,0.19060099553187645,0.13988936949744255,CDKN1A,1
WP_PHOSPHOINOSITIDES_METABOLISM,WP_PHOSPHOINOSITIDES_METABOLISM,1/46,49/21728,0.09874052530885946,0.19060099553187645,0.13988936949744255,MTMR11,1
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,2/46,251/21728,0.09884961975170421,0.19060099553187645,0.13988936949744255,TCN2/CDKN1A,2
BUFFA_HYPOXIA_METAGENE,BUFFA_HYPOXIA_METAGENE,1/46,50/21728,0.10065287993018868,0.19153107073329867,0.1405719873040762,HK2,1
BURTON_ADIPOGENESIS_7,BURTON_ADIPOGENESIS_7,1/46,50/21728,0.10065287993018868,0.19153107073329867,0.1405719873040762,CD44,1
GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,1/46,50/21728,0.10065287993018868,0.19153107073329867,0.1405719873040762,FNDC4,1
KEGG_GLUTATHIONE_METABOLISM,KEGG_GLUTATHIONE_METABOLISM,1/46,50/21728,0.10065287993018868,0.19153107073329867,0.1405719873040762,LAP3,1
OHGUCHI_LIVER_HNF4A_TARGETS_UP,OHGUCHI_LIVER_HNF4A_TARGETS_UP,1/46,50/21728,0.10065287993018868,0.19153107073329867,0.1405719873040762,CA3,1
REACTOME_SIGNALING_BY_EGFR,REACTOME_SIGNALING_BY_EGFR,1/46,50/21728,0.10065287993018868,0.19153107073329867,0.1405719873040762,EGF,1
REACTOME_SIGNALING_BY_ERBB2,REACTOME_SIGNALING_BY_ERBB2,1/46,50/21728,0.10065287993018868,0.19153107073329867,0.1405719873040762,EGF,1
WARTERS_IR_RESPONSE_5GY,WARTERS_IR_RESPONSE_5GY,1/46,50/21728,0.10065287993018868,0.19153107073329867,0.1405719873040762,CDKN1A,1
WESTON_VEGFA_TARGETS_6HR,WESTON_VEGFA_TARGETS_6HR,1/46,50/21728,0.10065287993018868,0.19153107073329867,0.1405719873040762,FHL3,1
WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,1/46,50/21728,0.10065287993018868,0.19153107073329867,0.1405719873040762,CDKN1A,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,2/46,256/21728,0.10216759791459745,0.19414338639830123,0.1424892658066661,AEBP1/PRUNE2,2
FRASOR_TAMOXIFEN_RESPONSE_UP,FRASOR_TAMOXIFEN_RESPONSE_UP,1/46,51/21728,0.10256126481455086,0.19414338639830123,0.1424892658066661,CD44,1
PID_CASPASE_PATHWAY,PID_CASPASE_PATHWAY,1/46,51/21728,0.10256126481455086,0.19414338639830123,0.1424892658066661,SREBF1,1
WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,1/46,51/21728,0.10256126481455086,0.19414338639830123,0.1424892658066661,CDKN1A,1
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,2/46,257/21728,0.10283495113656868,0.19440766512128368,0.1426832300817552,SLC22A4/PRUNE2,2
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,2/46,258/21728,0.10350353827412576,0.19541683658526346,0.143423899664393,CD44/RHOB,2
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,1/46,52/21728,0.10446568801972389,0.19545193242399952,0.14344965784440183,RETREG1,1
KEGG_ENDOMETRIAL_CANCER,KEGG_ENDOMETRIAL_CANCER,1/46,52/21728,0.10446568801972389,0.19545193242399952,0.14344965784440183,EGF,1
KENNY_CTNNB1_TARGETS_DN,KENNY_CTNNB1_TARGETS_DN,1/46,52/21728,0.10446568801972389,0.19545193242399952,0.14344965784440183,RETREG1,1
PID_PTP1B_PATHWAY,PID_PTP1B_PATHWAY,1/46,52/21728,0.10446568801972389,0.19545193242399952,0.14344965784440183,EGF,1
PRAMOONJAGO_SOX4_TARGETS_UP,PRAMOONJAGO_SOX4_TARGETS_UP,1/46,52/21728,0.10446568801972389,0.19545193242399952,0.14344965784440183,TIPARP,1
ROSS_AML_WITH_CBFB_MYH11_FUSION,ROSS_AML_WITH_CBFB_MYH11_FUSION,1/46,52/21728,0.10446568801972389,0.19545193242399952,0.14344965784440183,MTMR11,1
WANG_BARRETTS_ESOPHAGUS_UP,WANG_BARRETTS_ESOPHAGUS_UP,1/46,52/21728,0.10446568801972389,0.19545193242399952,0.14344965784440183,TCN2,1
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,1/46,53/21728,0.10636615758749912,0.1972121711537516,0.14474156445476796,RNASE3,1
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,1/46,53/21728,0.10636615758749912,0.1972121711537516,0.14474156445476796,RHOB,1
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,1/46,53/21728,0.10636615758749912,0.1972121711537516,0.14474156445476796,PLEKHA4,1
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SMIRNOV_RESPONSE_TO_IR_2HR_UP,1/46,53/21728,0.10636615758749912,0.1972121711537516,0.14474156445476796,CDKN1A,1
WP_VITAMIN_B12_METABOLISM,WP_VITAMIN_B12_METABOLISM,1/46,53/21728,0.10636615758749912,0.1972121711537516,0.14474156445476796,TCN2,1
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,2/46,265/21728,0.10821753561775665,0.1972121711537516,0.14474156445476796,CD44/TIPARP,2
FOSTER_KDM1A_TARGETS_UP,FOSTER_KDM1A_TARGETS_UP,2/46,265/21728,0.10821753561775665,0.1972121711537516,0.14474156445476796,HSPB8/CDKN1A,2
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,2/46,265/21728,0.10821753561775665,0.1972121711537516,0.14474156445476796,CD44/CHI3L2,2
BAKKER_FOXO3_TARGETS_UP,BAKKER_FOXO3_TARGETS_UP,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,GNAI2,1
BORLAK_LIVER_CANCER_EGF_UP,BORLAK_LIVER_CANCER_EGF_UP,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,AEBP1,1
BROWNE_HCMV_INFECTION_30MIN_UP,BROWNE_HCMV_INFECTION_30MIN_UP,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,RHOB,1
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,CDKN1A,1
KEGG_ARGININE_AND_PROLINE_METABOLISM,KEGG_ARGININE_AND_PROLINE_METABOLISM,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,LAP3,1
KEGG_NON_SMALL_CELL_LUNG_CANCER,KEGG_NON_SMALL_CELL_LUNG_CANCER,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,EGF,1
PID_RAC1_PATHWAY,PID_RAC1_PATHWAY,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,ACTR3,1
PID_TAP63_PATHWAY,PID_TAP63_PATHWAY,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,CDKN1A,1
PID_TGFBR_PATHWAY,PID_TGFBR_PATHWAY,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,TGFB2,1
REACTOME_G_PROTEIN_MEDIATED_EVENTS,REACTOME_G_PROTEIN_MEDIATED_EVENTS,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,GNAI2,1
REACTOME_SIGNALING_BY_PTK6,REACTOME_SIGNALING_BY_PTK6,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,EGF,1
ROVERSI_GLIOMA_COPY_NUMBER_DN,ROVERSI_GLIOMA_COPY_NUMBER_DN,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,AMFR,1
WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,1/46,54/21728,0.10826268154371466,0.1972121711537516,0.14474156445476796,CDKN1A,1
KOYAMA_SEMA3B_TARGETS_UP,KOYAMA_SEMA3B_TARGETS_UP,2/46,266/21728,0.10889571105117445,0.19811641282836004,0.14540522204680362,HK2/ACOX2,2
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,2/46,267/21728,0.1095750500392875,0.19910253453253995,0.14612897452805654,EGF/TGFB2,2
NAGASHIMA_NRG1_SIGNALING_DN,NAGASHIMA_NRG1_SIGNALING_DN,1/46,55/21728,0.11015526789828622,0.19940716411050566,0.14635255384081394,CD44,1
REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,1/46,55/21728,0.11015526789828622,0.19940716411050566,0.14635255384081394,SREBF1,1
REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,1/46,55/21728,0.11015526789828622,0.19940716411050566,0.14635255384081394,KCNMB1,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,2/46,269/21728,0.1109371879598743,0.2005722226207204,0.1472076348962238,RETREG1/ABCC3,2
MODY_HIPPOCAMPUS_POSTNATAL,MODY_HIPPOCAMPUS_POSTNATAL,1/46,56/21728,0.11204392464523816,0.20156785451066417,0.147938367266992,RHOB,1
PETROVA_PROX1_TARGETS_DN,PETROVA_PROX1_TARGETS_DN,1/46,56/21728,0.11204392464523816,0.20156785451066417,0.147938367266992,TCN2,1
WP_CCL18_SIGNALING_PATHWAY,WP_CCL18_SIGNALING_PATHWAY,1/46,56/21728,0.11204392464523816,0.20156785451066417,0.147938367266992,CD44,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,1/46,56/21728,0.11204392464523816,0.20156785451066417,0.147938367266992,TIPARP,1
AMIT_SERUM_RESPONSE_240_MCF10A,AMIT_SERUM_RESPONSE_240_MCF10A,1/46,57/21728,0.11392865976273148,0.20319379662479783,0.1491317084483997,GBP1,1
BYSTROEM_CORRELATED_WITH_IL5_DN,BYSTROEM_CORRELATED_WITH_IL5_DN,1/46,57/21728,0.11392865976273148,0.20319379662479783,0.1491317084483997,CD44,1
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,1/46,57/21728,0.11392865976273148,0.20319379662479783,0.1491317084483997,RASSF8,1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,1/46,57/21728,0.11392865976273148,0.20319379662479783,0.1491317084483997,RETSAT,1
NAGASHIMA_EGF_SIGNALING_UP,NAGASHIMA_EGF_SIGNALING_UP,1/46,57/21728,0.11392865976273148,0.20319379662479783,0.1491317084483997,TIPARP,1
PID_SHP2_PATHWAY,PID_SHP2_PATHWAY,1/46,57/21728,0.11392865976273148,0.20319379662479783,0.1491317084483997,EGF,1
WP_CARDIAC_HYPERTROPHIC_RESPONSE,WP_CARDIAC_HYPERTROPHIC_RESPONSE,1/46,57/21728,0.11392865976273148,0.20319379662479783,0.1491317084483997,EGF,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,2/46,276/21728,0.11574020118605959,0.2045356245541945,0.15011652734975725,GNAI2/GYS1,2
AMIT_SERUM_RESPONSE_60_MCF10A,AMIT_SERUM_RESPONSE_60_MCF10A,1/46,58/21728,0.11580948121309909,0.2045356245541945,0.15011652734975725,RHOB,1
KANNAN_TP53_TARGETS_UP,KANNAN_TP53_TARGETS_UP,1/46,58/21728,0.11580948121309909,0.2045356245541945,0.15011652734975725,CDKN1A,1
KOHOUTEK_CCNT2_TARGETS,KOHOUTEK_CCNT2_TARGETS,1/46,58/21728,0.11580948121309909,0.2045356245541945,0.15011652734975725,RETSAT,1
LEE_EARLY_T_LYMPHOCYTE_DN,LEE_EARLY_T_LYMPHOCYTE_DN,1/46,58/21728,0.11580948121309909,0.2045356245541945,0.15011652734975725,CD44,1
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,1/46,58/21728,0.11580948121309909,0.2045356245541945,0.15011652734975725,CCR10,1
REACTOME_SIGNALING_BY_ERBB4,REACTOME_SIGNALING_BY_ERBB4,1/46,58/21728,0.11580948121309909,0.2045356245541945,0.15011652734975725,EGF,1
WP_TGFBETA_RECEPTOR_SIGNALING,WP_TGFBETA_RECEPTOR_SIGNALING,1/46,58/21728,0.11580948121309909,0.2045356245541945,0.15011652734975725,EGF,1
AMIT_EGF_RESPONSE_240_HELA,AMIT_EGF_RESPONSE_240_HELA,1/46,59/21728,0.11768639694287253,0.2055967175508014,0.15089530413347382,FHL3,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,1/46,59/21728,0.11768639694287253,0.2055967175508014,0.15089530413347382,CDKN1A,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,1/46,59/21728,0.11768639694287253,0.2055967175508014,0.15089530413347382,GBP1,1
PID_ATF2_PATHWAY,PID_ATF2_PATHWAY,1/46,59/21728,0.11768639694287253,0.2055967175508014,0.15089530413347382,TGFB2,1
PID_NOTCH_PATHWAY,PID_NOTCH_PATHWAY,1/46,59/21728,0.11768639694287253,0.2055967175508014,0.15089530413347382,CDKN1A,1
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,1/46,59/21728,0.11768639694287253,0.2055967175508014,0.15089530413347382,CD44,1
WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,1/46,59/21728,0.11768639694287253,0.2055967175508014,0.15089530413347382,CDKN1A,1
WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING_PATHWAYS,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING_PATHWAYS,1/46,59/21728,0.11768639694287253,0.2055967175508014,0.15089530413347382,CDKN1A,1
ZHENG_IL22_SIGNALING_UP,ZHENG_IL22_SIGNALING_UP,1/46,59/21728,0.11768639694287253,0.2055967175508014,0.15089530413347382,PFKFB3,1
BOYLAN_MULTIPLE_MYELOMA_C_D_DN,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,2/46,280/21728,0.11850887834022078,0.20678444475730462,0.1517670226131651,PYGL/RHOB,2
BERNARD_PPAPDC1B_TARGETS_DN,BERNARD_PPAPDC1B_TARGETS_DN,1/46,60/21728,0.11955941488281585,0.207122044898546,0.15201480028488565,SH3BP2,1
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,1/46,60/21728,0.11955941488281585,0.207122044898546,0.15201480028488565,PYGL,1
LEE_LIVER_CANCER_CIPROFIBRATE_UP,LEE_LIVER_CANCER_CIPROFIBRATE_UP,1/46,60/21728,0.11955941488281585,0.207122044898546,0.15201480028488565,CDKN1A,1
REACTOME_GABA_RECEPTOR_ACTIVATION,REACTOME_GABA_RECEPTOR_ACTIVATION,1/46,60/21728,0.11955941488281585,0.207122044898546,0.15201480028488565,GNAI2,1
REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,1/46,60/21728,0.11955941488281585,0.207122044898546,0.15201480028488565,CDKN1A,1
WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,1/46,60/21728,0.11955941488281585,0.207122044898546,0.15201480028488565,TGFB2,1
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,2/46,283/21728,0.12059652417447389,0.20861538776603303,0.15311082180142244,GBP1/CDKN1A,2
REACTOME_SENSORY_PERCEPTION,REACTOME_SENSORY_PERCEPTION,2/46,284/21728,0.1212944885844185,0.20861538776603303,0.15311082180142244,KCNMB1/RETSAT,2
DASU_IL6_SIGNALING_UP,DASU_IL6_SIGNALING_UP,1/46,61/21728,0.12142854294795302,0.20861538776603303,0.15311082180142244,SREBF1,1
LINDSTEDT_DENDRITIC_CELL_MATURATION_A,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,1/46,61/21728,0.12142854294795302,0.20861538776603303,0.15311082180142244,GBP1,1
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,1/46,61/21728,0.12142854294795302,0.20861538776603303,0.15311082180142244,RETSAT,1
PID_TRKR_PATHWAY,PID_TRKR_PATHWAY,1/46,61/21728,0.12142854294795302,0.20861538776603303,0.15311082180142244,RGS19,1
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,1/46,61/21728,0.12142854294795302,0.20861538776603303,0.15311082180142244,AEBP1,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,2/46,285/21728,0.12199348211673501,0.20933792789262223,0.1536411216692857,CD44/RHOB,2
GERHOLD_ADIPOGENESIS_DN,GERHOLD_ADIPOGENESIS_DN,1/46,62/21728,0.12329378903760058,0.2105278230873861,0.15451443131858247,CD44,1
KEGG_COLORECTAL_CANCER,KEGG_COLORECTAL_CANCER,1/46,62/21728,0.12329378903760058,0.2105278230873861,0.15451443131858247,TGFB2,1
KEGG_GLYCOLYSIS_GLUCONEOGENESIS,KEGG_GLYCOLYSIS_GLUCONEOGENESIS,1/46,62/21728,0.12329378903760058,0.2105278230873861,0.15451443131858247,HK2,1
WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,1/46,62/21728,0.12329378903760058,0.2105278230873861,0.15451443131858247,EGF,1
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,2/46,289/21728,0.12479960326364435,0.2105278230873861,0.15451443131858247,TIPARP/RHOB,2
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,1/46,63/21728,0.1251551610353978,0.2105278230873861,0.15451443131858247,ERMAP,1
LEE_LIVER_CANCER_E2F1_UP,LEE_LIVER_CANCER_E2F1_UP,1/46,63/21728,0.1251551610353978,0.2105278230873861,0.15451443131858247,RHOB,1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,1/46,63/21728,0.1251551610353978,0.2105278230873861,0.15451443131858247,ABCC3,1
PHONG_TNF_TARGETS_UP,PHONG_TNF_TARGETS_UP,1/46,63/21728,0.1251551610353978,0.2105278230873861,0.15451443131858247,CD44,1
PID_ENDOTHELIN_PATHWAY,PID_ENDOTHELIN_PATHWAY,1/46,63/21728,0.1251551610353978,0.2105278230873861,0.15451443131858247,GNAI2,1
PID_MYC_REPRESS_PATHWAY,PID_MYC_REPRESS_PATHWAY,1/46,63/21728,0.1251551610353978,0.2105278230873861,0.15451443131858247,CDKN1A,1
SANSOM_WNT_PATHWAY_REQUIRE_MYC,SANSOM_WNT_PATHWAY_REQUIRE_MYC,1/46,63/21728,0.1251551610353978,0.2105278230873861,0.15451443131858247,CD44,1
VILLANUEVA_LIVER_CANCER_KRT19_DN,VILLANUEVA_LIVER_CANCER_KRT19_DN,1/46,63/21728,0.1251551610353978,0.2105278230873861,0.15451443131858247,RETSAT,1
WORSCHECH_TUMOR_REJECTION_UP,WORSCHECH_TUMOR_REJECTION_UP,1/46,63/21728,0.1251551610353978,0.2105278230873861,0.15451443131858247,CCR10,1
WP_LUNG_FIBROSIS,WP_LUNG_FIBROSIS,1/46,63/21728,0.1251551610353978,0.2105278230873861,0.15451443131858247,EGF,1
WP_NOTCH_SIGNALING_PATHWAY,WP_NOTCH_SIGNALING_PATHWAY,1/46,63/21728,0.1251551610353978,0.2105278230873861,0.15451443131858247,CDKN1A,1
ZWANG_EGF_PERSISTENTLY_DN,ZWANG_EGF_PERSISTENTLY_DN,1/46,63/21728,0.1251551610353978,0.2105278230873861,0.15451443131858247,ABCC3,1
POOLA_INVASIVE_BREAST_CANCER_UP,POOLA_INVASIVE_BREAST_CANCER_UP,2/46,292/21728,0.12691464815674813,0.21193137729981262,0.15554455350280258,GBP1/PRUNE2,2
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,1/46,64/21728,0.12701266680933598,0.21193137729981262,0.15554455350280258,AEBP1,1
KEGG_RETINOL_METABOLISM,KEGG_RETINOL_METABOLISM,1/46,64/21728,0.12701266680933598,0.21193137729981262,0.15554455350280258,RETSAT,1
PID_TCR_PATHWAY,PID_TCR_PATHWAY,1/46,64/21728,0.12701266680933598,0.21193137729981262,0.15554455350280258,SH3BP2,1
REACTOME_SEMAPHORIN_INTERACTIONS,REACTOME_SEMAPHORIN_INTERACTIONS,1/46,64/21728,0.12701266680933598,0.21193137729981262,0.15554455350280258,RHOB,1
WP_G1_TO_S_CELL_CYCLE_CONTROL,WP_G1_TO_S_CELL_CYCLE_CONTROL,1/46,64/21728,0.12701266680933598,0.21193137729981262,0.15554455350280258,CDKN1A,1
ZHAN_MULTIPLE_MYELOMA_UP,ZHAN_MULTIPLE_MYELOMA_UP,1/46,64/21728,0.12701266680933598,0.21193137729981262,0.15554455350280258,CDKN1A,1
AMIT_SERUM_RESPONSE_120_MCF10A,AMIT_SERUM_RESPONSE_120_MCF10A,1/46,65/21728,0.12886631421179018,0.21330611370673033,0.1565535251960104,GBP1,1
LEE_LIVER_CANCER_ACOX1_DN,LEE_LIVER_CANCER_ACOX1_DN,1/46,65/21728,0.12886631421179018,0.21330611370673033,0.1565535251960104,CA3,1
LEE_LIVER_CANCER_MYC_TGFA_DN,LEE_LIVER_CANCER_MYC_TGFA_DN,1/46,65/21728,0.12886631421179018,0.21330611370673033,0.1565535251960104,CA3,1
PID_LYSOPHOSPHOLIPID_PATHWAY,PID_LYSOPHOSPHOLIPID_PATHWAY,1/46,65/21728,0.12886631421179018,0.21330611370673033,0.1565535251960104,GNAI2,1
REACTOME_RAB_GERANYLGERANYLATION,REACTOME_RAB_GERANYLGERANYLATION,1/46,65/21728,0.12886631421179018,0.21330611370673033,0.1565535251960104,RAB36,1
WP_ENDOCHONDRAL_OSSIFICATION,WP_ENDOCHONDRAL_OSSIFICATION,1/46,65/21728,0.12886631421179018,0.21330611370673033,0.1565535251960104,TGFB2,1
WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,1/46,65/21728,0.12886631421179018,0.21330611370673033,0.1565535251960104,TGFB2,1
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,2/46,296/21728,0.12974828321153695,0.21452110679216485,0.15744525514836927,HK2/HSPB8,2
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,1/46,66/21728,0.13071611107954884,0.21465273053833048,0.15754185885608138,SLC22A4,1
BRUNO_HEMATOPOIESIS,BRUNO_HEMATOPOIESIS,1/46,66/21728,0.13071611107954884,0.21465273053833048,0.15754185885608138,HK2,1
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,1/46,66/21728,0.13071611107954884,0.21465273053833048,0.15754185885608138,ABCC3,1
LEE_LIVER_CANCER_CIPROFIBRATE_DN,LEE_LIVER_CANCER_CIPROFIBRATE_DN,1/46,66/21728,0.13071611107954884,0.21465273053833048,0.15754185885608138,CA3,1
URS_ADIPOCYTE_DIFFERENTIATION_UP,URS_ADIPOCYTE_DIFFERENTIATION_UP,1/46,66/21728,0.13071611107954884,0.21465273053833048,0.15754185885608138,PFKFB3,1
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,1/46,66/21728,0.13071611107954884,0.21465273053833048,0.15754185885608138,PRUNE2,1
BROWNE_INTERFERON_RESPONSIVE_GENES,BROWNE_INTERFERON_RESPONSIVE_GENES,1/46,67/21728,0.13256206523384362,0.21651540863914925,0.15890894964368776,GBP1,1
MARSON_FOXP3_TARGETS_UP,MARSON_FOXP3_TARGETS_UP,1/46,67/21728,0.13256206523384362,0.21651540863914925,0.15890894964368776,CD44,1
PID_TELOMERASE_PATHWAY,PID_TELOMERASE_PATHWAY,1/46,67/21728,0.13256206523384362,0.21651540863914925,0.15890894964368776,EGF,1
WP_PPAR_SIGNALING_PATHWAY,WP_PPAR_SIGNALING_PATHWAY,1/46,67/21728,0.13256206523384362,0.21651540863914925,0.15890894964368776,ACOX2,1
DURAND_STROMA_S_UP,DURAND_STROMA_S_UP,2/46,300/21728,0.1325970226700445,0.21651540863914925,0.15890894964368776,HSPB8/PRUNE2,2
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,2/46,301/21728,0.13331151571014685,0.2174372303483835,0.15958550989634535,CD44/TGFB2,2
AMIT_EGF_RESPONSE_120_HELA,AMIT_EGF_RESPONSE_120_HELA,1/46,68/21728,0.13440418448038094,0.21750677175954505,0.15963654900101637,CDKN1A,1
DANG_REGULATED_BY_MYC_UP,DANG_REGULATED_BY_MYC_UP,1/46,68/21728,0.13440418448038094,0.21750677175954505,0.15963654900101637,SREBF1,1
KEGG_P53_SIGNALING_PATHWAY,KEGG_P53_SIGNALING_PATHWAY,1/46,68/21728,0.13440418448038094,0.21750677175954505,0.15963654900101637,CDKN1A,1
PID_P75_NTR_PATHWAY,PID_P75_NTR_PATHWAY,1/46,68/21728,0.13440418448038094,0.21750677175954505,0.15963654900101637,RHOB,1
REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,1/46,68/21728,0.13440418448038094,0.21750677175954505,0.15963654900101637,CDKN1A,1
WP_MELANOMA,WP_MELANOMA,1/46,68/21728,0.13440418448038094,0.21750677175954505,0.15963654900101637,CDKN1A,1
WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING_PATHWAY,1/46,68/21728,0.13440418448038094,0.21750677175954505,0.15963654900101637,GNAI2,1
AKL_HTLV1_INFECTION_DN,AKL_HTLV1_INFECTION_DN,1/46,69/21728,0.1362424766093704,0.21901506772016302,0.16074354516521583,PRUNE2,1
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE,BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE,1/46,69/21728,0.1362424766093704,0.21901506772016302,0.16074354516521583,HSPB8,1
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,1/46,69/21728,0.1362424766093704,0.21901506772016302,0.16074354516521583,HSPB8,1
KEGG_PPAR_SIGNALING_PATHWAY,KEGG_PPAR_SIGNALING_PATHWAY,1/46,69/21728,0.1362424766093704,0.21901506772016302,0.16074354516521583,ACOX2,1
PID_MTOR_4PATHWAY,PID_MTOR_4PATHWAY,1/46,69/21728,0.1362424766093704,0.21901506772016302,0.16074354516521583,SREBF1,1
WP_DNA_DAMAGE_RESPONSE,WP_DNA_DAMAGE_RESPONSE,1/46,69/21728,0.1362424766093704,0.21901506772016302,0.16074354516521583,CDKN1A,1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,2/46,307/21728,0.1376173367844606,0.2194640906118324,0.1610731002602995,EGF/CDKN1A,2
FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,1/46,70/21728,0.1380769493955547,0.2194640906118324,0.1610731002602995,RGS19,1
HUANG_DASATINIB_RESISTANCE_DN,HUANG_DASATINIB_RESISTANCE_DN,1/46,70/21728,0.1380769493955547,0.2194640906118324,0.1610731002602995,RHOB,1
KEGG_LONG_TERM_DEPRESSION,KEGG_LONG_TERM_DEPRESSION,1/46,70/21728,0.1380769493955547,0.2194640906118324,0.1610731002602995,GNAI2,1
KEGG_RENAL_CELL_CARCINOMA,KEGG_RENAL_CELL_CARCINOMA,1/46,70/21728,0.1380769493955547,0.2194640906118324,0.1610731002602995,TGFB2,1
PID_CDC42_PATHWAY,PID_CDC42_PATHWAY,1/46,70/21728,0.1380769493955547,0.2194640906118324,0.1610731002602995,ACTR3,1
REACTOME_CIRCADIAN_CLOCK,REACTOME_CIRCADIAN_CLOCK,1/46,70/21728,0.1380769493955547,0.2194640906118324,0.1610731002602995,SREBF1,1
REACTOME_RHOB_GTPASE_CYCLE,REACTOME_RHOB_GTPASE_CYCLE,1/46,70/21728,0.1380769493955547,0.2194640906118324,0.1610731002602995,RHOB,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,1/46,70/21728,0.1380769493955547,0.2194640906118324,0.1610731002602995,AEBP1,1
VERNELL_RETINOBLASTOMA_PATHWAY_UP,VERNELL_RETINOBLASTOMA_PATHWAY_UP,1/46,70/21728,0.1380769493955547,0.2194640906118324,0.1610731002602995,CDKN1A,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,2/46,308/21728,0.13833805435807917,0.2194640906118324,0.1610731002602995,CD44/PYGL,2
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,2/46,308/21728,0.13833805435807917,0.2194640906118324,0.1610731002602995,ACTR3/GNAI2,2
DER_IFN_GAMMA_RESPONSE_UP,DER_IFN_GAMMA_RESPONSE_UP,1/46,71/21728,0.13990761059824197,0.2212279556896956,0.16236766838641178,GBP1,1
DOANE_BREAST_CANCER_CLASSES_UP,DOANE_BREAST_CANCER_CLASSES_UP,1/46,71/21728,0.13990761059824197,0.2212279556896956,0.16236766838641178,RHOB,1
SATOH_COLORECTAL_CANCER_MYC_DN,SATOH_COLORECTAL_CANCER_MYC_DN,1/46,71/21728,0.13990761059824197,0.2212279556896956,0.16236766838641178,RETSAT,1
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,2/46,311/21728,0.14050535444682088,0.2219311154116452,0.16288374423315663,RETSAT/CDKN1A,2
KEGG_LEISHMANIA_INFECTION,KEGG_LEISHMANIA_INFECTION,1/46,72/21728,0.14173446796133393,0.22314329917908166,0.16377341231945666,TGFB2,1
LANDIS_BREAST_CANCER_PROGRESSION_DN,LANDIS_BREAST_CANCER_PROGRESSION_DN,1/46,72/21728,0.14173446796133393,0.22314329917908166,0.16377341231945666,HSPB8,1
WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,1/46,72/21728,0.14173446796133393,0.22314329917908166,0.16377341231945666,CDKN1A,1
FURUKAWA_DUSP6_TARGETS_PCI35_DN,FURUKAWA_DUSP6_TARGETS_PCI35_DN,1/46,73/21728,0.14355752921335574,0.22503612687499008,0.16516263104944823,ACOX2,1
GAURNIER_PSMD4_TARGETS,GAURNIER_PSMD4_TARGETS,1/46,73/21728,0.14355752921335574,0.22503612687499008,0.16516263104944823,CCR10,1
HUANG_GATA2_TARGETS_DN,HUANG_GATA2_TARGETS_DN,1/46,73/21728,0.14355752921335574,0.22503612687499008,0.16516263104944823,HK2,1
PID_E2F_PATHWAY,PID_E2F_PATHWAY,1/46,73/21728,0.14355752921335574,0.22503612687499008,0.16516263104944823,CDKN1A,1
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,2/46,317/21728,0.1448625236618618,0.22641929430489147,0.1661777905932815,MICALL2/CDKN1A,2
DER_IFN_ALPHA_RESPONSE_UP,DER_IFN_ALPHA_RESPONSE_UP,1/46,74/21728,0.1453768020674855,0.22641929430489147,0.1661777905932815,GBP1,1
LEE_LIVER_CANCER_DENA_DN,LEE_LIVER_CANCER_DENA_DN,1/46,74/21728,0.1453768020674855,0.22641929430489147,0.1661777905932815,CA3,1
SESTO_RESPONSE_TO_UV_C1,SESTO_RESPONSE_TO_UV_C1,1/46,74/21728,0.1453768020674855,0.22641929430489147,0.1661777905932815,CDKN1A,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,1/46,74/21728,0.1453768020674855,0.22641929430489147,0.1661777905932815,AEBP1,1
WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,1/46,74/21728,0.1453768020674855,0.22641929430489147,0.1661777905932815,CDKN1A,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,2/46,319/21728,0.14632140890269404,0.22718803298573823,0.16674199734924233,SH3BP2/ABCC3,2
ANDERSEN_LIVER_CANCER_KRT19_DN,ANDERSEN_LIVER_CANCER_KRT19_DN,1/46,75/21728,0.1471922942215862,0.22718803298573823,0.16674199734924233,RETSAT,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,1/46,75/21728,0.1471922942215862,0.22718803298573823,0.16674199734924233,RHOB,1
JAIN_NFKB_SIGNALING,JAIN_NFKB_SIGNALING,1/46,75/21728,0.1471922942215862,0.22718803298573823,0.16674199734924233,HK2,1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,1/46,75/21728,0.1471922942215862,0.22718803298573823,0.16674199734924233,GBP1,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,1/46,75/21728,0.1471922942215862,0.22718803298573823,0.16674199734924233,AEBP1,1
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,1/46,75/21728,0.1471922942215862,0.22718803298573823,0.16674199734924233,RHOB,1
WP_PEPTIDE_GPCRS,WP_PEPTIDE_GPCRS,1/46,75/21728,0.1471922942215862,0.22718803298573823,0.16674199734924233,CCR10,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,2/46,321/21728,0.14778345578117064,0.22718803298573823,0.16674199734924233,HK2/ABCC3,2
REACTOME_RHO_GTPASE_EFFECTORS,REACTOME_RHO_GTPASE_EFFECTORS,2/46,322/21728,0.1485156488434813,0.22718803298573823,0.16674199734924233,ACTR3/RHOB,2
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,2/46,322/21728,0.1485156488434813,0.22718803298573823,0.16674199734924233,HK2/RGS19,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,1/46,76/21728,0.14900401335823243,0.22718803298573823,0.16674199734924233,GBP1,1
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,1/46,76/21728,0.14900401335823243,0.22718803298573823,0.16674199734924233,TCN2,1
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN,1/46,76/21728,0.14900401335823243,0.22718803298573823,0.16674199734924233,LAP3,1
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,1/46,76/21728,0.14900401335823243,0.22718803298573823,0.16674199734924233,CDKN1A,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,1/46,76/21728,0.14900401335823243,0.22718803298573823,0.16674199734924233,RETREG1,1
REACTOME_ECM_PROTEOGLYCANS,REACTOME_ECM_PROTEOGLYCANS,1/46,76/21728,0.14900401335823243,0.22718803298573823,0.16674199734924233,TGFB2,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,1/46,76/21728,0.14900401335823243,0.22718803298573823,0.16674199734924233,CD44,1
WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,1/46,76/21728,0.14900401335823243,0.22718803298573823,0.16674199734924233,CDKN1A,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,1/46,76/21728,0.14900401335823243,0.22718803298573823,0.16674199734924233,CA3,1
FRASOR_RESPONSE_TO_ESTRADIOL_DN,FRASOR_RESPONSE_TO_ESTRADIOL_DN,1/46,77/21728,0.1508119671447432,0.22802643624596208,0.16735733360774424,TGFB2,1
GROSS_HYPOXIA_VIA_HIF1A_UP,GROSS_HYPOXIA_VIA_HIF1A_UP,1/46,77/21728,0.1508119671447432,0.22802643624596208,0.16735733360774424,ACOX2,1
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,1/46,77/21728,0.1508119671447432,0.22802643624596208,0.16735733360774424,CDKN1A,1
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,1/46,77/21728,0.1508119671447432,0.22802643624596208,0.16735733360774424,HSPB8,1
MAHAJAN_RESPONSE_TO_IL1A_UP,MAHAJAN_RESPONSE_TO_IL1A_UP,1/46,77/21728,0.1508119671447432,0.22802643624596208,0.16735733360774424,RHOB,1
MUNSHI_MULTIPLE_MYELOMA_UP,MUNSHI_MULTIPLE_MYELOMA_UP,1/46,77/21728,0.1508119671447432,0.22802643624596208,0.16735733360774424,ABCC3,1
REACTOME_SENSORY_PROCESSING_OF_SOUND,REACTOME_SENSORY_PROCESSING_OF_SOUND,1/46,77/21728,0.1508119671447432,0.22802643624596208,0.16735733360774424,KCNMB1,1
RODRIGUES_THYROID_CARCINOMA_DN,RODRIGUES_THYROID_CARCINOMA_DN,1/46,77/21728,0.1508119671447432,0.22802643624596208,0.16735733360774424,CD44,1
CHEBOTAEV_GR_TARGETS_UP,CHEBOTAEV_GR_TARGETS_UP,1/46,78/21728,0.15261616323320726,0.22931962351103682,0.16830645326290977,LAP3,1
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1/46,78/21728,0.15261616323320726,0.22931962351103682,0.16830645326290977,EGF,1
REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,1/46,78/21728,0.15261616323320726,0.22931962351103682,0.16830645326290977,CDKN1A,1
REACTOME_REGULATION_OF_INSULIN_SECRETION,REACTOME_REGULATION_OF_INSULIN_SECRETION,1/46,78/21728,0.15261616323320726,0.22931962351103682,0.16830645326290977,GNAI2,1
SEKI_INFLAMMATORY_RESPONSE_LPS_UP,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,1/46,78/21728,0.15261616323320726,0.22931962351103682,0.16830645326290977,CD44,1
WOO_LIVER_CANCER_RECURRENCE_DN,WOO_LIVER_CANCER_RECURRENCE_DN,1/46,78/21728,0.15261616323320726,0.22931962351103682,0.16830645326290977,ACOX2,1
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,1/46,79/21728,0.1544166092605177,0.23106716556011422,0.1695890412931219,PYGL,1
PID_P73PATHWAY,PID_P73PATHWAY,1/46,79/21728,0.1544166092605177,0.23106716556011422,0.1695890412931219,CDKN1A,1
REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,1/46,79/21728,0.1544166092605177,0.23106716556011422,0.1695890412931219,CDKN1A,1
RUAN_RESPONSE_TO_TNF_DN,RUAN_RESPONSE_TO_TNF_DN,1/46,79/21728,0.1544166092605177,0.23106716556011422,0.1695890412931219,HK2,1
BOYLAN_MULTIPLE_MYELOMA_D_DN,BOYLAN_MULTIPLE_MYELOMA_D_DN,1/46,80/21728,0.15621331284839823,0.2327947622098432,0.17085699063096296,CD44,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,1/46,80/21728,0.15621331284839823,0.2327947622098432,0.17085699063096296,GBP1,1
REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,1/46,80/21728,0.15621331284839823,0.2327947622098432,0.17085699063096296,RHOB,1
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,1/46,80/21728,0.15621331284839823,0.2327947622098432,0.17085699063096296,CA3,1
BIOCARTA_MAPK_PATHWAY,BIOCARTA_MAPK_PATHWAY,1/46,81/21728,0.15800628160343178,0.2340236040091686,0.1717588846847691,TGFB2,1
MORI_PRE_BI_LYMPHOCYTE_UP,MORI_PRE_BI_LYMPHOCYTE_UP,1/46,81/21728,0.15800628160343178,0.2340236040091686,0.1717588846847691,CDKN1A,1
ROSS_AML_WITH_MLL_FUSIONS,ROSS_AML_WITH_MLL_FUSIONS,1/46,81/21728,0.15800628160343178,0.2340236040091686,0.1717588846847691,RNASE3,1
ROSS_LEUKEMIA_WITH_MLL_FUSIONS,ROSS_LEUKEMIA_WITH_MLL_FUSIONS,1/46,81/21728,0.15800628160343178,0.2340236040091686,0.1717588846847691,RNASE3,1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,1/46,81/21728,0.15800628160343178,0.2340236040091686,0.1717588846847691,HK2,1
ZAMORA_NOS2_TARGETS_DN,ZAMORA_NOS2_TARGETS_DN,1/46,81/21728,0.15800628160343178,0.2340236040091686,0.1717588846847691,HSPB8,1
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,2/46,336/21728,0.1588444823988219,0.2349934163486675,0.17247066709873163,TGFB2/RHOB,2
BHAT_ESR1_TARGETS_VIA_AKT1_DN,BHAT_ESR1_TARGETS_VIA_AKT1_DN,1/46,82/21728,0.15979552311709389,0.2349934163486675,0.17247066709873163,TGFB2,1
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1/46,82/21728,0.15979552311709389,0.2349934163486675,0.17247066709873163,CD44,1
PID_REG_GR_PATHWAY,PID_REG_GR_PATHWAY,1/46,82/21728,0.15979552311709389,0.2349934163486675,0.17247066709873163,CDKN1A,1
PID_SMAD2_3NUCLEAR_PATHWAY,PID_SMAD2_3NUCLEAR_PATHWAY,1/46,82/21728,0.15979552311709389,0.2349934163486675,0.17247066709873163,CDKN1A,1
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,1/46,82/21728,0.15979552311709389,0.2349934163486675,0.17247066709873163,RHOB,1
ZHU_CMV_24_HR_UP,ZHU_CMV_24_HR_UP,1/46,82/21728,0.15979552311709389,0.2349934163486675,0.17247066709873163,GBP1,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,1/46,83/21728,0.16158104496577774,0.23594412406885973,0.17316842790099252,TIPARP,1
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,1/46,83/21728,0.16158104496577774,0.23594412406885973,0.17316842790099252,TGFB2,1
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,1/46,83/21728,0.16158104496577774,0.23594412406885973,0.17316842790099252,CD44,1
NGUYEN_NOTCH1_TARGETS_DN,NGUYEN_NOTCH1_TARGETS_DN,1/46,83/21728,0.16158104496577774,0.23594412406885973,0.17316842790099252,TIPARP,1
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,1/46,83/21728,0.16158104496577774,0.23594412406885973,0.17316842790099252,CDKN1A,1
SWEET_KRAS_TARGETS_UP,SWEET_KRAS_TARGETS_UP,1/46,83/21728,0.16158104496577774,0.23594412406885973,0.17316842790099252,TGFB2,1
WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,WP_GLIOBLASTOMA_SIGNALING_PATHWAYS,1/46,83/21728,0.16158104496577774,0.23594412406885973,0.17316842790099252,CDKN1A,1
JACKSON_DNMT1_TARGETS_UP,JACKSON_DNMT1_TARGETS_UP,1/46,84/21728,0.16336285471082623,0.23687613933069804,0.17385246959225822,CDKN1A,1
KEGG_ECM_RECEPTOR_INTERACTION,KEGG_ECM_RECEPTOR_INTERACTION,1/46,84/21728,0.16336285471082623,0.23687613933069804,0.17385246959225822,CD44,1
ONDER_CDH1_SIGNALING_VIA_CTNNB1,ONDER_CDH1_SIGNALING_VIA_CTNNB1,1/46,84/21728,0.16336285471082623,0.23687613933069804,0.17385246959225822,PRUNE2,1
PID_CMYB_PATHWAY,PID_CMYB_PATHWAY,1/46,84/21728,0.16336285471082623,0.23687613933069804,0.17385246959225822,CDKN1A,1
REACTOME_PI_METABOLISM,REACTOME_PI_METABOLISM,1/46,84/21728,0.16336285471082623,0.23687613933069804,0.17385246959225822,PLEKHA4,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1/46,84/21728,0.16336285471082623,0.23687613933069804,0.17385246959225822,SREBF1,1
WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,1/46,84/21728,0.16336285471082623,0.23687613933069804,0.17385246959225822,EGF,1
NABA_SECRETED_FACTORS,NABA_SECRETED_FACTORS,2/46,343/21728,0.1640602709725689,0.23764974316705784,0.17442024707215642,EGF/TGFB2,2
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,1/46,85/21728,0.16514095989856004,0.23802623444623466,0.17469656843930542,GYS1,1
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,1/46,85/21728,0.16514095989856004,0.23802623444623466,0.17469656843930542,GNAI2,1
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1/46,85/21728,0.16514095989856004,0.23802623444623466,0.17469656843930542,CDKN1A,1
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,1/46,85/21728,0.16514095989856004,0.23802623444623466,0.17469656843930542,CD44,1
SASSON_RESPONSE_TO_FORSKOLIN_DN,SASSON_RESPONSE_TO_FORSKOLIN_DN,1/46,85/21728,0.16514095989856004,0.23802623444623466,0.17469656843930542,GBP1,1
YAGI_AML_WITH_11Q23_REARRANGED,YAGI_AML_WITH_11Q23_REARRANGED,2/46,345/21728,0.165556370688636,0.23838802134907863,0.17496209770157423,AEBP1/RGS19,2
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP,1/46,86/21728,0.1669153680603057,0.23868568410990462,0.17518056380044542,TIPARP,1
HILLION_HMGA1B_TARGETS,HILLION_HMGA1B_TARGETS,1/46,86/21728,0.1669153680603057,0.23868568410990462,0.17518056380044542,CD44,1
KEGG_TGF_BETA_SIGNALING_PATHWAY,KEGG_TGF_BETA_SIGNALING_PATHWAY,1/46,86/21728,0.1669153680603057,0.23868568410990462,0.17518056380044542,TGFB2,1
REACTOME_PLATELET_HOMEOSTASIS,REACTOME_PLATELET_HOMEOSTASIS,1/46,86/21728,0.1669153680603057,0.23868568410990462,0.17518056380044542,KCNMB1,1
REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,1/46,86/21728,0.1669153680603057,0.23868568410990462,0.17518056380044542,SLC22A4,1
SASSON_RESPONSE_TO_GONADOTROPHINS_DN,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,1/46,86/21728,0.1669153680603057,0.23868568410990462,0.17518056380044542,GBP1,1
SASSON_RESPONSE_TO_GONADOTROPHINS_UP,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,1/46,86/21728,0.1669153680603057,0.23868568410990462,0.17518056380044542,RHOB,1
KAYO_CALORIE_RESTRICTION_MUSCLE_DN,KAYO_CALORIE_RESTRICTION_MUSCLE_DN,1/46,87/21728,0.1686860867124279,0.24050621999313712,0.17651672480077069,DDO,1
KEGG_HEMATOPOIETIC_CELL_LINEAGE,KEGG_HEMATOPOIETIC_CELL_LINEAGE,1/46,87/21728,0.1686860867124279,0.24050621999313712,0.17651672480077069,CD44,1
WP_TCELL_ACTIVATION_SARSCOV2,WP_TCELL_ACTIVATION_SARSCOV2,1/46,87/21728,0.1686860867124279,0.24050621999313712,0.17651672480077069,CDKN1A,1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,1/46,88/21728,0.17045312335635476,0.24089379031843508,0.17680117750412913,TGFB2,1
KANG_IMMORTALIZED_BY_TERT_UP,KANG_IMMORTALIZED_BY_TERT_UP,1/46,88/21728,0.17045312335635476,0.24089379031843508,0.17680117750412913,TGFB2,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,1/46,88/21728,0.17045312335635476,0.24089379031843508,0.17680117750412913,GBP1,1
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,1/46,88/21728,0.17045312335635476,0.24089379031843508,0.17680117750412913,PYGL,1
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,1/46,88/21728,0.17045312335635476,0.24089379031843508,0.17680117750412913,CDKN1A,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,1/46,88/21728,0.17045312335635476,0.24089379031843508,0.17680117750412913,CDKN1A,1
SASSON_RESPONSE_TO_FORSKOLIN_UP,SASSON_RESPONSE_TO_FORSKOLIN_UP,1/46,88/21728,0.17045312335635476,0.24089379031843508,0.17680117750412913,RHOB,1
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,1/46,88/21728,0.17045312335635476,0.24089379031843508,0.17680117750412913,CD44,1
WP_RETINOBLASTOMA_GENE_IN_CANCER,WP_RETINOBLASTOMA_GENE_IN_CANCER,1/46,88/21728,0.17045312335635476,0.24089379031843508,0.17680117750412913,CDKN1A,1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,2/46,353/21728,0.17156554873360252,0.24222983998415157,0.17778175551649888,GBP1/AEBP1,2
IVANOVSKA_MIR106B_TARGETS,IVANOVSKA_MIR106B_TARGETS,1/46,89/21728,0.17221648547861046,0.2424406834407623,0.17793650160334715,CDKN1A,1
SEIDEN_ONCOGENESIS_BY_MET,SEIDEN_ONCOGENESIS_BY_MET,1/46,89/21728,0.17221648547861046,0.2424406834407623,0.17793650160334715,ACTR3,1
SWEET_KRAS_ONCOGENIC_SIGNATURE,SWEET_KRAS_ONCOGENIC_SIGNATURE,1/46,89/21728,0.17221648547861046,0.2424406834407623,0.17793650160334715,CDKN1A,1
KEGG_DILATED_CARDIOMYOPATHY,KEGG_DILATED_CARDIOMYOPATHY,1/46,90/21728,0.1739761805508404,0.24444327693674284,0.1794062816573844,TGFB2,1
REACTOME_OPIOID_SIGNALLING,REACTOME_OPIOID_SIGNALLING,1/46,90/21728,0.1739761805508404,0.24444327693674284,0.1794062816573844,GNAI2,1
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,2/46,357/21728,0.17458436067625044,0.24506033202377847,0.17985916201527405,AMFR/PRUNE2,2
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,1/46,91/21728,0.17573221602984324,0.2461948920224857,0.18069185904517826,TGFB2,1
MORI_IMMATURE_B_LYMPHOCYTE_DN,MORI_IMMATURE_B_LYMPHOCYTE_DN,1/46,91/21728,0.17573221602984324,0.2461948920224857,0.18069185904517826,CDKN1A,1
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,2/46,359/21728,0.17609716353270852,0.24623036366675732,0.18071789304326072,GBP1/PYGL,2
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,2/46,359/21728,0.17609716353270852,0.24623036366675732,0.18071789304326072,MICALL2/RHOB,2
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,2/46,360/21728,0.17685439459380328,0.24692008478981176,0.1812241057876586,SLC22A4/PACRG,2
DURCHDEWALD_SKIN_CARCINOGENESIS_UP,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,1/46,92/21728,0.17748459935759797,0.24692008478981176,0.1812241057876586,HSPB8,1
LEIN_PONS_MARKERS,LEIN_PONS_MARKERS,1/46,92/21728,0.17748459935759797,0.24692008478981176,0.1812241057876586,HSPB8,1
REACTOME_EPH_EPHRIN_SIGNALING,REACTOME_EPH_EPHRIN_SIGNALING,1/46,92/21728,0.17748459935759797,0.24692008478981176,0.1812241057876586,ACTR3,1
REACTOME_RHO_GTPASES_ACTIVATE_PKNS,REACTOME_RHO_GTPASES_ACTIVATE_PKNS,1/46,92/21728,0.17748459935759797,0.24692008478981176,0.1812241057876586,RHOB,1
SANSOM_APC_TARGETS_DN,SANSOM_APC_TARGETS_DN,2/46,361/21728,0.17761217133501633,0.24692008478981176,0.1812241057876586,SLC22A4/ABCC3,2
MORI_MATURE_B_LYMPHOCYTE_UP,MORI_MATURE_B_LYMPHOCYTE_UP,1/46,93/21728,0.17923333796129304,0.24822191026158064,0.18217956535350852,SH3BP2,1
SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,1/46,93/21728,0.17923333796129304,0.24822191026158064,0.18217956535350852,TGFB2,1
WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING_PATHWAY,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING_PATHWAY,1/46,93/21728,0.17923333796129304,0.24822191026158064,0.18217956535350852,GNAI2,1
WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,1/46,93/21728,0.17923333796129304,0.24822191026158064,0.18217956535350852,CDKN1A,1
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,1/46,94/21728,0.18097843925335577,0.24968481152936808,0.18325324461429485,CD44,1
KAYO_CALORIE_RESTRICTION_MUSCLE_UP,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,1/46,94/21728,0.18097843925335577,0.24968481152936808,0.18325324461429485,MTMR11,1
WP_TNFALPHA_SIGNALING_PATHWAY,WP_TNFALPHA_SIGNALING_PATHWAY,1/46,94/21728,0.18097843925335577,0.24968481152936808,0.18325324461429485,PYGL,1
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,1/46,94/21728,0.18097843925335577,0.24968481152936808,0.18325324461429485,ACTR3,1
CHEN_LIVER_METABOLISM_QTL_CIS,CHEN_LIVER_METABOLISM_QTL_CIS,1/46,95/21728,0.18271991063148063,0.2511316307257317,0.18431512062701613,ACTR3,1
LIM_MAMMARY_LUMINAL_MATURE_DN,LIM_MAMMARY_LUMINAL_MATURE_DN,1/46,95/21728,0.18271991063148063,0.2511316307257317,0.18431512062701613,AEBP1,1
WESTON_VEGFA_TARGETS,WESTON_VEGFA_TARGETS,1/46,95/21728,0.18271991063148063,0.2511316307257317,0.18431512062701613,FHL3,1
WINTER_HYPOXIA_UP,WINTER_HYPOXIA_UP,1/46,95/21728,0.18271991063148063,0.2511316307257317,0.18431512062701613,PYGL,1
WANG_LMO4_TARGETS_UP,WANG_LMO4_TARGETS_UP,2/46,369/21728,0.18369337018453233,0.252230479893534,0.18512160811060824,TIPARP/RHOB,2
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,1/46,96/21728,0.1844577594786564,0.25256256019268347,0.1853653345588406,AMFR,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1/46,96/21728,0.1844577594786564,0.25256256019268347,0.1853653345588406,CDKN1A,1
WP_G_PROTEIN_SIGNALING_PATHWAYS,WP_G_PROTEIN_SIGNALING_PATHWAYS,1/46,96/21728,0.1844577594786564,0.25256256019268347,0.1853653345588406,GNAI2,1
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,1/46,97/21728,0.1861919931631969,0.25397778935713594,0.18640402543743334,HSPB6,1
GAVIN_FOXP3_TARGETS_CLUSTER_T4,GAVIN_FOXP3_TARGETS_CLUSTER_T4,1/46,97/21728,0.1861919931631969,0.25397778935713594,0.18640402543743334,CD44,1
NAKAMURA_ADIPOGENESIS_LATE_UP,NAKAMURA_ADIPOGENESIS_LATE_UP,1/46,97/21728,0.1861919931631969,0.25397778935713594,0.18640402543743334,TGFB2,1
REACTOME_ANTIMICROBIAL_PEPTIDES,REACTOME_ANTIMICROBIAL_PEPTIDES,1/46,97/21728,0.1861919931631969,0.25397778935713594,0.18640402543743334,RNASE3,1
BROWNE_HCMV_INFECTION_10HR_UP,BROWNE_HCMV_INFECTION_10HR_UP,1/46,98/21728,0.1879226190387684,0.2546614930899198,0.18690582178868156,GBP1,1
IGARASHI_ATF4_TARGETS_DN,IGARASHI_ATF4_TARGETS_DN,1/46,98/21728,0.1879226190387684,0.2546614930899198,0.18690582178868156,RETREG1,1
KIM_MYC_AMPLIFICATION_TARGETS_DN,KIM_MYC_AMPLIFICATION_TARGETS_DN,1/46,98/21728,0.1879226190387684,0.2546614930899198,0.18690582178868156,PRUNE2,1
QI_PLASMACYTOMA_DN,QI_PLASMACYTOMA_DN,1/46,98/21728,0.1879226190387684,0.2546614930899198,0.18690582178868156,AEBP1,1
TAKAO_RESPONSE_TO_UVB_RADIATION_DN,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,1/46,98/21728,0.1879226190387684,0.2546614930899198,0.18690582178868156,AEBP1,1
WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,WP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1/46,98/21728,0.1879226190387684,0.2546614930899198,0.18690582178868156,SH3BP2,1
WP_SMALL_CELL_LUNG_CANCER,WP_SMALL_CELL_LUNG_CANCER,1/46,98/21728,0.1879226190387684,0.2546614930899198,0.18690582178868156,CDKN1A,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,2/46,375/21728,0.18827528077873856,0.25490117379007554,0.18708173263286124,SREBF1/CDKN1A,2
HAHTOLA_SEZARY_SYNDROM_UP,HAHTOLA_SEZARY_SYNDROM_UP,1/46,99/21728,0.18964964444441879,0.2557799446269535,0.18772669620170598,CCR10,1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,1/46,99/21728,0.18964964444441879,0.2557799446269535,0.18772669620170598,RETREG1,1
WP_COMPLEMENT_SYSTEM,WP_COMPLEMENT_SYSTEM,1/46,99/21728,0.18964964444441879,0.2557799446269535,0.18772669620170598,GNAI2,1
WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,WP_HIPPO_SIGNALING_REGULATION_PATHWAYS,1/46,99/21728,0.18964964444441879,0.2557799446269535,0.18772669620170598,GNAI2,1
HATADA_METHYLATED_IN_LUNG_CANCER_UP,HATADA_METHYLATED_IN_LUNG_CANCER_UP,2/46,377/21728,0.1898063589093807,0.2557799446269535,0.18772669620170598,RETREG1/HSPB6,2
REACTOME_VISUAL_PHOTOTRANSDUCTION,REACTOME_VISUAL_PHOTOTRANSDUCTION,1/46,100/21728,0.19137307670460457,0.25765177457908695,0.18910050388345329,RETSAT,1
KANG_IMMORTALIZED_BY_TERT_DN,KANG_IMMORTALIZED_BY_TERT_DN,1/46,101/21728,0.1930929231292201,0.25876593210477744,0.18991822675711792,CD44,1
KEGG_MELANOGENESIS,KEGG_MELANOGENESIS,1/46,101/21728,0.1930929231292201,0.25876593210477744,0.18991822675711792,GNAI2,1
REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,1/46,101/21728,0.1930929231292201,0.25876593210477744,0.18991822675711792,HSPB8,1
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,1/46,101/21728,0.1930929231292201,0.25876593210477744,0.18991822675711792,AMFR,1
WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,1/46,101/21728,0.1930929231292201,0.25876593210477744,0.18991822675711792,EGF,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,2/46,383/21728,0.19441033160148516,0.25986506620952937,0.19072492336684874,KCNE4/DDO,2
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,2/46,383/21728,0.19441033160148516,0.25986506620952937,0.19072492336684874,CD44/CDKN1A,2
BROWNE_HCMV_INFECTION_20HR_DN,BROWNE_HCMV_INFECTION_20HR_DN,1/46,102/21728,0.19480919101362648,0.25986506620952937,0.19072492336684874,SLC22A4,1
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,1/46,102/21728,0.19480919101362648,0.25986506620952937,0.19072492336684874,PRUNE2,1
WP_NEURAL_CREST_DIFFERENTIATION,WP_NEURAL_CREST_DIFFERENTIATION,1/46,102/21728,0.19480919101362648,0.25986506620952937,0.19072492336684874,RHOB,1
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,2/46,384/21728,0.19517917224643963,0.26011930124755284,0.1909115161969335,HSPB8/ACOX2,2
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,2/46,385/21728,0.1959484312286338,0.26047233736387876,0.19117062292187398,HK2/RHOB,2
WANG_SMARCE1_TARGETS_DN,WANG_SMARCE1_TARGETS_DN,2/46,385/21728,0.1959484312286338,0.26047233736387876,0.19117062292187398,HK2/LAP3,2
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,1/46,103/21728,0.19652188763867817,0.26047233736387876,0.19117062292187398,CD44,1
DER_IFN_BETA_RESPONSE_UP,DER_IFN_BETA_RESPONSE_UP,1/46,103/21728,0.19652188763867817,0.26047233736387876,0.19117062292187398,GBP1,1
HUMMERICH_SKIN_CANCER_PROGRESSION_DN,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,1/46,103/21728,0.19652188763867817,0.26047233736387876,0.19117062292187398,AEBP1,1
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,1/46,103/21728,0.19652188763867817,0.26047233736387876,0.19117062292187398,ABCC3,1
CADWELL_ATG16L1_TARGETS_UP,CADWELL_ATG16L1_TARGETS_UP,1/46,104/21728,0.19823102027075312,0.2622947701258853,0.19250817611417062,CA3,1
HAN_SATB1_TARGETS_DN,HAN_SATB1_TARGETS_DN,2/46,388/21728,0.19825866762618644,0.2622947701258853,0.19250817611417062,AMFR/TGFB2,2
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,2/46,389/21728,0.1990295494780507,0.2630744686339204,0.19308042670700076,AEBP1/SREBF1,2
GHANDHI_DIRECT_IRRADIATION_UP,GHANDHI_DIRECT_IRRADIATION_UP,1/46,105/21728,0.1999365961617795,0.2630744686339204,0.19308042670700076,CDKN1A,1
LEIN_CHOROID_PLEXUS_MARKERS,LEIN_CHOROID_PLEXUS_MARKERS,1/46,105/21728,0.1999365961617795,0.2630744686339204,0.19308042670700076,TCN2,1
REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,1/46,105/21728,0.1999365961617795,0.2630744686339204,0.19308042670700076,EGF,1
STEIN_ESRRA_TARGETS_DN,STEIN_ESRRA_TARGETS_DN,1/46,105/21728,0.1999365961617795,0.2630744686339204,0.19308042670700076,RGS19,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,1/46,105/21728,0.1999365961617795,0.2630744686339204,0.19308042670700076,RHOB,1
BROWNE_HCMV_INFECTION_8HR_UP,BROWNE_HCMV_INFECTION_8HR_UP,1/46,106/21728,0.201638622549263,0.26459366759858044,0.19419542500338643,RHOB,1
ROESSLER_LIVER_CANCER_METASTASIS_UP,ROESSLER_LIVER_CANCER_METASTASIS_UP,1/46,106/21728,0.201638622549263,0.26459366759858044,0.19419542500338643,GYS1,1
WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY,1/46,106/21728,0.201638622549263,0.26459366759858044,0.19419542500338643,CD44,1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,1/46,107/21728,0.20333710665631755,0.2661000041982495,0.1953009831175537,KCNE4,1
SERVITJA_ISLET_HNF1A_TARGETS_DN,SERVITJA_ISLET_HNF1A_TARGETS_DN,1/46,107/21728,0.20333710665631755,0.2661000041982495,0.1953009831175537,MTMR11,1
ZHU_CMV_ALL_UP,ZHU_CMV_ALL_UP,1/46,107/21728,0.20333710665631755,0.2661000041982495,0.1953009831175537,GBP1,1
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,1/46,108/21728,0.20503205569169103,0.2678346673450018,0.19657411882816464,GNAI2,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,1/46,108/21728,0.20503205569169103,0.2678346673450018,0.19657411882816464,CCR10,1
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,1/46,109/21728,0.20672347684979364,0.2695584904965835,0.19783929865121294,RASSF8,1
WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,1/46,109/21728,0.20672347684979364,0.2695584904965835,0.19783929865121294,TGFB2,1
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,2/46,400/21728,0.20753411528166976,0.27005942546966366,0.19820695401076588,GNAI2/AEBP1,2
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,2/46,401/21728,0.20830939117988811,0.27005942546966366,0.19820695401076588,ACTR3/CD44,2
BRUECKNER_TARGETS_OF_MIRLET7A3_UP,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,1/46,110/21728,0.20841137731072668,0.27005942546966366,0.19820695401076588,ACOX2,1
LE_EGR2_TARGETS_UP,LE_EGR2_TARGETS_UP,1/46,110/21728,0.20841137731072668,0.27005942546966366,0.19820695401076588,CD44,1
LEE_EARLY_T_LYMPHOCYTE_UP,LEE_EARLY_T_LYMPHOCYTE_UP,1/46,110/21728,0.20841137731072668,0.27005942546966366,0.19820695401076588,AEBP1,1
REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,1/46,110/21728,0.20841137731072668,0.27005942546966366,0.19820695401076588,CDKN1A,1
WOOD_EBV_EBNA1_TARGETS_UP,WOOD_EBV_EBNA1_TARGETS_UP,1/46,110/21728,0.20841137731072668,0.27005942546966366,0.19820695401076588,CD44,1
REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,1/46,111/21728,0.21009576424030885,0.27199898048968557,0.19963046771330098,CDKN1A,1
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,1/46,112/21728,0.21177664479010505,0.2734426847245346,0.20069005753648234,AEBP1,1
MARKEY_RB1_CHRONIC_LOF_UP,MARKEY_RB1_CHRONIC_LOF_UP,1/46,112/21728,0.21177664479010505,0.2734426847245346,0.20069005753648234,CDKN1A,1
PASINI_SUZ12_TARGETS_UP,PASINI_SUZ12_TARGETS_UP,1/46,112/21728,0.21177664479010505,0.2734426847245346,0.20069005753648234,PLEKHA4,1
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,2/46,407/21728,0.21296790962585577,0.27449197240665857,0.20146016994782703,HK2/RHOB,2
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,2/46,407/21728,0.21296790962585577,0.27449197240665857,0.20146016994782703,GNAI2/SCARA3,2
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1/46,113/21728,0.213454026097454,0.2746302908973454,0.201561687184912,EGF,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,1/46,113/21728,0.213454026097454,0.2746302908973454,0.201561687184912,CDKN1A,1
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,2/46,408/21728,0.21374542923189016,0.27476141168992974,0.2016579217557306,RETREG1/CDKN1A,2
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,2/46,409/21728,0.21452325062582406,0.2755170180756819,0.20221249021743332,SREBF1/PACRG,2
MATZUK_SPERMATOZOA,MATZUK_SPERMATOZOA,1/46,114/21728,0.21512791528549535,0.27554014589901865,0.20222946461263733,PACRG,1
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SMIRNOV_RESPONSE_TO_IR_6HR_DN,1/46,114/21728,0.21512791528549535,0.27554014589901865,0.20222946461263733,HK2,1
WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,1/46,114/21728,0.21512791528549535,0.27554014589901865,0.20222946461263733,CDKN1A,1
MOHANKUMAR_HOXA1_TARGETS_UP,MOHANKUMAR_HOXA1_TARGETS_UP,2/46,410/21728,0.2153013691748884,0.27554014589901865,0.20222946461263733,HSPB8/RHOB,2
DAZARD_RESPONSE_TO_UV_SCC_DN,DAZARD_RESPONSE_TO_UV_SCC_DN,1/46,115/21728,0.21679831946319827,0.2763135280992506,0.2027970794252939,TIPARP,1
KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,1/46,115/21728,0.21679831946319827,0.2763135280992506,0.2027970794252939,KCNMB1,1
LAIHO_COLORECTAL_CANCER_SERRATED_UP,LAIHO_COLORECTAL_CANCER_SERRATED_UP,1/46,115/21728,0.21679831946319827,0.2763135280992506,0.2027970794252939,GBP1,1
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,1/46,115/21728,0.21679831946319827,0.2763135280992506,0.2027970794252939,ACOX2,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,2/46,412/21728,0.21685847929444632,0.2763135280992506,0.2027970794252939,HK2/ABCC3,2
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,1/46,116/21728,0.21846524572538728,0.27738581987899436,0.20358407542480095,GNAI2,1
REACTOME_PARASITE_INFECTION,REACTOME_PARASITE_INFECTION,1/46,116/21728,0.21846524572538728,0.27738581987899436,0.20358407542480095,ACTR3,1
RICKMAN_HEAD_AND_NECK_CANCER_C,RICKMAN_HEAD_AND_NECK_CANCER_C,1/46,116/21728,0.21846524572538728,0.27738581987899436,0.20358407542480095,AMFR,1
SENESE_HDAC2_TARGETS_UP,SENESE_HDAC2_TARGETS_UP,1/46,116/21728,0.21846524572538728,0.27738581987899436,0.20358407542480095,TGFB2,1
FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,1/46,118/21728,0.221788692811972,0.280867776923458,0.20613961703783376,AEBP1,1
FOROUTAN_INTEGRATED_TGFB_EMT_UP,FOROUTAN_INTEGRATED_TGFB_EMT_UP,1/46,118/21728,0.221788692811972,0.280867776923458,0.20613961703783376,SLC22A4,1
WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,1/46,118/21728,0.221788692811972,0.280867776923458,0.20613961703783376,EGF,1
TSENG_IRS1_TARGETS_UP,TSENG_IRS1_TARGETS_UP,1/46,119/21728,0.22344522775554654,0.28247217109463163,0.20731714335874596,ACTR3,1
WP_SPINAL_CORD_INJURY,WP_SPINAL_CORD_INJURY,1/46,119/21728,0.22344522775554654,0.28247217109463163,0.20731714335874596,RHOB,1
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,2/46,422/21728,0.22466030718148072,0.2835730268305218,0.2081251035394973,HK2/ABCC3,2
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,1/46,120/21728,0.2250983130220211,0.2835730268305218,0.2081251035394973,PYGL,1
REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,1/46,120/21728,0.2250983130220211,0.2835730268305218,0.2081251035394973,SREBF1,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1/46,120/21728,0.2250983130220211,0.2835730268305218,0.2081251035394973,CDKN1A,1
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,2/46,423/21728,0.22544187502898422,0.283759304506968,0.20826181985956055,CA3/RHOB,2
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,1/46,121/21728,0.2267479556359132,0.2851557117710964,0.2092866966247394,MTMR11,1
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,1/46,122/21728,0.2283941626077628,0.2869770674014351,0.21062345926885725,PFKFB3,1
REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1/46,123/21728,0.2300369409341556,0.28829175830123216,0.21158836126500596,TCN2,1
TOOKER_GEMCITABINE_RESISTANCE_DN,TOOKER_GEMCITABINE_RESISTANCE_DN,1/46,123/21728,0.2300369409341556,0.28829175830123216,0.21158836126500596,RHOB,1
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,1/46,123/21728,0.2300369409341556,0.28829175830123216,0.21158836126500596,CD44,1
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,2/46,430/21728,0.2309191609586292,0.2891474813385253,0.2122164091711427,LAP3/SCARA3,2
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,1/46,124/21728,0.2316762975977532,0.28959537199719154,0.2125451332770676,CD44,1
YAGI_AML_SURVIVAL,YAGI_AML_SURVIVAL,1/46,124/21728,0.2316762975977532,0.28959537199719154,0.2125451332770676,SLC22A4,1
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,2/46,432/21728,0.23248599865518277,0.2903571903962231,0.21310426097319896,EGF/CDKN1A,2
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,2/46,433/21728,0.2332697125943636,0.29038862435417423,0.21312733155867156,AMFR/GYS1,2
MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,1/46,125/21728,0.23331223956731928,0.29038862435417423,0.21312733155867156,TGFB2,1
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,1/46,125/21728,0.23331223956731928,0.29038862435417423,0.21312733155867156,CDKN1A,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,1/46,125/21728,0.23331223956731928,0.29038862435417423,0.21312733155867156,RETREG1,1
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,2/46,434/21728,0.23405361761804147,0.2910615313431905,0.21362120376621824,HSPB8/KCNE4,2
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,1/46,126/21728,0.2349447737977457,0.29117087351002674,0.21370145416960945,PFKFB3,1
CHEBOTAEV_GR_TARGETS_DN,CHEBOTAEV_GR_TARGETS_DN,1/46,126/21728,0.2349447737977457,0.29117087351002674,0.21370145416960945,TGFB2,1
INGRAM_SHH_TARGETS_UP,INGRAM_SHH_TARGETS_UP,1/46,126/21728,0.2349447737977457,0.29117087351002674,0.21370145416960945,RASSF8,1
WIERENGA_STAT5A_TARGETS_GROUP1,WIERENGA_STAT5A_TARGETS_GROUP1,1/46,126/21728,0.2349447737977457,0.29117087351002674,0.21370145416960945,PLEKHA4,1
KIM_WT1_TARGETS_8HR_DN,KIM_WT1_TARGETS_8HR_DN,1/46,127/21728,0.23657390723008076,0.2926895609928474,0.21481607706988654,TGFB2,1
REACTOME_CARDIAC_CONDUCTION,REACTOME_CARDIAC_CONDUCTION,1/46,127/21728,0.23657390723008076,0.2926895609928474,0.21481607706988654,KCNE4,1
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/46,128/21728,0.23819964679155547,0.2944496912598086,0.21610790407525696,FNDC4,1
KEGG_AXON_GUIDANCE,KEGG_AXON_GUIDANCE,1/46,129/21728,0.23982199939561066,0.2959505524456472,0.2172094435735385,GNAI2,1
PID_PDGFRB_PATHWAY,PID_PDGFRB_PATHWAY,1/46,129/21728,0.23982199939561066,0.2959505524456472,0.2172094435735385,ACTR3,1
LENAOUR_DENDRITIC_CELL_MATURATION_DN,LENAOUR_DENDRITIC_CELL_MATURATION_DN,1/46,130/21728,0.24144097194192293,0.29769507594879957,0.21848981617730404,CD44,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,1/46,131/21728,0.2430565713164332,0.2986712105159561,0.21920623871624798,PYGL,1
SANSOM_APC_TARGETS_UP,SANSOM_APC_TARGETS_UP,1/46,131/21728,0.2430565713164332,0.2986712105159561,0.21920623871624798,CD44,1
WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,1/46,131/21728,0.2430565713164332,0.2986712105159561,0.21920623871624798,SREBF1,1
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,1/46,131/21728,0.2430565713164332,0.2986712105159561,0.21920623871624798,RHOB,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,1/46,132/21728,0.2446688043913715,0.2998899123985534,0.2201006906968693,TIPARP,1
KEGG_TIGHT_JUNCTION,KEGG_TIGHT_JUNCTION,1/46,132/21728,0.2446688043913715,0.2998899123985534,0.2201006906968693,GNAI2,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_5,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,1/46,132/21728,0.2446688043913715,0.2998899123985534,0.2201006906968693,KCNJ8,1
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,2/46,449/21728,0.24583229742600746,0.3005914420342286,0.22061557016087482,PLEKHA4/RETSAT,2
REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,1/46,133/21728,0.24627767802528522,0.3005914420342286,0.22061557016087482,GNAI2,1
WHITFIELD_CELL_CYCLE_G1_S,WHITFIELD_CELL_CYCLE_G1_S,1/46,133/21728,0.24627767802528522,0.3005914420342286,0.22061557016087482,HSPB8,1
WP_TGFBETA_SIGNALING_PATHWAY,WP_TGFBETA_SIGNALING_PATHWAY,1/46,133/21728,0.24627767802528522,0.3005914420342286,0.22061557016087482,CDKN1A,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,1/46,133/21728,0.24627767802528522,0.3005914420342286,0.22061557016087482,LAP3,1
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,2/46,451/21728,0.24740522006877683,0.30171368301070345,0.2214392257886179,CD44/RASSF8,2
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,1/46,134/21728,0.2478831990630641,0.30204255348020415,0.22168059641995383,PRUNE2,1
SERVITJA_LIVER_HNF1A_TARGETS_UP,SERVITJA_LIVER_HNF1A_TARGETS_UP,1/46,135/21728,0.2494853743359685,0.3037395405433706,0.22292608021005272,ABCC3,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,2/46,454/21728,0.24976547712134498,0.30382545455197163,0.22298913579095708,CD44/KCNE4,2
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,1/46,136/21728,0.251084210661655,0.305173600552724,0.2239785917668268,CDKN1A,1
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,2/46,456/21728,0.25133951824587636,0.30522805817129034,0.22401856029849335,SH3BP2/SREBF1,2
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,1/46,137/21728,0.25267971484420215,0.30608653844953476,0.22464863184935002,GBP1,1
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,1/46,137/21728,0.25267971484420215,0.30608653844953476,0.22464863184935002,SH3BP2,1
PID_P53_DOWNSTREAM_PATHWAY,PID_P53_DOWNSTREAM_PATHWAY,1/46,137/21728,0.25267971484420215,0.30608653844953476,0.22464863184935002,CDKN1A,1
CHUNG_BLISTER_CYTOTOXICITY_UP,CHUNG_BLISTER_CYTOTOXICITY_UP,1/46,138/21728,0.25427189367413894,0.3072452048562512,0.22549902149522322,CDKN1A,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,1/46,138/21728,0.25427189367413894,0.3072452048562512,0.22549902149522322,TIPARP,1
RIEGE_DELTANP63_DIRECT_TARGETS_UP,RIEGE_DELTANP63_DIRECT_TARGETS_UP,1/46,138/21728,0.25427189367413894,0.3072452048562512,0.22549902149522322,CD44,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1/46,139/21728,0.2558607539284692,0.30876520962573506,0.2266146112026266,HSPB8,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,2/46,463/21728,0.2568515555074271,0.30876520962573506,0.2266146112026266,GNAI2/RHOB,2
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,1/46,140/21728,0.2574463023706991,0.30876520962573506,0.2266146112026266,AEBP1,1
HOLLERN_EMT_BREAST_TUMOR_UP,HOLLERN_EMT_BREAST_TUMOR_UP,1/46,140/21728,0.2574463023706991,0.30876520962573506,0.2266146112026266,SCARA3,1
ONDER_CDH1_TARGETS_1_UP,ONDER_CDH1_TARGETS_1_UP,1/46,140/21728,0.2574463023706991,0.30876520962573506,0.2266146112026266,CD44,1
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1/46,140/21728,0.2574463023706991,0.30876520962573506,0.2266146112026266,CD44,1
REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,1/46,140/21728,0.2574463023706991,0.30876520962573506,0.2266146112026266,RHOB,1
SABATES_COLORECTAL_ADENOMA_UP,SABATES_COLORECTAL_ADENOMA_UP,1/46,140/21728,0.2574463023706991,0.30876520962573506,0.2266146112026266,CD44,1
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,1/46,140/21728,0.2574463023706991,0.30876520962573506,0.2266146112026266,ABCC3,1
BOYLAN_MULTIPLE_MYELOMA_C_D_UP,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,1/46,141/21728,0.2590285457508614,0.3103730470383877,0.2277946646503158,CDKN1A,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,2/46,466/21728,0.2592150068713707,0.3103730470383877,0.2277946646503158,TIPARP/TGFB2,2
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,1/46,142/21728,0.26060749080554524,0.31178288916505004,0.22882940177558295,CD44,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/46,143/21728,0.2621831442579192,0.312636150636499,0.22945564304428348,FNDC4,1
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,1/46,143/21728,0.2621831442579192,0.312636150636499,0.22945564304428348,CDKN1A,1
REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,1/46,143/21728,0.2621831442579192,0.312636150636499,0.22945564304428348,ACTR3,1
RUIZ_TNC_TARGETS_DN,RUIZ_TNC_TARGETS_DN,1/46,143/21728,0.2621831442579192,0.312636150636499,0.22945564304428348,CD44,1
REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,1/46,144/21728,0.2637555128177588,0.31373707431152603,0.230263653088169,GNAI2,1
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,1/46,144/21728,0.2637555128177588,0.31373707431152603,0.230263653088169,TGFB2,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,1/46,144/21728,0.2637555128177588,0.31373707431152603,0.230263653088169,RGS19,1
JOHNSTONE_PARVB_TARGETS_2_UP,JOHNSTONE_PARVB_TARGETS_2_UP,1/46,145/21728,0.26532460318147155,0.3150865475947041,0.231254083207438,GNAI2,1
KIM_ALL_DISORDERS_DURATION_CORR_DN,KIM_ALL_DISORDERS_DURATION_CORR_DN,1/46,145/21728,0.26532460318147155,0.3150865475947041,0.231254083207438,FNDC4,1
BASSO_B_LYMPHOCYTE_NETWORK,BASSO_B_LYMPHOCYTE_NETWORK,1/46,146/21728,0.2668904220321252,0.3156534355192345,0.23167014396366323,CD44,1
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,1/46,146/21728,0.2668904220321252,0.3156534355192345,0.23167014396366323,CD44,1
KAUFFMANN_DNA_REPLICATION_GENES,KAUFFMANN_DNA_REPLICATION_GENES,1/46,146/21728,0.2668904220321252,0.3156534355192345,0.23167014396366323,EGF,1
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,1/46,146/21728,0.2668904220321252,0.3156534355192345,0.23167014396366323,CD44,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,1/46,146/21728,0.2668904220321252,0.3156534355192345,0.23167014396366323,KCNE4,1
KAAB_FAILED_HEART_ATRIUM_DN,KAAB_FAILED_HEART_ATRIUM_DN,1/46,147/21728,0.26845297603947016,0.3169843772453027,0.2326469730635216,ACOX2,1
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,1/46,147/21728,0.26845297603947016,0.3169843772453027,0.2326469730635216,RHOB,1
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,1/46,148/21728,0.2700122718599688,0.31779041736765806,0.23323855677582744,CD44,1
RODWELL_AGING_KIDNEY_DN,RODWELL_AGING_KIDNEY_DN,1/46,148/21728,0.2700122718599688,0.31779041736765806,0.23323855677582744,EGF,1
RODWELL_AGING_KIDNEY_NO_BLOOD_DN,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,1/46,148/21728,0.2700122718599688,0.31779041736765806,0.23323855677582744,EGF,1
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,1/46,148/21728,0.2700122718599688,0.31779041736765806,0.23323855677582744,CHI3L2,1
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,1/46,149/21728,0.2715683161368202,0.31910377503921333,0.23420248026471482,RGS19,1
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1/46,149/21728,0.2715683161368202,0.31910377503921333,0.23420248026471482,CDKN1A,1
DARWICHE_PAPILLOMA_RISK_HIGH_UP,DARWICHE_PAPILLOMA_RISK_HIGH_UP,1/46,150/21728,0.2731211154999832,0.3194483096108055,0.23445534738041696,PLEKHA4,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,1/46,150/21728,0.2731211154999832,0.3194483096108055,0.23445534738041696,PLEKHA4,1
TSAI_RESPONSE_TO_IONIZING_RADIATION,TSAI_RESPONSE_TO_IONIZING_RADIATION,1/46,150/21728,0.2731211154999832,0.3194483096108055,0.23445534738041696,CDKN1A,1
WHITFIELD_CELL_CYCLE_S,WHITFIELD_CELL_CYCLE_S,1/46,150/21728,0.2731211154999832,0.3194483096108055,0.23445534738041696,HSPB8,1
WP_REGULATION_OF_ACTIN_CYTOSKELETON,WP_REGULATION_OF_ACTIN_CYTOSKELETON,1/46,150/21728,0.2731211154999832,0.3194483096108055,0.23445534738041696,EGF,1
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,2/46,484/21728,0.27340369119104113,0.3194483096108055,0.23445534738041696,FNDC4/PACRG,2
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,2/46,484/21728,0.27340369119104113,0.3194483096108055,0.23445534738041696,HK2/CCR10,2
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,2/46,485/21728,0.2741921026027442,0.3201115529581152,0.23494212707125547,CD44/KCNJ8,2
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,1/46,151/21728,0.27467067656620814,0.3201547275088439,0.23497381452736202,RETREG1,1
SMID_BREAST_CANCER_ERBB2_UP,SMID_BREAST_CANCER_ERBB2_UP,1/46,151/21728,0.27467067656620814,0.3201547275088439,0.23497381452736202,ABCC3,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,1/46,152/21728,0.2762170059390572,0.32118256504541537,0.2357281838554736,RETREG1,1
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,1/46,152/21728,0.2762170059390572,0.32118256504541537,0.2357281838554736,CDKN1A,1
LANDIS_ERBB2_BREAST_TUMORS_324_DN,LANDIS_ERBB2_BREAST_TUMORS_324_DN,1/46,152/21728,0.2762170059390572,0.32118256504541537,0.2357281838554736,HSPB8,1
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,1/46,154/21728,0.2792999959530973,0.32450720683653134,0.23816826577984254,CDKN1A,1
MEISSNER_NPC_HCP_WITH_H3K4ME2,MEISSNER_NPC_HCP_WITH_H3K4ME2,2/46,493/21728,0.2804988398664744,0.325510128790395,0.23890434860768733,AEBP1/KCNJ8,2
BIDUS_METASTASIS_DN,BIDUS_METASTASIS_DN,1/46,155/21728,0.2808366697357132,0.325510128790395,0.23890434860768733,CCR10,1
DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/46,155/21728,0.2808366697357132,0.325510128790395,0.23890434860768733,MTMR11,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,1/46,156/21728,0.2823701381078526,0.32702611841564394,0.24001699144698083,GBP1,1
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,2/46,496/21728,0.28286338977008985,0.32733592591111754,0.24024437103168045,ACTR3/CD44,2
BROWNE_HCMV_INFECTION_14HR_UP,BROWNE_HCMV_INFECTION_14HR_UP,1/46,157/21728,0.28390040760752977,0.3282739960374148,0.24093285661983765,RGS19,1
WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,1/46,158/21728,0.28542748475972757,0.3297767752204024,0.24203580380967463,RGS19,1
SENGUPTA_EBNA1_ANTICORRELATED,SENGUPTA_EBNA1_ANTICORRELATED,1/46,160/21728,0.28847208805659874,0.3327641429451616,0.24422834738116764,SREBF1,1
WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,1/46,160/21728,0.28847208805659874,0.3327641429451616,0.24422834738116764,SREBF1,1
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,1/46,161/21728,0.2899896271863003,0.33424877537371656,0.24531797597301447,GYS1,1
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,1/46,162/21728,0.29150399993862675,0.33492931847148083,0.24581745261318844,TGFB2,1
REACTOME_S_PHASE,REACTOME_S_PHASE,1/46,162/21728,0.29150399993862675,0.33492931847148083,0.24581745261318844,CDKN1A,1
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,1/46,162/21728,0.29150399993862675,0.33492931847148083,0.24581745261318844,HK2,1
WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,1/46,162/21728,0.29150399993862675,0.33492931847148083,0.24581745261318844,KCNJ8,1
WP_EGFEGFR_SIGNALING_PATHWAY,WP_EGFEGFR_SIGNALING_PATHWAY,1/46,163/21728,0.29301521277377585,0.336399096216924,0.24689617878425418,EGF,1
AMIT_EGF_RESPONSE_480_HELA,AMIT_EGF_RESPONSE_480_HELA,1/46,164/21728,0.29452327213906226,0.3375958455348935,0.24777451893704344,CD44,1
WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,1/46,164/21728,0.29452327213906226,0.3375958455348935,0.24777451893704344,TGFB2,1
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,1/46,166/21728,0.2975299561850534,0.34077285661005324,0.2501062490255999,TGFB2,1
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,1/46,167/21728,0.2990285936962067,0.34221899041791615,0.2511676220054542,AMFR,1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,1/46,168/21728,0.3005241033984458,0.3436592665045319,0.2522246957793697,CDKN1A,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,1/46,170/21728,0.303505764896583,0.3467953972419585,0.2545264222225917,AEBP1,1
BROWNE_HCMV_INFECTION_18HR_UP,BROWNE_HCMV_INFECTION_18HR_UP,1/46,173/21728,0.30795495774576176,0.3513254828728203,0.2578512255422296,RETREG1,1
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1/46,173/21728,0.30795495774576176,0.3513254828728203,0.2578512255422296,CD44,1
KATSANOU_ELAVL1_TARGETS_UP,KATSANOU_ELAVL1_TARGETS_UP,1/46,174/21728,0.3094318341987282,0.3527328298649024,0.25888413139267974,KCNMB1,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,1/46,175/21728,0.3109056272592673,0.353856483144378,0.2597088235636778,CHI3L2,1
VILLANUEVA_LIVER_CANCER_KRT19_UP,VILLANUEVA_LIVER_CANCER_KRT19_UP,1/46,175/21728,0.3109056272592673,0.353856483144378,0.2597088235636778,HK2,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,1/46,176/21728,0.31237634322205987,0.3546951430477579,0.2603243481824198,HK2,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,1/46,176/21728,0.31237634322205987,0.3546951430477579,0.2603243481824198,CD44,1
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,1/46,176/21728,0.31237634322205987,0.3546951430477579,0.2603243481824198,LAP3,1
REACTOME_FATTY_ACID_METABOLISM,REACTOME_FATTY_ACID_METABOLISM,1/46,177/21728,0.31384398836922867,0.35608277240640185,0.26134278250662235,ACOX2,1
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,1/46,179/21728,0.3167700912825365,0.3585609932550179,0.26316164368843786,HK2,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,1/46,179/21728,0.3167700912825365,0.3585609932550179,0.26316164368843786,SCARA3,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,1/46,179/21728,0.3167700912825365,0.3585609932550179,0.26316164368843786,FNDC4,1
LEE_LIVER_CANCER_SURVIVAL_DN,LEE_LIVER_CANCER_SURVIVAL_DN,1/46,180/21728,0.31822856155034485,0.359930900349454,0.26416707096428166,ACTR3,1
KEGG_ENDOCYTOSIS,KEGG_ENDOCYTOSIS,1/46,181/21728,0.3196839860059175,0.3612952297027127,0.26516840452228135,EGF,1
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,1/46,182/21728,0.32113637086894853,0.36208999825814575,0.26575171559998934,KCNMB1,1
DARWICHE_PAPILLOMA_RISK_HIGH_DN,DARWICHE_PAPILLOMA_RISK_HIGH_DN,1/46,182/21728,0.32113637086894853,0.36208999825814575,0.26575171559998934,CA3,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,1/46,182/21728,0.32113637086894853,0.36208999825814575,0.26575171559998934,CA3,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,1/46,183/21728,0.32258572234671845,0.36315939239343303,0.26653658490726734,SCARA3,1
LI_AMPLIFIED_IN_LUNG_CANCER,LI_AMPLIFIED_IN_LUNG_CANCER,1/46,183/21728,0.32258572234671845,0.36315939239343303,0.26653658490726734,ABCC3,1
DOANE_RESPONSE_TO_ANDROGEN_UP,DOANE_RESPONSE_TO_ANDROGEN_UP,1/46,184/21728,0.3240320466341192,0.36450462965048325,0.2675239060447467,MICALL2,1
FOROUTAN_PRODRANK_TGFB_EMT_UP,FOROUTAN_PRODRANK_TGFB_EMT_UP,1/46,185/21728,0.32547534991367866,0.36556100493790394,0.26829922032103154,SLC22A4,1
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,1/46,185/21728,0.32547534991367866,0.36556100493790394,0.26829922032103154,ABCC3,1
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,1/46,186/21728,0.32691563835558446,0.36661073133456884,0.2690696547217779,AMFR,1
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,1/46,186/21728,0.32691563835558446,0.36661073133456884,0.2690696547217779,CDKN1A,1
FOROUTAN_TGFB_EMT_UP,FOROUTAN_TGFB_EMT_UP,1/46,192/21728,0.3354944013979385,0.37594040342118307,0.2759170583367086,SLC22A4,1
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,1/46,193/21728,0.3369137577099601,0.37723934260960784,0.276870399548685,MTMR11,1
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,1/46,194/21728,0.33833014810444995,0.37824110620775053,0.277605632214908,CDKN1A,1
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1/46,194/21728,0.33833014810444995,0.37824110620775053,0.277605632214908,CD44,1
PLASARI_TGFB1_TARGETS_10HR_UP,PLASARI_TGFB1_TARGETS_10HR_UP,1/46,195/21728,0.33974357864160953,0.37923648116268965,0.27833617601123717,HK2,1
REACTOME_MUSCLE_CONTRACTION,REACTOME_MUSCLE_CONTRACTION,1/46,195/21728,0.33974357864160953,0.37923648116268965,0.27833617601123717,KCNE4,1
NABA_ECM_GLYCOPROTEINS,NABA_ECM_GLYCOPROTEINS,1/46,196/21728,0.34115405536953847,0.3802255036785786,0.2790620575092871,AEBP1,1
REACTOME_CELLULAR_SENESCENCE,REACTOME_CELLULAR_SENESCENCE,1/46,196/21728,0.34115405536953847,0.3802255036785786,0.2790620575092871,CDKN1A,1
RAMALHO_STEMNESS_UP,RAMALHO_STEMNESS_UP,1/46,197/21728,0.3425615843242569,0.38150099636726,0.2799981904372413,CDKN1A,1
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,1/46,198/21728,0.34396617152973197,0.3827712576501238,0.28093048383613445,CCR10,1
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,1/46,199/21728,0.3453678229978989,0.38374202555322107,0.2816429675748141,EGF,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,1/46,199/21728,0.3453678229978989,0.38374202555322107,0.2816429675748141,TGFB2,1
FISCHER_G1_S_CELL_CYCLE,FISCHER_G1_S_CELL_CYCLE,1/46,200/21728,0.34676654472868496,0.3841187852227603,0.28191948592392785,HSPB8,1
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,1/46,200/21728,0.34676654472868496,0.3841187852227603,0.28191948592392785,AEBP1,1
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,1/46,200/21728,0.34676654472868496,0.3841187852227603,0.28191948592392785,GBP1,1
REACTOME_MITOTIC_G2_G2_M_PHASES,REACTOME_MITOTIC_G2_G2_M_PHASES,1/46,200/21728,0.34676654472868496,0.3841187852227603,0.28191948592392785,CDKN1A,1
WELCSH_BRCA1_TARGETS_UP,WELCSH_BRCA1_TARGETS_UP,1/46,201/21728,0.3481623427100339,0.38507658041918313,0.2826224484964023,CDKN1A,1
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,1/46,201/21728,0.3481623427100339,0.38507658041918313,0.2826224484964023,PLEKHA4,1
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,1/46,202/21728,0.3495552229179283,0.3863224643528933,0.2835368504252451,EGF,1
HOLLMANN_APOPTOSIS_VIA_CD40_UP,HOLLMANN_APOPTOSIS_VIA_CD40_UP,1/46,203/21728,0.35094519131641266,0.38697378510174785,0.2840148796645133,LAP3,1
REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1/46,203/21728,0.35094519131641266,0.38697378510174785,0.2840148796645133,RAB36,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,1/46,203/21728,0.35094519131641266,0.38697378510174785,0.2840148796645133,GBP1,1
REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1/46,205/21728,0.3537164164817843,0.3894372087308939,0.2858228806003149,GNAI2,1
SHEPARD_CRASH_AND_BURN_MUTANT_UP,SHEPARD_CRASH_AND_BURN_MUTANT_UP,1/46,205/21728,0.3537164164817843,0.3894372087308939,0.2858228806003149,PFKFB3,1
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,1/46,207/21728,0.35647606568064105,0.39158355699767383,0.2873981677855886,LAP3,1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1/46,207/21728,0.35647606568064105,0.39158355699767383,0.2873981677855886,CDKN1A,1
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,1/46,207/21728,0.35647606568064105,0.39158355699767383,0.2873981677855886,SREBF1,1
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,1/46,210/21728,0.3605939379259664,0.39580712338580715,0.2904980048951369,CDKN1A,1
REACTOME_PHOSPHOLIPID_METABOLISM,REACTOME_PHOSPHOLIPID_METABOLISM,1/46,211/21728,0.36196082512995387,0.39670687561483986,0.2911583675111456,PLEKHA4,1
SANSOM_APC_TARGETS,SANSOM_APC_TARGETS,1/46,211/21728,0.36196082512995387,0.39670687561483986,0.2911583675111456,CD44,1
SHEPARD_BMYB_MORPHOLINO_UP,SHEPARD_BMYB_MORPHOLINO_UP,1/46,212/21728,0.36332485366757616,0.3979010859652458,0.2920348442184127,RAB36,1
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,1/46,213/21728,0.3646860293847771,0.3990903717795674,0.2929077066200673,EGF,1
KIM_WT1_TARGETS_UP,KIM_WT1_TARGETS_UP,1/46,216/21728,0.3687524978981649,0.40232590064133866,0.2952823851530987,CD44,1
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,1/46,216/21728,0.3687524978981649,0.40232590064133866,0.2952823851530987,CD44,1
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,1/46,216/21728,0.3687524978981649,0.40232590064133866,0.2952823851530987,RGS19,1
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,1/46,216/21728,0.3687524978981649,0.40232590064133866,0.2952823851530987,PYGL,1
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,1/46,217/21728,0.3701023205597809,0.4034950111366032,0.29614044011550333,CD44,1
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,1/46,219/21728,0.3727935003626811,0.4061236480284655,0.2980696973914908,EGF,1
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,1/46,222/21728,0.3768091927358592,0.4101901872875345,0.30105428627782016,CD44,1
CHEN_HOXA5_TARGETS_9HR_UP,CHEN_HOXA5_TARGETS_9HR_UP,1/46,223/21728,0.37814215921656924,0.41071620289440103,0.30144034927494695,TIPARP,1
REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,1/46,223/21728,0.37814215921656924,0.41071620289440103,0.30144034927494695,GNAI2,1
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,1/46,223/21728,0.37814215921656924,0.41071620289440103,0.30144034927494695,CDKN1A,1
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,1/46,224/21728,0.3794723364161059,0.41154441870108716,0.30204820857117903,PYGL,1
THUM_SYSTOLIC_HEART_FAILURE_DN,THUM_SYSTOLIC_HEART_FAILURE_DN,1/46,224/21728,0.3794723364161059,0.41154441870108716,0.30204820857117903,KCNJ8,1
LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,1/46,226/21728,0.38212434578918464,0.41411083811234506,0.3039318020555941,CD44,1
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,1/46,229/21728,0.38608158255041614,0.4180868519029899,0.3068499508340637,RHOB,1
KAUFFMANN_DNA_REPAIR_GENES,KAUFFMANN_DNA_REPAIR_GENES,1/46,230/21728,0.3873951435161672,0.41888363765730235,0.30743474241127605,CDKN1A,1
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,1/46,230/21728,0.3873951435161672,0.41888363765730235,0.30743474241127605,RETREG1,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,1/46,235/21728,0.39392181719106245,0.42562342393967256,0.31238132965735677,CD44,1
BROWNE_HCMV_INFECTION_20HR_UP,BROWNE_HCMV_INFECTION_20HR_UP,1/46,236/21728,0.39521896493261655,0.42638950829783784,0.312943588304257,RHOB,1
FISCHER_G2_M_CELL_CYCLE,FISCHER_G2_M_CELL_CYCLE,1/46,236/21728,0.39521896493261655,0.42638950829783784,0.312943588304257,TGFB2,1
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,1/46,237/21728,0.39651339670318664,0.42683327781709024,0.3132692877481512,RAB36,1
LEE_RECENT_THYMIC_EMIGRANT,LEE_RECENT_THYMIC_EMIGRANT,1/46,237/21728,0.39651339670318664,0.42683327781709024,0.3132692877481512,CHI3L2,1
MARKEY_RB1_ACUTE_LOF_UP,MARKEY_RB1_ACUTE_LOF_UP,1/46,237/21728,0.39651339670318664,0.42683327781709024,0.3132692877481512,TIPARP,1
MULLIGHAN_MLL_SIGNATURE_1_DN,MULLIGHAN_MLL_SIGNATURE_1_DN,1/46,238/21728,0.39780511806336794,0.4279060988070352,0.3140566721552905,RHOB,1
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,1/46,240/21728,0.4003804517393278,0.4303570459762975,0.3158555161394096,CDKN1A,1
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/46,242/21728,0.40294501022311113,0.4321525627392834,0.3171733146493035,HK2,1
KAYO_AGING_MUSCLE_UP,KAYO_AGING_MUSCLE_UP,1/46,242/21728,0.40294501022311113,0.4321525627392834,0.3171733146493035,CDKN1A,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,1/46,242/21728,0.40294501022311113,0.4321525627392834,0.3171733146493035,SCARA3,1
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,1/46,243/21728,0.40422326255159224,0.43320305299320677,0.31794430967414306,CDKN1A,1
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,1/46,245/21728,0.4067717408525585,0.4352907927942508,0.31947658186205996,CDKN1A,1
REACTOME_SIGNALING_BY_NOTCH,REACTOME_SIGNALING_BY_NOTCH,1/46,245/21728,0.4067717408525585,0.4352907927942508,0.31947658186205996,EGF,1
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1/46,249/21728,0.41183674517544433,0.4403859000769869,0.3232160762089537,SLC22A4,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,1/46,250/21728,0.4130963713089666,0.44075771773215716,0.32348896742447253,CDKN1A,1
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,1/46,250/21728,0.4130963713089666,0.44075771773215716,0.32348896742447253,MTMR11,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,1/46,250/21728,0.4130963713089666,0.44075771773215716,0.32348896742447253,DDO,1
KOBAYASHI_EGFR_SIGNALING_24HR_DN,KOBAYASHI_EGFR_SIGNALING_24HR_DN,1/46,253/21728,0.41685943656210234,0.44444572280518263,0.32619573557607234,ACOX2,1
PLASARI_TGFB1_TARGETS_10HR_DN,PLASARI_TGFB1_TARGETS_10HR_DN,1/46,254/21728,0.41810853858390185,0.4451228934997487,0.32669273708039626,SCARA3,1
QI_PLASMACYTOMA_UP,QI_PLASMACYTOMA_UP,1/46,254/21728,0.41810853858390185,0.4451228934997487,0.32669273708039626,SH3BP2,1
WP_GPCRS_CLASS_A_RHODOPSINLIKE,WP_GPCRS_CLASS_A_RHODOPSINLIKE,1/46,258/21728,0.42307882460346424,0.45008385596113215,0.3303337774059562,CCR10,1
JAEGER_METASTASIS_DN,JAEGER_METASTASIS_DN,1/46,259/21728,0.42431489232904607,0.45073743141180717,0.33081346145723195,ABCC3,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,1/46,259/21728,0.42431489232904607,0.45073743141180717,0.33081346145723195,TGFB2,1
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,1/46,262/21728,0.42800757161074765,0.4543272173027702,0.33344814278990975,CA3,1
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,1/46,263/21728,0.42923330773792123,0.4552950228383217,0.33415845233360675,TIPARP,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,1/46,265/21728,0.43167707622771667,0.45721823267362244,0.3355699696791523,KCNE4,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,1/46,265/21728,0.43167707622771667,0.45721823267362244,0.3355699696791523,SH3BP2,1
CAIRO_HEPATOBLASTOMA_DN,CAIRO_HEPATOBLASTOMA_DN,1/46,267/21728,0.4341106080966638,0.4594601326570529,0.3372153859283343,RETREG1,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1/46,268/21728,0.43532354840827814,0.4600722632594776,0.33766465201838974,AEBP1,1
WANG_CLIM2_TARGETS_UP,WANG_CLIM2_TARGETS_UP,1/46,268/21728,0.43532354840827814,0.4600722632594776,0.33766465201838974,ABCC3,1
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1/46,270/21728,0.43774180391383166,0.46195459656117605,0.33904616851059816,GNAI2,1
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,1/46,270/21728,0.43774180391383166,0.46195459656117605,0.33904616851059816,ABCC3,1
MEISSNER_BRAIN_HCP_WITH_H3K27ME3,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,1/46,271/21728,0.4389471295275872,0.4625532978306696,0.33948557829895243,AEBP1,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,1/46,271/21728,0.4389471295275872,0.4625532978306696,0.33948557829895243,PYGL,1
NABA_CORE_MATRISOME,NABA_CORE_MATRISOME,1/46,275/21728,0.44374320546710055,0.46726771817523294,0.34294567192389147,AEBP1,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,1/46,279/21728,0.4484991666866782,0.471590856922178,0.3461185890005967,PRUNE2,1
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,1/46,279/21728,0.4484991666866782,0.471590856922178,0.3461185890005967,HSPB8,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,1/46,281/21728,0.45086220691900714,0.4737320290091017,0.3476900771892572,AMFR,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,1/46,287/21728,0.45789205485192774,0.480770079315927,0.3528555718246114,CA3,1
LU_EZH2_TARGETS_UP,LU_EZH2_TARGETS_UP,1/46,288/21728,0.45905510533823024,0.48164247665733273,0.35349585764106234,RGS19,1
GABRIELY_MIR21_TARGETS,GABRIELY_MIR21_TARGETS,1/46,289/21728,0.46021571472043366,0.4825110530329926,0.3541333391044323,TGFB2,1
GRADE_COLON_AND_RECTAL_CANCER_UP,GRADE_COLON_AND_RECTAL_CANCER_UP,1/46,290/21728,0.46137388800850043,0.4833758219742237,0.3547680261458731,CD44,1
REACTOME_CELL_CYCLE_CHECKPOINTS,REACTOME_CELL_CYCLE_CHECKPOINTS,1/46,292/21728,0.46368294629184714,0.4854442398001288,0.3562861171963196,CDKN1A,1
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,1/46,293/21728,0.4648338412568861,0.48629803017495293,0.356912746647461,CD44,1
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,1/46,295/21728,0.4671283876831377,0.4883461875562723,0.3584159677817722,TGFB2,1
BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,1/46,296/21728,0.46827204905422803,0.4891891002367656,0.35903461367649364,KCNE4,1
SABATES_COLORECTAL_ADENOMA_DN,SABATES_COLORECTAL_ADENOMA_DN,1/46,299/21728,0.47168864505006347,0.49240355314801443,0.361393823762354,SLC22A4,1
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,1/46,300/21728,0.4728227307436419,0.49323234502034585,0.362002105855223,TIPARP,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,1/46,304/21728,0.4773353059408959,0.4975817351648448,0.36519428983786423,GBP1,1
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,1/46,305/21728,0.47845753222575005,0.49839326273515633,0.36578990099836156,AMFR,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,1/46,307/21728,0.48069491777296247,0.5003644154851369,0.3672366054849171,CDKN1A,1
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,1/46,309/21728,0.48292291285348943,0.5023229724803154,0.36867406546468157,TCN2,1
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,1/46,313/21728,0.4873508856207768,0.5065654366667572,0.371787772392081,HSPB8,1
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,1/46,314/21728,0.48845206980295985,0.5073463475747076,0.3723609128116366,EGF,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,1/46,317/21728,0.49174175699786726,0.510032580577187,0.37433244207879207,RHOB,1
ZWANG_DOWN_BY_2ND_EGF_PULSE,ZWANG_DOWN_BY_2ND_EGF_PULSE,1/46,317/21728,0.49174175699786726,0.510032580577187,0.37433244207879207,MTMR11,1
HORIUCHI_WTAP_TARGETS_DN,HORIUCHI_WTAP_TARGETS_DN,1/46,318/21728,0.4928337134304531,0.5107997744633003,0.37489551505074153,CD44,1
LEI_MYB_TARGETS,LEI_MYB_TARGETS,1/46,323/21728,0.4982591633256541,0.5160541334444275,0.3787518903174709,CDKN1A,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,1/46,325/21728,0.5004134092106616,0.5179153771273799,0.38011792833087554,TIPARP,1
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,1/46,327/21728,0.5025586059761231,0.51976460675134,0.3814751487663192,EGF,1
REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1/46,331/21728,0.506822000681076,0.5238003570830793,0.3844371404798497,CCR10,1
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,1/46,334/21728,0.5099960681425726,0.5267053410304346,0.3865692194423008,ABCC3,1
MULLIGHAN_NPM1_SIGNATURE_3_UP,MULLIGHAN_NPM1_SIGNATURE_3_UP,1/46,335/21728,0.5110496430170908,0.5274177810496666,0.38709210645460107,SH3BP2,1
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,1/46,337/21728,0.5131501487661593,0.5292089016436209,0.3884066784476956,SH3BP2,1
BLUM_RESPONSE_TO_SALIRASIB_DN,BLUM_RESPONSE_TO_SALIRASIB_DN,1/46,341/21728,0.5173247115778468,0.5327562725766177,0.39101022981848316,PFKFB3,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,1/46,341/21728,0.5173247115778468,0.5327562725766177,0.39101022981848316,CDKN1A,1
JOHNSTONE_PARVB_TARGETS_2_DN,JOHNSTONE_PARVB_TARGETS_2_DN,1/46,342/21728,0.5183628685548616,0.533446529030908,0.3915168354629749,RASSF8,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,1/46,347/21728,0.523520976154167,0.5383726350521576,0.39513229331232763,TGFB2,1
RICKMAN_METASTASIS_UP,RICKMAN_METASTASIS_UP,1/46,351/21728,0.5276085176785539,0.5421916021501794,0.39793517950913343,RASSF8,1
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,1/46,354/21728,0.5306516426722121,0.5449326358886031,0.39994692913493846,RETSAT,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,1/46,357/21728,0.5336755874690504,0.5476501074523165,0.40194138557843334,PFKFB3,1
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,1/46,359/21728,0.53568095341116,0.5493192237950367,0.40316641397951514,SCARA3,1
KOYAMA_SEMA3B_TARGETS_DN,KOYAMA_SEMA3B_TARGETS_DN,1/46,364/21728,0.540657531744167,0.5540306862396057,0.4066243366883785,TGFB2,1
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,1/46,366/21728,0.5426335193120638,0.555270714892373,0.40753444120231513,CD44,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,1/46,366/21728,0.5426335193120638,0.555270714892373,0.40753444120231513,CDKN1A,1
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,1/46,367/21728,0.5436183923628851,0.5558862263231195,0.40798618861174146,AEBP1,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,1/46,371/21728,0.5475371795033286,0.5594988796898003,0.41063765326053575,TIPARP,1
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1/46,374/21728,0.5504546487304627,0.5620839722951908,0.4125349517171963,DDO,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,1/46,377/21728,0.5533537125575259,0.5646466454668632,0.414415795692921,RGS19,1
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,1/46,378/21728,0.554315996723249,0.5652307983464916,0.41484452786083703,PYGL,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,1/46,382/21728,0.558144892809633,0.5687351332213406,0.41741649342052667,RHOB,1
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,1/46,385/21728,0.560995428842992,0.5712383229089456,0.41925368018943293,RETREG1,1
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,1/46,386/21728,0.5619416037140612,0.5718002283406237,0.4196660841033543,RNASE3,1
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,1/46,399/21728,0.5740618185329419,0.5837234480173674,0.42841699161202057,CHI3L2,1
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,1/46,405/21728,0.5795445203257168,0.5888854621389553,0.4322055914500791,TGFB2,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,1/46,408/21728,0.5822599207578968,0.5912303116939428,0.4339265663321787,AEBP1,1
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,1/46,409/21728,0.5831612361258673,0.5917311353271573,0.43429413997514044,CD44,1
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,1/46,416/21728,0.5894173933142414,0.5976609932207342,0.4386462897612794,SH3BP2,1
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,1/46,419/21728,0.592070398137122,0.5999315704394319,0.4403127533315902,PFKFB3,1
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,1/46,423/21728,0.5955816656789674,0.6030680273983957,0.44261471920129086,RNASE3,1
PUJANA_BRCA2_PCC_NETWORK,PUJANA_BRCA2_PCC_NETWORK,1/46,425/21728,0.5973261947336528,0.6044124091861804,0.44360141247711676,CHI3L2,1
SHEN_SMARCA2_TARGETS_UP,SHEN_SMARCA2_TARGETS_UP,1/46,428/21728,0.5999291932649251,0.606622963901075,0.4452238232333842,ACTR3,1
CUI_TCF21_TARGETS_2_UP,CUI_TCF21_TARGETS_2_UP,1/46,433/21728,0.6042309899103726,0.6105469932892266,0.4481038186681729,FNDC4,1
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,1/46,437/21728,0.607639817255833,0.6131369067647585,0.45000465534604045,ACTR3,1
MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,1/46,437/21728,0.607639817255833,0.6131369067647585,0.45000465534604045,AEBP1,1
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,1/46,438/21728,0.6084875260720572,0.6135653079307948,0.45031907536699356,PRUNE2,1
GARY_CD5_TARGETS_DN,GARY_CD5_TARGETS_DN,1/46,440/21728,0.6101775720817548,0.6148418898669524,0.45125600773538216,GBP1,1
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,1/46,450/21728,0.6185213271862268,0.6228166141805755,0.45710896329332984,RHOB,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,1/46,453/21728,0.6209902055364522,0.6248687009214822,0.45861506833511323,TIPARP,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,1/46,454/21728,0.6218096861731303,0.6252593931699298,0.45890181233742217,RHOB,1
MCCABE_BOUND_BY_HOXC6,MCCABE_BOUND_BY_HOXC6,1/46,458/21728,0.6250703104064297,0.6281025295144304,0.46098849897574523,RNASE3,1
REACTOME_GPCR_LIGAND_BINDING,REACTOME_GPCR_LIGAND_BINDING,1/46,463/21728,0.6291074370353168,0.6312842793779996,0.46332370704258263,CCR10,1
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,1/46,463/21728,0.6291074370353168,0.6312842793779996,0.46332370704258263,CDKN1A,1
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,1/46,467/21728,0.6323064916893815,0.6340556106152165,0.4653576931629647,HSPB8,1
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,1/46,472/21728,0.6362673702405086,0.6375865147537924,0.4679491589227471,TGFB2,1
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,1/46,473/21728,0.6370545221490962,0.6379344317100757,0.46820450850009904,CD44,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,1/46,476/21728,0.6394059925611562,0.6398472665380789,0.46960841123048847,CDKN1A,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,1/46,483/21728,0.6448349497124835,0.6448349497124835,0.4732690629105777,TIPARP,1
